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ABSTRACT 
 
David Anthony Hubert: Regulation of the Stability of Plant Disease Resistance 
Proteins 
(Under the direction of Jeffrey L. Dangl) 
 
 
 Plants, like animals, can recognize specific pathogens by virtue of a highly-
evolved immune system.  Recognition of pathogens by plants leads to a well-defined 
series of outputs, including production of reactive oxygen species, cell wall 
thickening, and a form of programmed cell death called the Hypersensitive 
Response (HR). At the forefront of this recognition process are the disease 
Resistance (R) genes.  The proteins encoded by R genes are positive regulators of 
cell death and thus their accumulation is tightly regulated.  Here I present evidence 
implicating cytosolic HSP90 as a central figure in the maintenance of appropriate R 
protein levels.  Cytosolic HSP90 is encoded by four genes in our model plant 
system, Arabidopsis thaliana.  I present data for genetic interactions between two of 
these HSP90 paralogs.  I also demonstrate a physical interaction between HSP90 
and RAR1 and SGT1, two proteins previously identified as playing a role in R protein 
accumulation.  Consistent with the physical interaction, double mutant analyses 
uncovered a genetic interaction between HSP90 and SGT1.  Furthermore mutant 
forms of HSP90 and RAR1 reveal that changes in their ability to physically interact 
with each other and with SGT1 can explain the phenotypes of the mutants in planta.  
I also describe a genetic screen to identify new additional loci required for the 
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function of the Arabidopsis R gene, RPM1.  The phenotype of one mutant identified 
in this screen suggests that transcriptional regulation of R genes may play a more 
significant role in maintaining R protein levels than previously expected. 
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CHAPTER 1 
 
Introduction 
 
Preface 
The following chapter was published in Current Opinion in Immunology in 
February 2003 under the title “Resistance gene signaling in plants- complex 
similarities to animal innate immunity.” It is included here with several minor 
changes.  I was second author on the paper, contributing ideas to the whole 
manuscript and much of the text to the section on RAR1 and SGT1.  This review 
was published at the same time as I was working on the data in Chapter 2 and prior 
to work on the other chapters in this dissertation.  As such it provides a good 
introduction and serves as a good reference point for the contribution of the 
subsequent chapters to the field of plant disease resistance. 
 
Summary 
During the past year, several important publications have significantly 
enhanced our current understanding of plant disease resistance. Among the most 
important discoveries are the role of SGT1 in resistance (R) gene mediated 
defenses, mounting support for the so-called “guard hypothesis” of R gene function, 
and evidence for intramolecular interactions within R proteins as a mode of signaling 
control.  There are many emerging parallels between the plant R gene and animal 
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innate immunity receptor complexes. Plant SGT1 shows similarity to co-chaperones 
of the animal HSP90 complex and many receptor-like R gene products appear to 
indirectly interact with their pathogen-derived signal. Considering these and other 
similarities, researchers from both fields should be looking carefully over each 
other’s shoulders. 
 
Introduction 
Like animals, plants offer up a bountiful and concentrated supply of resources 
for would be pathogens. Until recently, research on animal immunity has focused on 
so-called “acquired immunity.” Acquired immunity is the process by which the 
circulating immune system of animals somatically generates new resistance 
specificities against non-self invaders. Underlying this level of resistance in animals 
is the more evolutionarily ancient innate immune system, which relies on preformed 
receptors to detect conserved microbial specific patterns and trigger downstream 
defense responses (Kimbrell and Beutler, 2001). Plants, on the other hand, lack the 
ability to somatically generate new resistance specificities and rely on meiotically 
formed pathogen recognition mechanisms. This does not mean that plants have a 
less active or effective response to pathogens. Triggering of R gene pathways gives 
rise to massive cellular ion influxes, an oxidative burst leading to the accumulation of 
superoxide and hydrogen peroxide, nitric oxide production, the hypersensitive 
response (HR; a form of programmed cell death thought to limit pathogen ingress), 
and the production of toxic antimicrobial metabolites (Dangl and Jones, 2001). We 
are just beginning to understand the elegant and varied defensive mechanisms 
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plants utilize to get around their biggest limitations– lack of a circulating immune 
system and immobility. 
In this review, we hope to give the reader a brief look at some of the most 
interesting recent discoveries concerning R gene mediated defense signaling. 
Additionally, we provide historical context for these discoveries and comparisons to 
the animal innate immune response. For those interested in further reading on 
broader topics in plant disease resistance, we recommend the yearly “Biotic 
Interactions” special issue in the journal Current Opinions in Plant Biology.  
 
Resistance Genes - Sentries at the Gate 
For plant pathogens from every kingdom, from viruses to bacteria, fungi and 
aphids, to utilize host plant resources they must first circumvent preformed defense 
mechanisms such as the dense epidermal layer and waxy coverings on most leaves. 
Successful pathogens avoid these early obstacles by stealth (e.g., slipping in 
through stomatal openings on leaves and stems) and brute force (e.g., fungal and 
oomycete “penetration pegs” which literally drive a growing spike through the 
epidermis). Having found their way into the plant apoplast (the space between cells), 
pathogens must interact directly with individual plant cells to gain access to nutrients 
necessary for growth and reproduction. This is achieved by the production of 
virulence factors (also called effector proteins) that are released into the apoplast or 
injected directly into plant cells. Bacterial plant pathogens use a type III secretion 
system (like those of Salmonella, Shigella, Yersinia and pathogenic E. coli) to deliver 
type III effectors directly into the host cell (Nimchuk et al., 2001). Due to the lack of a 
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circulating immune system, essentially all plant cells must be individually capable of 
recognizing pathogens and activating an effective defense system.  
The sentries at the gate are plant resistance (R) proteins, which either directly 
or indirectly (see guard hypothesis below) recognize pathogen effectors. In this role, 
pathogen effectors are called avirulence (avr) proteins. Avr genes are structurally 
diverse and are theoretically maintained in their respective genomes by virtue of 
virulence roles advantageous to the pathogen. Evidence for virulence function has 
been demonstrated for several, but not all, Avr proteins (Nimchuk et al., 2001). 
Recognition is typically “race specific,” meaning that a given R protein recognizes 
the Avr proteins from one or very few pathogen isolates. This R–avr genetic 
interaction initiates what is referred to as gene-for-gene resistance (Flor, 1971). 
Five classes of highly polymorphic, but mostly structurally conserved R 
proteins have been identified and these can be broadly grouped into those with 
extracellular or intracellular leucine rich-repeat (LRR) regions (Dangl and Jones, 
2001). Thus far, the putative intracellular class is the largest. The model plant 
species Arabidopsis thaliana is predicted to encode approximately 150 related R-like 
genes with central nucleotide binding (NB) domains and C-terminal LRRs. The 
putative encoded proteins differ structurally in their N-termini where they have either 
a region of Toll and Interleukin 1 Receptor homology (TIR) or a predicted coiled-coil 
motif (CC). Loss of function mutations in genes of this NB-LRR class only give loss 
of disease resistance phenotypes, suggesting that it is a gene family dedicated to R 
function. In contrast, there is another class of extracellular LRR proteins that are 
multifunctional (Dangl and Jones, 2001).  
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Although no plant resistance gene has been crystallized, the three 
dimensional structure has been solved for LRR containing proteins from numerous 
other species (Kobe and Kajava, 2001). LRRs are fairly uniform in structure across 
kingdoms and typically consist of a ligand binding face composed of repeating β 
strands backed by α helices. The LRR is under diversifying selection in plant R 
genes (Michelmore and Meyers, 1998) and potentially provides an evolutionarily 
flexible interface for ligand binding. In mammalian ribonuclease inhibitor, which is 
essentially one large LRR, the β strands flexibly combine to efficiently bind and 
inhibit a wide variety of ribonucleases with sequence identities as low as 24% (Kobe 
and Deisenhofer, 1996). In vitro generated (Thomas et al., 1997) and naturally 
occurring recombination events (Dodds et al., 2001) between the LRRs of highly 
related R genes can result in reversals of Avr recognition specificities. These data 
strongly implicate the LRR as the pathogen recognition specificity determinant, but 
what do R proteins recognize? 
 
Guard Hypothesis – Gone Fishing 
Almost every lab studying R-avr genetic interactions has tried their hand at 
proving a physical interaction with their favorite R-Avr combination. With the 
exception of the in vitro interaction between Pi-ta (a CC-NB-LRR R protein) from rice 
and its corresponding avirulence protein AvrPita (Bryan et al., 2000) from the fungal 
pathogen Magnaporthe grisea, no direct interaction between a pathogen avirulence 
product and an NB-LRR type R protein has been demonstrated. Pto, from tomato, 
encodes a serine/threonine kinase that can phosphorylate a variety of targets, some 
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with defense functions. It is probably an atypical R gene. Pto requires the NB-LRR 
type protein Prf to trigger defense responses against Pseudomonas syringae 
bacterial strains expressing avrPto (Salmeron et al., 1996). Yeast two-hybrid and 
genetic data strongly suggest a physical interaction between Pto and AvrPto, but 
AvrPto does not appear to interact with Prf. The Prf/Pto-avrPto genetic and Pto-
AvrPto physical interactions may have been the Rosetta Stone for R-avr interactions 
all along.  
The “guard hypothesis” suggests that the NB-LRR protein Prf detects and 
potentially “guards” or monitors, the Pto-AvrPto physical interaction (Dangl and 
Jones, 2001; van der Biezen and Jones, 1998). If AvrPto functions as a virulence 
factor targeting the Pto kinase and altering its ability to activate defenses, then Prf 
might be activated as a consequence of this interaction. So, Prf may act like a 
fishing pole with Pto as the bait and AvrPto as the trophy catch. Additionally, 
evidence is mounting that this model could be generalized to other R-avr 
interactions, suggesting that many of us have been fishing without bait for years. 
The explicit assumptions of the guard hypothesis are: 1) there is specificity in the 
interaction of R protein/host target (or “guardee”) pairings, and 2) the Avr/guardee 
interaction in the absence of an R protein is a positive virulence mechanism for the 
pathogen. 
Arabidopsis plants with functional RPM1 are resistant to Pseudomonas 
syringae pathogens expressing avrRpm1. Despite considerable investigator effort, 
there is no evidence for a direct RPM1-AvrRpm1 physical interaction. The recently 
described RIN4 protein, which has no known motifs, interacts in yeast two-hybrid 
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assays and in vivo with both proteins and is necessary for the RPM1-avrRpm1-
mediated HR (Mackey et al., 2002). All three of these proteins localize to the 
membrane fraction and mutations in AvrRpm1 that inhibit proper localization also 
strongly reduce the associated HR. RIN4 is not necessary for the function of the 
closely related RPS2 gene, demonstrating the expected specificity for a putatively 
guarded host target of AvrRpm1 virulence function. Nevertheless, RIN4 and RPS2 
do interact in vivo although they do not interact by yeast two-hybrid analysis. This 
suggests that RPM1 and RPS2 may be found within conserved protein complexes, 
although their specific binding to individual components differ (Mackey, Belkhadir, 
Dangl unpublished). Parallel observations have been made for the RAR1 and 
SGT1b proteins (see below). 
The tomato Cf2 gene conditions resistance to the fungal pathogen 
Cladosporium fulvum carrying Avr2 and also requires the recently cloned RCR3 
gene for its resistance function (Kruger et al., 2002). RCR3 encodes a functional 
cysteine protease suggesting interesting parallels to the Drosophila Toll receptor. 
Toll requires a ligand processed by a cysteine protease for downstream signaling 
(Levashina et al., 1999) and, like Cf2, is required for innate immunity to fungal 
pathogens. Because RCR3 is not required for other highly related Cf resistance 
genes, it is also a good candidate for a guarded protein. Nevertheless, no direct 
physical contacts have been demonstrated for this three-way genetic interaction. 
Several other candidate host genes for the role of “guardee” exist for various R-avr 
pairs and have been summarized in a review by Van der Hoorn et al., 2002. To date, 
none of the guardee candidate proteins has a clear function as the target of a 
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pathogen virulence factor, though RIN4 does have a deduced function in plant 
defense (Mackey et al., 2002). Therefore, while evidence mounting in its favor, the 
jury is still out on the guard hypothesis. 
 
Resistance Gene Signaling – A Little Self Control 
Once the R-avr interaction is triggered, how does signal transduction 
proceed? Circumstantial evidence has accumulated that R proteins have 
intramolecular interactions that might affect their ability to signal downstream and 
bind other molecules. The tomato Mi gene, a CC-NB-LRR, is required for resistance 
to potato aphids and root-knot nematodes (Rossi et al., 1998). N-terminal domain 
swapping experiments between the functional Mi-1.1 allele and the non-functional 
Mi-1.2 allele generated lethal phenotypes (Hwang et al., 2000). When these same 
constructs were transiently expressed, pathogen-free cell death phenotypes similar 
to the HR were observed and the cell death phenotype could be suppressed by co-
expression of the N-terminal domain from the parent allele. These data suggests 
that the N-terminal domain of Mi regulates signaling from the LRR leading to cell 
death. RIN4 and AtTIP49a, a recently described negative regulator of some R genes 
(Holt III et al., 2002), each interact by yeast two-hybrid assay with the N-terminal 
portion of RPM1. Both of these proteins demonstrate a marked reduction in their 
interaction with RPM1 when the two hybrid bait includes the NB domain, suggesting 
that this domain may inhibit some RPM1 interactions. The best, but still incomplete, 
evidence for the importance of intramolecular interactions as a regulator of R protein 
function has only just emerged. 
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  Moffett et al., 2002 worked with potato Rx, a CC-NB-LRR protein necessary 
for recognition of potato virus X (PVX) via its coat protein (CP). They demonstrated 
that functional Rx could be reconstituted by transiently co-expressing separate 
portions of the protein. Functional Rx was generated in trans using combinations of 
both CC-NB and LRR or CC and NB-LRR. Additionally, they utilized 
immunoprecipitation experiments to show that these molecules physically interact in 
vivo when transiently co-expressed. Whether they directly interact or are brought 
together by shared interactions with other proteins is unknown because in vitro 
interaction experiments were not reported. Importantly, expression of biologically 
active CP triggered a normal HR response and eliminated the interaction between 
the separately expressed Rx peptides. Taken together, these data suggests that Rx 
intramolecular interactions are modified as a result of Avr protein perception, and 
that this renders Rx competent for further downstream signaling. CP did not 
immunoprecipitate with Rx, suggesting that 1) Rx is in complex with or, rapidly 
recruits other proteins following PVX infection (guard hypothesis) or 2) Rx only 
transiently interacts with CP, which is not detectable by immunoprecipitation.  
Interestingly, two recently identified R genes, RPW8.1 and RPW8.2, which 
confer resistance to numerous powdery mildew isolates, consist of only a CC motif 
and a single transmembrane domain (Xiao et al., 2001). Because these proteins 
require EDS1 for their function, it will be interesting to see if they additionally require 
and interact with an LRR type protein, thus naturally recapitulating the Rx findings. 
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RAR1 and SGT1b – Complex Arrangements 
Most NB-LRR resistance genes have been demonstrated to signal 
predominately through one of two pathways (Aarts et al., 1998). These two 
pathways were initially defined by mutations in the EDS1 (enhanced disease 
susceptibility) (Parker et al., 1996) and NDR1 (non-race specific disease resistance) 
(Century et al., 1997) genes. CC-NB-LRRs signal through NDR1 while TIR-NB-
LRRs signal through EDS1 (Aarts et al., 1998), although there are exceptions 
(McDowell et al., 2000). When either NDR1 or EDS1 are non-functional, R gene 
signaling through these pathways is abolished and the result is complete 
susceptibility. PAD4, which interacts in vivo with EDS1 (Feys et al., 2001), is also 
required for the function of TIR-NB-LRRs. EDS1 and PAD4 encode proteins with 
homology to catalytic lipases, and may be involved in lipid signaling (Falk et al., 
1999; Zhou et al., 1998). The involvement of lipid signals in both animal (Wang et 
al., 1996) and plant (Rustérucci et al., 1996) cell death has been previously 
documented. Nevertheless, no catalytic function has been demonstrated for either 
EDS1 or PAD4. NDR1 encodes a putative glycosylphosphatidylinositol (GPI)-
anchored protein (B. Staskawicz, personal comm.), although nothing is known about 
its biochemical function. 
Adding significantly to our knowledge of R-avr signal transduction in R-Avr 
signaling are numerous recent publications concerning the RAR1 and SGT1 genes. 
RAR1 was initially identified in barley and acts as a non-redundant convergence 
point for race specific disease resistance to numerous powdery mildew isolates 
(Shirasu et al., 1999). The predicted RAR1 protein has two novel 60 amino acid zinc 
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binding domains (designated CHORD for Cys- and His-rich domain) and a plant-
specific C-terminal extension. Animal proteins sharing this CHORD domain all have 
a C-terminal domain not found in plant RAR1 proteins, a region of so-called SGT1 
homology.  The SGT1 protein in yeast is a component of the SCF complex, which is 
an integral component in protein ubiquitylation (Kitigawa et al., 1999).  
There are two SGT1 genes in Arabidopsis, designated SGT1a and SGT1b. 
Two papers have now revealed the importance of the Arabidopsis SGT1b gene in 
the resistance response mediated by numerous R genes, including both CC-NB-
LRR and TIR-NB-LRR pathways (Austin et al., 2002; Tör et al., 2002). Additionally, 
SGT1 also has a role in non-host resistance, which refers to a presumably non-
specific class of resistance where a plant species is resistant to all known isolates of 
a given pathogen. For example, Nicotiana benthamiana plants silenced for SGT1 
become susceptible to bacterial pathogens normally pathogenic to members of the 
Brassicaceae (Peart et al., 2002). These data strongly suggest that SGT1, like 
RAR1, serves as a convergence point for numerous defense related pathways. Not 
all non-host resistance is compromised in SGT1 silenced N. benthamiana plants and 
there are Arabidopsis R genes that do not require SGT1b (Austin et al., 2002). In 
some cases these R genes do require RAR1. For other R genes, both (RPP5) or 
neither (RPP1A) gene are required. These results are presently puzzling, especially 
considering that RAR1 and SGT1b interact in vivo in Arabidopsis. One possible 
explanation for these observations is that SGT1a and b act together as a 
convergence point for these pathways. This is unlikely as sgt1a loss-of-function 
mutants do not alter the response of the SGT1b-independent R genes (K. Shirasu, 
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personal comm.). Unfortunately, an sgt1a/sgt1b double mutant is lethal (K. Shirasu, 
personal comm.). 
SGT1b also interacts in vivo with two E3 ubiquitin ligase subunits, SKP1 and 
CUL1 (Azevedo et al., 2002; Liu et al., 2002). SCF complexes have E3 ligase 
activity and define substrate specificity for ubiquitylation (Gray and Estelle, 2000). 
These interactions prompted Azevedo et al. (Azevedo et al., 2002) to test SGT1b for 
interaction with CSN4 and CSN5, two components of the COP9 signalosome. The 
COP9 signalosome resembles the lid portion of the 19S regulatory subunit of the 
26S proteasome and was originally identified for its role in photomorphogenesis 
(Schwechheimer and Deng, 2001). CSN4 and CSN5 interacted with SGT1b and, 
although RAR1 additionally interacted with these components, RAR1 was not 
required for the SGT1-CSN4/5 interactions. Furthermore, silencing of CSN3 and 
CSN8, two additional components of the COP9 signalosome, inhibits N gene-
mediated resistance to tobacco mosaic virus in N. benthamiana (Liu et al., 2002). 
By way of analogy, auxin, a phytohormone involved in multiple developmental 
processes, induces the expression of the AUX/IAA genes (Abel et al., 1994). AUX 
proteins can negatively regulate their own expression and auxin relieves this 
negative regulation by inducing the degradation of AUX/IAA repressor proteins at the 
COP9 signalosome (Schwechheimer and Deng, 2001). It is not yet clear if the COP9 
signalosome might mechanistically regulate defense responses in a similar fashion. 
There is evidence that at least one R protein, RPM1, is degraded following elicitor 
perception just prior to onset of the HR (Boyes et al., 1998). Intriguingly, RPM1 does 
not accumulate in an Arabidopsis rar1 mutant (Tornero et al., 2002), suggesting that 
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RAR1 is required for either RPM1 stability or accumulation. Presently, no data 
concerning the degradation of other resistance proteins is available and potential 
targets of regulation by the COP9 signalosome are unknown. There is also rapidly 
growing evidence that ubiquitylation controls much more than protein turnover.  For 
example, ubiquitylation of VP16 in yeast simultaneously activates its transcriptional 
activities and drives its future degradation (Salghetti et al., 2001). 
Are there functional similarities between these R gene signaling molecules 
and the animal innate immune response? Actually, there are quite a few. For 
example, bacterial lipopolisaccharide (LPS) is a potent activator of animal innate 
immune responses. LPS associates with the LPS binding protein and CD14 in the 
plasma membrane (Wright et al., 1990). CD14 is, perhaps like NDR1, a GPI-linked 
protein. CD14 is associated with triton insoluble, heterogeneous regions of the 
plasma membrane called lipid rafts and is not competent to transduce the LPS 
signal on its own (Triantafilou et al., 2002; Triantafilou and Triantafilou, 2002). 
Numerous other signaling proteins are also constitutively localized with CD14 or 
rapidly recruited into the CD14 lipid raft, including Hsp70, Hsp90, and the Toll-like 
receptor TLR4 (Byrd et al., 1999; Jiang et al., 2000). Co-localization of these 
proteins in lipid rafts appears necessary for full cellular LPS stimulation (Triantafilou 
et al., 2002). TLR4 is a Toll-like receptor with homology to the N-terminal regions of 
plant TIR-NB-LRRs and it will be interesting to see whether other partners in the 
CD14 signalosome function in R-dependent responses in plants.  
As with TLR4, steroid hormone receptors, such as the progesterone receptor, 
form mature complexes with HSP70 and HSP90 and these complexes require the 
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proteins HOP and p23 (Hernandez et al., 2002; Lange et al., 2000). Human and 
Arabidopsis SGT1, like HOP and p23, have tetratricopeptide repeats (TPR), a 
degenerate 34 amino acid sequence involved in protein-protein interactions (Richter 
and Buchner, 2001). Strengthening the links tying these numerous proteins together, 
Arabidopsis HSP90 physically interacts with human p23 via the TPR (Owens-Grillo 
et al., 1996). Excitingly, HSP90 and SGT1-like proteins were recently isolated in a 
screen for RAR1 interactors from N. benthamiana (Liu et al., 2002). Potentially 
coming full circle to the SGT1/COP9 interaction, the mature progesterone receptor in 
complex with HSP90 and p23 binds ligand and is subsequently phosphorylated, 
ubiquitinated and degraded by the 26S proteasome (Lange et al., 2000). 
 
Conclusion 
Although some of these comparisons to the mammalian innate immune 
response are presently circumstantial, the inclusion of SGT1 and RAR1 in the stable 
of R gene-mediated signaling components is exciting and full of potential. The 
breadth and quality of biochemical data in the animal literature should supply the 
plant disease resistance field with an abundance of launching points for future 
experiments. Due to the many unique advantages of Arabidopsis as a genetic 
model, such as rapidly progressing efforts to identify loss of function (T-DNA) alleles 
for every gene and the relative ease of working with whole organisms, the animal 
innate and acquired immune response community should also keep a watchful eye 
on molecular plant pathologists. 
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CHAPTER 2 
 
Cytosolic HSP90 associates with and modulates the Arabidopsis RPM1 
disease resistance protein  
 
Preface 
 The following chapter was published, as titled with several minor changes, in 
The EMBO Journal (2003, 21, 5679-5689).  I share co-first authorship with Pablo 
Tornero and Youssef Belkhadir.  For this paper I contributed the data presented in 
Figures 2.2, 2.4-2.8A, and 2.10, and corroborated independently the results 
presented in Figures 2.1 and 2.3.  Additionally, I created all the figures and wrote the 
manuscript with input from all authors. 
 
Abstract 
The Arabidopsis protein RPM1 activates disease resistance in response to 
Pseudomonas syringae proteins targeted to the inside of the host cell via the 
bacterial type III delivery system. We demonstrate that specific mutations in the 
ATP-binding domain of a single Arabidopsis cytosolic HSP90 isoform compromise 
RPM1 function. These mutations do not affect the function of related 
disease resistance proteins. RPM1 associates with HSP90 in plant cells The 
Arabidopsis proteins RAR1 and SGT1 are required for the action of many R 
proteins, and display some structural similarity to HSP90 co-chaperones. Each 
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associates with HSP90 in plant cells. Our data suggest that 1) RPM1 is an HSP90 
client protein and that 2) RAR1 and SGT1 may function independently as HSP90 co-
factors. Dynamic interactions among these proteins can regulate RPM1 stability and 
function, perhaps similar to the formation and regulation of animal steroid receptor 
complexes.  
 
Introduction 
Our understanding of disease resistance specificity in plants centers on the 
structure and function of pathogen-specific Resistance (R) gene products. R proteins 
confer resistance to pathogen strains expressing a molecule that specifically triggers 
its action (Dangl and Jones, 2001). The largest class of R protein contains a 
nucleotide binding site (NB) and leucine-rich repeats (LRR), and are termed NB-LRR 
(Dangl and Jones, 2001). The repertoire of R proteins, though deployed with broad 
population polymorphism, may still not be sufficiently diverse to mediate direct 
recognition of all relevant pathogens. The question of repertoire size, among others, 
drove the formulation of the “guard hypothesis.” Here, pathogen molecules that 
trigger R action are most easily thought of as virulence factors whose presence is 
sensed by the host cell. Experimental evidence supports this model, though it is not 
yet fully generalizable (Dangl and Jones, 2001; Holt et al., 2003; Shirasu and 
Schulze-Lefert, 2003; Van der Hoorn et al., 2002). NB-LRR activation may include a 
large conformational change, perhaps akin to the ”jackknife model” leading to 
proximity induced activation as proposed for Apaf-1 (Hwang and Williamson, 2003; 
Moffett et al., 2002). This, in turn, leads to a series of cellular events that collectively 
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form the defense response (Hammond-Kosack and Parker, 2003). It is unclear what 
portion of this diverse defense response is actually required to halt pathogen growth.  
Arabidopsis RPM1 is an NB-LRR protein that confers recognition to bacterial 
strains expressing either of two divergent type III effector genes, avrRpm1 or avrB 
(Grant et al., 1995). These two type III effector proteins have virulence function on 
hosts lacking RPM1 (rpm1; disease susceptible; Ashfield et al., 1995; Ritter and 
Dangl, 1995). Recognition of AvrRpm1 or AvrB by RPM1 may be the consequence 
of their action on the Arabidopsis RIN4 protein. RIN4 is a protein of unknown 
function and is phosphorylated in response to the presence of either AvrRpm1 or 
AvrB (Mackey et al., 2002). RIN4 can interact with RPM1, AvrRpm1, and AvrB in 
vivo. All four of these proteins localize to the plasma membrane (Boyes et al., 1998; 
Mackey et al., 2002; Nimchuk et al., 2000).  
A limited set of genetically defined proteins are broadly required for the action 
of Arabidopsis R genes subsets (Hammond-Kosack and Parker, 2003). The ndr1 
mutation compromises the function of a subset of NB-LRR R proteins (Century et al., 
1997). NDR1 is a putative GPI-anchored protein (B. Staskawicz, pers. comm.). 
Mutations in RAR1 and SGT1b, one of two SGT1 orthologues in Arabidopsis, 
compromise the function of many R proteins (Azevedo et al., 2002; Muskett et al., 
2002; Tör et al., 2002; Tornero et al., 2002b). Plant SGT1 proteins share similarity 
with the yeast SGT1 protein, a regulator of the SCF ubiquitin ligase complexes in a 
variety of cellular processes (Kitigawa et al., 1999). RAR1 and SGT1 can interact in 
vivo, and presumably function together (Azevedo et al., 2002). 
RPM1 function is compromised by ndr1 and by rar1 but, surprisingly, is not 
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compromised by either sgt1a or sgt1b. Because an sgt1a / sgt1b double mutant is 
lethal (Takahashi et al., 2003), overlapping contributions of these genes to RPM1 
function cannot be determined. We performed a large-scale screen for loss of 
RPM1-mediated hypersensitive cell death (HR) in response to conditional 
expression of an avrRpm1 transgene (Tornero et al., 2002a). We describe here four 
mutant alleles of the Arabidopsis HSP90.2 gene that caused loss of RPM1-specified 
HR and disease resistance in that screen. This represents the first phenotype 
attributed to mutation of a plant cytosolic HSP90. 
We demonstrate that RPM1 is the first client protein described for plant 
cytosolic HSP90, using as criteria 1) in vivo HSP90-RPM1 interaction, 2) modulation 
of RPM1 function by particular mutant alleles of the HSP90.2 isoform, and 3) greatly 
decreased steady state RPM1 levels in these hsp90.2 mutant backgrounds. We 
describe genetic interactions between HSP90.2 and both RPM1 and NDR1. We 
provide evidence for in vivo interactions between HSP90s and both RAR1 and 
SGT1. Thus, we describe a possible mechanism by which RAR1 and SGT1 affect 
disease resistance protein signaling through probable co-factor interactions with 
cytosolic HSP90s. 
 
Results 
lra2 mutations specifically affect RPM1-mediated pathogen recognition 
We screened ~500,000 EMS mutagenized Arabidopsis M2 individuals for 
mutants affecting recognition of avrRpm1. Among others, we identified four allelic 
mutations that we called lra2-1, lra2-2, lra2-3, and lra2-4 (lra2; loss of recognition of 
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avrRpm1; Tornero et al., 2002a). Two of these, independently isolated, were later 
found to carry the same mutation.  
Both the lra2-2 and lra2-3 alleles have an intermediate effect on RPM1 
function (as did the other two alleles, data not shown) measured by pathogen growth 
and disease symptoms following challenge with Pseudomonas syringae pv. tomato 
(Pto) strain DC3000 expressing either avrRpm1 or avrB (Figure 2.1, and data not 
shown). We did not see a significant effect on other R genes active against different 
type III effectors from P. syringae (Figure 2.1). RPM1-mediated HR was also altered, 
but not completely abolished, in the lra2 mutants in response to infiltration with Pto 
DC3000(avrRpm1). This is similar to the effect of rar1 on RPM1-mediated HR 
(Tornero et al., 2002b). While normal RPM1-mediated HR occurs 5 to 8 hr after 
inoculation, we observed a low frequency of HR on leaves from all lra2 alleles by 20 
hours (data not shown). The effect of lra2 mutations on the HR was also specific to 
RPM1. 
Basal resistance against virulent pathogens (Pto DC3000) was not 
significantly affected (Figure 2.1). We also observed no alteration in the responses 
of lra2 alleles to infection with a series of Peronospora parasitica isolates (Holub et 
al., 1994). This included isolates that were either specifically recognized by various 
R genes in the lra2 parental background (Cala2 (recognized by RPP1a), Emoy2 
(RPP4), Emwa1 (RPP4), and Hiks1 (RPP7)) or caused downy mildew disease 
(Emco5 and Noco2) (data not shown). 
We observed that lra2-2 and lra2-4 displayed a partial penetrance phenotype 
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Figure 2.1: Mutations in lra2 specifically affect RPM1 signaling. Growth of Pto 
DC3000 containing the indicated avirulence genes in lra2 mutants and 
corresponding controls (used throughout). The a11 line is the Col-0 parent 
containing the estradiol-inducible avrRpm1 transgene (Tornero et al., 2002a). The 
a11;rpm1-1 line is the a11 transgene crossed into an isogenic rpm1-1 background. 
Bacterial numbers here and in Figures 2.2 and 2.3 are expressed as the log10 of 
colony forming units (cfu) per milligram fresh weight (f.w.) (Tornero and Dangl, 
2001). Error bars indicate ±SE. Growth of Pto DC3000(vector) did not show a 
significant difference in growth in lra2 mutants. Pto DC3000(avrRpm1) and Pto 
DC3000(avrB) exhibited consistent increased growth in lra2 mutants intermediate to 
growth observed in rpm1 mutants in four independent experiments.  
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for both HR and onset of disease symptoms. After inoculation with low doses of Pto 
DC3000(avrRpm1), lra2-2 and lra2-4 plants either developed symptoms 
characteristic of disease (in 0-80% of plants), or were completely asymptomatic 
(data not shown). Progeny from self-fertilization of either symptomatic or 
asymptomatic individuals displayed similar variable penetrance in the next 
generation (data not shown). The partially penetrant disease phenotype did 
influence the standard deviation in our bacterial growth assays (Figure 2.1). 
 
LRA2 and RPM1 interact genetically 
We made test-cross F1s between rpm1 and all lra2 alleles and assayed two 
phenotypes for allelism: the HR resulting from estradiol-induction of the avrRpm1 
transgene contained in these lines (Tornero et al., 2002a) and bacterial symptoms 
resulting from Pto DC3000(avrRpm1) infection. Both of these assays initially 
suggested that lra2 was allelic to rpm1 in the F1 generation. However, F2 progenies 
from these F1s contained a large percentage of phenotypically wild type individuals. 
This is inconsistent with allelism, and is consistent with non-allelic non-
complementation. In this condition, F1 individuals of a cross between two unlinked 
recessive mutants (each mutation thus heterozygous) display a phenotype similar to 
either homozygous single mutant. This often indicates that the two genes act 
together, that the protein products often physically interact or are part of the same 
protein complex, or that half the wild type dose of the two, in combination, is 
insufficient for wild type function (e.g. Belanger et al., 1994; Larkin et al., 1999).  
We assayed HR response and bacterial growth in the lra2 alleles and in 
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various F1 progeny (Figure 2.2) to address the apparent genetic interaction between 
LRA2 and RPM1. The wild type parental plant line, containing the estradiol-inducible 
avrRpm1 transgene (called a11; Tornero et al., 2002a) responded to estradiol with a 
strong HR (Figure 2.2A). The isogenic a11;rpm1-1 control (Tornero et al., 2002a), 
and the tested lra2 alleles exhibited no HR. The obvious induction of HR in F1 
progeny of backcrosses to a11 demonstrated that both rpm1 and the tested lra2 
alleles were recessive in this assay. Strikingly, F1 progeny of (a11;rpm1-1 x lra2-2, 
or x lra2-3) did not respond to estradiol (Figure 2.2A). Furthermore, lra2-2 and lra2-3 
partially compromised RPM1 inhibition of bacterial growth, and were fully recessive 
for this phenotype when assayed as F1s backcrossed to the a11 parental line 
(Figure 2.2B). The F1 progeny of (a11;rpm1-1 x lra2-x) exhibited modest, but 
reproducible, reduction of RPM1 function. These plants allowed bacterial growth 
between that of the lra2 parent and the (a11 x a11;rpm1-1) F1 control. This genetic 
interaction is specific to lra2 and rpm1, as we did not observe non-allelic non-
complementation in other trans-heterozygous combinations of mutants affecting the 
RPM1 pathway tested (tested were rar1 x rpm1, ndr1 x rpm1, rar1 x ndr1, rar1 x lra2 
and ndr1 x lra2 (data not shown)). The data in Figure 2.2 strongly support the 
conclusion that rpm1 and lra2 exhibit non-allelic non-complementation. Our data 
thus suggest that the respective wild type RPM1 and LRA2 proteins work in the 
same pathway, and potentially interact physically.  
 
ndr1 and lra2 display both synergistic and epistatic interactions 
Like lra2, ndr1 supported an intermediate level of bacterial growth when 
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Figure 2.2: LRA2 and RPM1 interact genetically. (A) Trypan blue staining of an 
HR assay following estradiol-induction of avrRpm1 expression. Two week old plants 
were treated with 10µM ED with 0.02% Silwet, and stained with trypan blue 2 days 
later. Row one displays parental responses to conditional expression of avrRpm1. 
Row two displays that the lra2 and rpm1 mutants are recessive. Row 3 shows that 
rpm1;lra2 trans-heterozygotes do not express HR. Three independent repetitions 
were performed. (B) Growth of Pto DC3000(avrRpm1) in same genotypes as (A). 
Error bars indicate ±SE of triplicates from this experiment. The experiment was 
performed six times with similar results. 
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challenged with Pto DC3000(avrRpm1) (Figure 2.3). Additionally, the RPM1-
mediated HR is severely attenuated in lra2 (see above), but not compromised in 
ndr1 (Century et al., 1995; Tornero et al., 2002b). These incomplete phenotypic 
effects allowed us to assay for genetic interaction between lra2 and ndr1. We 
constructed lra2;ndr1 double mutants and tested them for bacterial growth and HR. 
The lra2;ndr1 double mutants were completely compromised for RPM1 function, 
allowing as much pathogen growth as an rpm1 mutant following application of Pto 
DC3000(avrRpm1) (Figure 2.3; note log scale). The lra2;ndr1 double mutant also 
displayed full loss of Pto DC3000(avrRpm1) triggered HR, suggesting that LRA2 is 
required for the RPM1-dependent HR remaining in ndr1 mutants. Note that while the 
ndr1 allele is a null (Century et al., 1997), the lra2 mutants presented here are not 
(see below). 
 
LRA2 is HSP90.2 
We cloned LRA2 based on its map position. Our mapping population of 
disease susceptible (lra2;lra2) individuals narrowed the LRA2 interval to a ~52 kb 
region on the bottom arm of chromosome V (see Materials and Methods and Figure 
2.4). We sequenced candidate genes from this interval in the lra2-1 mutant and 
found a G/A transition at position 21937 (nucleotide positions relative to the 
published sequence of P1 clone MDA7, Genbank Accession: AB011476). This 
created a G95E mutation in the cytosolic HSP90.2 (At5g56030; Figure  
2.5A). We sequenced this gene from the other three independently isolated lra2 
alleles and found mutations in lra2-2 (C21952T; S100F, independently isolated in 
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Figure 2.3: lra2 and ndr1 affect RPM1 function synergistically. Growth of Pto 
DC3000(avrRpm1) in lra2;ndr1 double mutants with corresponding controls, as in 
Figures 2.1 and 2.2. Both lra2 and ndr1 single mutants exhibit intermediate growth, 
while the double mutant exhibits complete susceptibility. 
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Figure 2.4: LRA2 is HSP90.2. Map based cloning of lra2 mutants began with 
genetic definition of a 52 kB interval on the lower arm of Chromosome V using the 
markers shown on the left and right. This region was contained on the P1 clone 
MDA7 (Kaneko et al., 1998). Candidate clones, including all three of the 
constitutively expressed cytosolic HSP90s in Arabidopsis, are given in green with 
the arrow pointing in the direction of transcription.  
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lra2-4); and in lra2-3 (G21785A; D80N) (Figure 2.5A). To avoid confusion and to 
follow accepted nomenclature conventions, we re-designate the lra2 alleles hsp90.2-
1, hsp90.2-2, and hsp90.2-3 for lra2-1, lra2-2, and lra2-3, respectively. 
All mutations were within the conserved ATPase domain of this HSP90 
(Figure 2.5A). The hsp90.2-3 change (D80N; yellow in Figure 2.5B) alters a residue 
previously shown to make multiple ATP contacts in the crystal structure of yeast 
HSP90 (Prodromou et al., 1997 ). The hsp90.2-1 (G95E) and hsp90.2-2 (S100F) 
changes are both adjacent to residues that make direct contact with ATP (N93 and 
R99). The G95E change should alter the local charge density while the S100F 
change results in addition of a large hydrophobic side chain. We used molecular 
markers based on the mutation to outcross hsp90.2-3 from the conditional avrRpm1 
expression transgenes (Materials and Methods). This line expressed the same 
significant reduction of RPM1 function as its parent line, measured by both disease 
symptoms (Figure 2.6A, compare to Figure 2.1) and pathogen growth (Figure 2.6B). 
Thus, the transgenes carrying the estradiol inducible avrRpm1 system have no 
effect on the mutant phenotype. Finally, an insertion allele, hsp90.2-5 (a T-DNA 
insertion at approximately nt23453, aa position 601 of 699, SiGNAL line 
SALK_058553; Figure 2.4) was viable and exhibited no alteration of RPM1-mediated 
resistance (Figure 2.6B). We did not detect a truncated form by Western blot (data 
not shown), and assume that this allele is a null. We infer that one of the other three 
highly homologous cytosolic HSP90s compensates for the loss of HSP90.2 
(Borkovich et al., 1989). HSP90.2 is constitutively expressed, especially in flower 
structures and roots (Yabe et al., 1994). We observed only very modest pleiotropic   
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Figure 2.5: Clustering of hsp90.2 mutations in the highly conserved N-terminal 
ATPase domain. (A) Alignment of the N-terminal ATPase domains of HSP90 
orthologues across diverse kingdoms, highlighting the residues mutated in our 
hsp90.2 alleles in red. Proteins compared: AtHSP90.2 (swissprot id: HS82_ARATH), 
ScHSP82 (swissprot id: HS82_YEAST), DmHSP83 (swissprot id: HS83_DROME), 
HsHSP90a (swissprot id: HS9A_HUMAN), EcHptG (swissprot id: HTPG_ECOLI). 
(B) Hsp90.2 threaded over the structure of yeast HSP90 bound to ADP (center 
space filling structure) viewed from two different angles. Residues that make direct 
interactions with ADP are in violet. The three residues mutated in our hsp90.2 alleles 
are in yellow. Note that D80 makes direct contacts with ADP, and is mutated in 
hsp90.2-3.  
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Figure 2.6: RPM1 function is not compromised by an hsp90.2 insertion allele 
and the hsp90.2-3 phenotype is independent of the conditional avrRpm1 
expression system. (A) Bacterial growth assay with Pto DC3000(avrRpm1). The 
hsp90.2-5 (Salk 058553) T-DNA insertion allele displays a wild type response to Pto 
DC3000(avrRpm1). By contrast, the hsp90.2-3 allele outcrossed from the 
transgenic, conditional avrRpm1 expression system is still compromised for RPM1 
function. (B) This line, and controls, were spray infected with Pto DC3000(avrRpm1), 
and still exhibits symptoms intermediate to a full loss of function rpm1 mutant.  
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developmental changes in the hsp90.2 mutants (Figure 2.7; Queitsch et al., 2002). 
Thus, the hsp90.2 alleles identified in our screen are rare, specific, and not 
compensated for by other HSP90 isoforms.  
 
HSP90 associates with RPM1 in vivo 
An RPM1-myc epitope-tagged protein is a peripheral plasma membrane 
protein (Boyes et al., 1998), and fails to accumulate in rar1 plants (Tornero et al., 
2002b). We crossed an RPM1-myc transgene (Boyes et al., 1998) into both the fully 
penetrant hsp90.2-3 allele and the partially penetrant hsp90.2-2 allele. Both alleles 
exhibited greatly decreased RPM1-myc levels compared to wild type plants (Figure 
2.8A). Curiously, hsp90.2-2 consistently accumulated less RPM1-myc than hsp90.2-
3. This suggests that the partial penetrance phenotype of hsp90.2-2 is not simply 
correlated to RPM1 levels. 
Given the genetic interaction between rpm1 and hsp90.2, we asked whether 
HSP90s could co-immunoprecipitate (co-IP) with RPM1-myc. We probed protein 
blots of anti-myc IPs with an antibody raised against cytosolic HSP90 from Pharbitis 
nil, which should detect all four isoforms of cytosolic HSP90 in Arabidopsis (Krishna 
et al., 1997). We successfully detected HSP90 in IPs from RPM1-myc plant extracts, 
but not in IPs from rpm1 mutant extracts (Figure 2.8B). The HSP90 antibody failed to 
detect a clear difference in protein levels between our point mutants or insertion 
allele and wild type (data not shown). We therefore cannot ascertain whether the 
HSP90 detected in our co-IPs is, or contains, HSP90.2. We were unable to detect 
HSP90 in anti-RIN4 co-IPs, but could co-IP RPM1-myc with anti-RIN4 from the  
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Figure 2.7: Phenotypic pleiotropy in hsp90.2 mutants suggests functions in 
additional Arabidopsis processes. While overall morphology is unaffected (row 1), 
hsp90.2 mutants show slight flattening of the leaves (adaxial view row 2 and abaxial 
view row 3), and young flower buds are not completely closed (row 4). Leaves often 
appeared somewhat flattened in hsp90.2. We often found that all the buds in a 
flower cluster were slightly opened prematurely. We did not observe a difference in 
gross morphological architecture of the roots. These phenotypes were weak and the 
bud phenotype was variably penetrant in all hsp90.2 alleles, in contrast to the 
disease resistance phenotype. We recapitulated heat shock conditions known to 
cause loss of R function in other systems, notably the tobacco N gene, but failed to 
see an effect on RPM1 function in wild type plants at 30°C. These same conditions 
also revealed no pronounced phenotypic effects in hsp90.2 plants.  
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Figure 2.8: HSP90 Interacts with RPM1. (A) hsp90.2 mutations severely affect 
RPM1-myc accumulation. Forty (40) μg total protein were loaded and western blots 
were probed with anti-myc monoclonal antibody. (B) Top: anti-myc and co-IPs 
demonstrate that Hsp90 associates with RPM1-myc in planta. The relative amounts 
of protein from the immune pellet and the total extracts are not equivalent. The pellet 
is over represented by 20-fold. This experiment is representative of six independent 
replicates for RPM1-myc. Bottom: Control showing specificity of IP reagents, and 
that RPM1-myc is extracted from transgenic lines in appropriate mutant 
backgrounds under the conditions used for the co-IP. 
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 same extracts (data not shown). These data suggest that RIN4 and HSP90 
interactions with RPM1 might be mutually exclusive. 
  
Disease signaling components RAR1 and SGT1 also associate with HSP90 
in planta 
RAR1 and SGT1 can be co-immunoprecipitated from plant cell extracts 
(Azevedo et al., 2002). As well, there are structural similarities between plant SGT1 
and animal proteins required for HSP90 assembly and function (Dubacq et al., 2002; 
Garcia-Ranea et al., 2002; see Discussion). These observations prompted us to 
explore the physical relationships between RAR1, SGT1, and HSP90. 
We used antibodies raised against either RAR1 or SGT1 (Azevedo et al., 2002) to IP 
HSP90 from total plant extracts. We found that anti-RAR1 is able to co-IP HSP90 
from wild type extracts, but not from rar1-20 extracts (Figure 2.9A). Arabidopsis 
contains two SGT1 genes encoding proteins of slightly different mobility (Austin et 
al., 2002; Tör et al., 2002); both are detected by our antisera under the IP conditions 
used. We found that anti-SGT1 antibody is consistently able to co-IP HSP90 from 
wild type Col-0 and Ws-0 extracts (6/6 experiments; Figure 2.9B). However, we 
detected no, or only very low amounts, of HSP90 in anti-SGT1 IPs from sgt1b 
extracts in multiple experiments (Figure 2.9B). This suggests that the majority of 
HSP90 we detected is associated with SGT1b, and that SGT1a may weakly 
associate with HSP90. We invariably detected HSP90 in IPs from sgt1a extracts 
(Figure 2.9B), strengthening this conclusion. Thus, in our experimental conditions, 
there is a preference for HSP90 to associate with SGT1b compared to SGT1a,  
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Figure 2.9: HSP90 associates with RAR1 and SGT1. (A) Hsp90 associates with 
RAR1 in planta (top). The relative amounts of protein from the co-IP pellet and the 
total extracts are not equivalent. The pellet is over represented by 10-fold. This 
experiment is representative of two independent replicates. An extraction control is 
displayed below the co-IP. (B) HSP90 displays an apparent preference for SGT1b 
over SGT1a. The relative amounts of protein from the co-IP pellet and the total 
extracts are not equivalent. The pellet is over represented by 10-fold. This 
experiment is representative of 3/7 independent replicates for sgt1b and 4/4 
independent replicates for sgt1a. Extraction controls beneath the co-IPs 
demonstrate the differential mobilities of SGT1a and SGT1b and the effect of the 
respective mutations. 
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consistent with yeast two hybrid data (Takahashi et al., 2003). 
Additionally, we detected HSP90 in anti-SGT1 IPs from rar1 mutant extracts 
and in anti-RAR1 co-IPs from sgt1b mutant extracts (Figure 2.9C). This suggests 
that RAR1 and SGT1b can independently associate with HSP90. We corroborated 
this finding in the converse experiment (IP with anti-RAR1 and blot with anti-HSP90) 
using the null rar1-20 allele (data not shown). We were, surprisingly, able to detect 
consistently HSP90 from anti-RAR1 IPs in rar1-21 mutant extracts (Figure 2.9C). 
The rar1-21 mutation introduces a stop codon near the end of the CHORD I domain 
(Tornero et al., 2002b), and consequently lacks the CHORD II domain, known to be 
the RAR1-SGT1 interaction platform (Azevedo et al., 2002). While we were unable 
to detect this small RAR1 fragment by direct immunoblot, it appears sufficient to IP 
HSP90, consistent with two hybrid interaction data presented elsewhere (Takahashi 
et al., 2003).  
Artifactual detection of HSP90 in immunoblots is a concern, because it can 
represent up to 1-2% of total cellular protein (Lai et al., 1984). We therefore used 
several different antisera to test this and found that none of them could co-IP HSP90 
(see Materials and Methods), thus suggesting strongly that our data represent 
specific interactions.  
 
Discussion 
We provide genetic and biochemical data demonstrating that RPM1 is a 
cytosolic HSP90 client. We demonstrate that mutations in the Arabidopsis HSP90.2 
can specifically modulate RPM1 function. RPM1 accumulation is greatly diminished 
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in specific hsp90.2 missense mutants. We provide pairwise co-IP data 
demonstrating interactions between HSP90s and RPM1, RAR1 and SGT1. We show 
that the HSP90 interaction with RAR1 does not require SGT1, nor does the HSP90 
interaction with SGT1 require RAR1. Surprisingly, we did not find an association of 
HSP90s with RIN4 (RPM1 Interacting Protein 4), a protein clearly implicated in 
RPM1 and RPS2 function (Axtell and Staskawicz, 2003; Mackey et al., 2003), 
suggesting that RIN4 and HSP90 association with RPM1-myc might be mutually 
exclusive. 
Our data suggest that RAR1, SGT1 and HSP90 may work together to 
coordinate RPM1 function. The key questions emerging from our work are: why do 
specific hsp90.2 missense mutations result in diminution of RPM1 levels, and hence 
RPM1 function? Is the requirement for HSP90 in RPM1 signaling indicative of a 
common regulatory mechanism among the NB-LRR class of R proteins? And, do 
RAR1 and SGT1 act as co-factors for HSP90 in R protein signaling? 
 
Genetic interactions support a quantitative function for HSP90.2 in R- 
mediated disease resistance  
Our four hsp90.2 missense alleles are recessive and significantly reduce, but 
do not eliminate, RPM1 function. They do not reproducibly affect any of the seven 
other R functions tested. The hsp90.2 alleles exhibit non-allelic non-
complementation with rpm1, suggesting that the two wild type proteins act together. 
The fact that far less steady state RPM1-myc protein accumulates in two hsp90.2 
alleles provides a simple, dosage-based mechanistic explanation for this genetic 
  43
observation. 
Our results suggest that specific HSP90.2 missense mutations alter RPM1 
function. The four hsp90.2 alleles reported here compare to 95 rpm1 alleles also 
identified in this screen (Tornero et al., 2002a). RPM1 is 926 amino acids long, 
HSP90.2 is 699; thus target size cannot explain this mutant ratio. Furthermore, the 
insertional hsp90.2-5 allele is viable, apparently null, and exhibited full RPM1 
function. We assume that one of the other three cytosolic HSP90s can compensate 
for the full loss of HSP90.2, as observed in other systems (Borkovich et al., 1989). 
Thus, our hsp90.2 alleles also prohibit functional compensation. Significantly, we did 
not recover alleles in any of the other HSP90 genes as loss of RPM1 function 
mutants. Thus, our hsp90.2 mutants are rare, and suggest a preferential utilization of 
HSP90.2 in RPM1 accumulation and, hence, in RPM1 function. 
Importantly, a mutation exactly orthologous to hsp90-2.3 (D80N) has been 
studied in yeast HSP90 (D79N). This mutant yeast protein homo-dimerizes properly, 
and a wild type / mutant mixed dimer exhibits wild type levels of ATP hydrolysis 
(Richter et al., 2001). But mutant dimers are unable to bind or hydrolyze ATP 
(Obermann et al., 1998; Panaretou et al., 1998), and in competition assays are 
unable to interfere with ATP hydrolysis, even in 8-fold excess (Richter et al., 2001). 
Interestingly, a transcriptionally inducible yeast hsp90(D79N) also prevented 
phenotypic compensation by a wild type, constitutively expressed isoform 
(Panaretou et al., 1998). This may explain how we identified our mutants in plants 
that normally contain four copies of cytosolic HSP90, as well as suggesting that 
HSP90 isoforms might have non-overlapping functions in Arabidopsis.  
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Our other two mutations, hsp90.2-1 (G95E) and hsp90.2-2 (S100F) have not 
been identified in screens in other systems. Both are solvent exposed and adjacent 
to ATP interacting residues. It is possible that these mutations also interfere with 
ATP binding. Altered ATP binding/hydrolysis can also directly affect client protein 
binding and release by HSP90, as well as the interaction of HSP90 with its co-
chaperones, thus de-stabilizing the complex (Obermann et al., 1998; Panaretou et 
al., 1998).  
Our evidence of both synergism (in pathogen growth assays) and epistasis (in 
an HR assay) between hsp90.2 and ndr1 suggests that HSP90 and NDR1 act 
together in the RPM1-dependent disease resistance response. A requirement for 
HSP90.2 early in RPM1 signaling is consistent with our proposal that it is part of, or 
required for the assembly of, a poised RPM1 receptor complex. These results 
suggest an interesting parallel with animal innate immunity. NDR1 is a putative GPI-
anchored protein. In animal systems, HSP90 co-localizes with the GPI-anchored 
protein CD14, and both act in the TLR4-dependent innate immune response to 
lipopolysaccharide (Triantafilou et al., 2002). As well, HSP90 inhibitors prevent the 
innate immune response activation by bacterial DNA (Zhu and Pisetsky, 2001). We 
propose that NDR1 and HSP90 function together, perhaps transiently, during RPM1 
signaling. 
 
Could RAR1 and SGT1 function as HSP90 co-factors in disease resistance  
pathways?  
Several observations indicate that RAR1 and HSP90 function together in 
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RPM1-dependent HR. We demonstrated that RAR1 and SGT1 can associate with 
HSP90 in vivo. We noted a severe attenuation of RPM1-dependent HR in hsp90.2 
mutants and we found decreased RPM1-myc stability seen in hsp90.2 mutants, two 
phenotypes observed in rar1 plants (Tornero et al., 2002b). The epistasis of hsp90.2 
over ndr1 with respect to HR was also observed with rar1;ndr1 double mutants 
assayed for RPM1 function, and for the synergistic interaction of rar1 and ndr1 in 
RPP7 mediated resistance (Tornero et al., 2002b). These data are, in sum, 
consistent with RAR1 and HSP90 acting together in both RPM1-dependent HR, and 
possibly more broadly, in NB-LRR function. Our data are further consistent with 
recent findings demonstrating that RAR1 and NDR1 contribute quantitatively to the 
function of various NB-LRR R proteins (Muskett et al., 2002; Tornero et al., 2002b). 
Because an sgt1a;sgt1b double mutant is lethal in Arabidopsis (Takahashi et 
al., 2003), it is impossible to determine if SGT1 isoforms have overlapping function 
in RPM1 signaling. Recent gene silencing experiments corroborate a role for HSP90 
in the function of several R genes that also require SGT1 and RAR1 for their 
function (Liu et al., 2004). Structural modeling also supports the contention that 
RAR1 and SGT1 might act as co-factors of HSP90 (Shirasu and Schulze-Lefert, 
2003). SGT1 and RAR1 homologs in animals have predicted structural homology to 
the HSP90 partner protein, p23 (Dubacq et al., 2002; Garcia-Ranea et al., 2002; 
Figure 2.10). Additionally, the TPR domain of SGT1 shares structural homology with 
other HSP90 partner proteins including HOP/STI1 (Garcia-Ranea et al., 2002). 
We propose that RAR1 and HSP90 normally act to not only maintain RPM1 in 
a signal competent conformation, but also stabilize RPM1 against degradation. This 
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is reminiscent of the assembly of activation competent steroid receptors with an 
HSP90 isoform-homodimer and various co-chaperones (Picard, 2002; Pratt and 
Toft, 2003). HSP90 binding to the steroid receptor is not sufficient to render the 
receptor competent; co-factor binding and continual ATP turnover are required to 
maintain the steroid binding cleft in a receptive conformation (Pratt and Toft, 2003). 
Further conformational change accompanies ligand binding.  
Inhibition of ATP binding and/or turnover in our hsp90.2 mutants should result 
in a locked HSP90 conformation, bound to RPM1 but unable to hold it appropriately, 
thus leading to RPM1 disappearance. This would mimic the effect on client proteins 
observed after treatment with the ATP binding inhibitor geldanamycin in other 
systems. RPM1 instability is consistent with results showing that HSP90 can rapidly 
shut off transcriptional responses by binding transcription factors and causing their 
degradation (Freeman and Yamamoto, 2002). Steroid receptor levels, like RPM1 
(Boyes et al., 1998), drop after signaling (Lange et al., 2000; Wallace and Cidlowski, 
2001).  
Evidence for a second HSP90 function in protein stability is also emerging. 
First, human SKP2, a member of the SCF complex, is able to co-immunoprecipitate 
HSP90b in mouse NIH 3T3 cells (Lyapina et al., 1998). Degradation of HSP90 client 
proteins, triggered by either geldanamycin treatment or over-expression of the E3 
ligase CHIP, can be inhibited by the addition of proteasome inhibitors (Connell et al., 
2001; Schneider et al., 1996; Segnitz and Gehring, 1997; Whitesell and Cook, 
1996). However, full steroid binding is not recovered in these experiments, also 
suggesting two functions for HSP90. One, reversible by lactacystin, is required for  
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Figure 2.10: SGT1a and SGT1b contain strong structural similarity to two 
different HSP90 co-chaperones, HOP and p23. (A) The TPR motifs of AtSGT1s 
are predicted to fold like the TPR motif of the HSP90 co-chaperone, HOP (seen 
here). (B) The CS domain found in AtSGT1s is predicted to fold in a similar 
conformation as p23 (seen here). 
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degradation, and another, not completely reversed by lactacystin, is required to mold 
a steroid-binding complex. Initiation of RPM1 function leads to RPM1 degradation 
(Boyes et al., 1998), perhaps involving SGT1 that is first recruited to an HSP90-
RPM1 complex, and then guides RPM1 to the proteasome. RAR1 may normally 
block this conversion, perhaps in conjunction with (or antagonistically to) SGT1. This 
notion is consistent with our findings that RAR and SGT1 do not require each other 
to associate with HSP90.  
A model where HSP90, in association with RAR1 and SGT1, controls levels 
of properly poised R protein complexes is consistent with the two functions of 
HSP90 discussed above—conformational molding and trafficking to the proteasome. 
Because of both R protein sequence polymorphism, and the possibility that R 
proteins might associate with additional cellular proteins, one could expect 
differential functional requirements for maintenance of this poised complex. For 
example, we also could co-IP HSP90 with anti-HA monoclonal antibody detecting an 
RPS2-HA fusion (data not shown) suggesting that at least one other NB-LRR protein 
can interact with a cytosolic HSP90. But we observed no change in RPS2 function in 
our mutants. This model is consistent with the fact that RPM1-mediated HR is very 
fast compared to others, including RPS2, and that RPM1 is degraded following 
triggering, unlike RPS2 (Axtell and Staskawicz, 2003). A requirement for a finely 
tuned conformational poise in NB-LRR R protein function was recently suggested 
using split Rx molecules (Moffett et al., 2002).  
We thus favor an overall model whereby different NB-LRR R proteins, 
perhaps in association with the cellular proteins they guard, are kept in active 
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sentinel mode by varying degrees of dynamic re-shaping and maintenance of 
appropriate steady state levels driven by HSP90, RAR1 and SGT1. This model can 
encompass a continuous quantitative function for HSP90 in both the assembly of 
conformationally charged R protein complexes and the regulation of signal flux 
through those complexes.  
 
Materials and Methods 
 
Plant lines 
Transgenic Arabidopsis ecotype Columbia (Col-0) (line a11) and rpm1-1 (line 
a11r) containing estradiol inducible avrRpm1 have been described in (Tornero et al., 
2002a). Mutant lines used (all in Col-0 unless noted) were ndr1-1 (Century et al., 
1997), rar1-20; a null allele, originally pbs2 (Warren et al., 1999), rar1-21 (Tornero et 
al., 2002b), rps2-101C (Mindrinos et al., 1994), rps5-2 (Warren et al., 1998), ecotype 
RLD (Hinsch and Staskawicz, 1996) as a rps4 mutant control, sgt1a (T-DNA 
insertion in Ws-0 ecotype), and sgt1b (edm1-1; Tör et al., 2002). We constructed 
double mutants of hsp90.2 and rpm1-1 by identifying F2 individuals susceptible to 
Pto DC3000(avrRpm1) which were molecularly heterozygous for rpm1-1, yet did not 
give rise to resistant offspring in the next generation. The F3s from such a line were 
then selected for a homozygous rpm1-1 mutant. These lines were confirmed after 
identification of the hsp90.2 mutations using PCR based markers. A similar 
procedure was used for creation of hsp90.2 and ndr1 double mutants. A 
homozygous insertion in the SALK T-DNA insertion line 058553 was identified by 
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molecular analysis of a segregating pool. The insertion site was confirmed by 
sequencing of T-DNA specific product. Primer sequences for selection of mutations 
available on request. 
 
Bacterial strains, inoculation and growth quantification 
Pto DC3000 derivatives containing pVSP61 (empty vector), avrRpm1, avrB, 
avrRpt2, avrPphB, or avrRps4 were maintained as described (Ritter and Dangl, 
1996). Plant inoculations and counting of the bacteria were performed as described 
(Tornero and Dangl, 2001). Where indicated, high concentrations of bacteria 
(OD600=0.075, 3.75 X 107 colony-forming units/mL) were infiltrated into the bottom 
part of the leaf with a blunt syringe to test for the induction of HR. 
 
Estradiol induction 
Two-week-old plants grown under short day (8 hr.) conditions were sprayed 
with 0.02% Silwet L-77 (CKWitco Corporation) and 10μM β-Estradiol (Sigma E 8875) 
in distilled water from a 10 mM β-Estradiol stock dissolved in 100% ethanol (Tornero 
et al., 2002a).  
 
Mapping and tests for disease symptoms 
Rough mapping was performed by crossing hsp90.2 mutants and Landsberg 
erecta (La-er). F2s were tested for lra2 like disease symptoms. One to three week 
old F2 plants were sprayed with a 10mM MgCl2 suspension containing Pto 
DC3000(avrRpm1) at concentration OD600=0.1 (5 X 107 colony-forming units/mL) 
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with 0.02% Silwet L-77, covered with a clear lid for 4 hrs, and assessed for chlorosis 
and other symptoms of P. syringae infection 4-6 days later under short day 
conditions. Chi-square analyses showed that all mutations were recessive; lra2-1: 
480 wt, 612 mutant X2=3.843; p=0.05; lra2-2: 217 wt, 89 mutant X2=2.723, p=0.099; 
lra2-3: 457 wt, 155 mutant X2=0.035, p=0.85. Susceptible F2 individuals were 
allowed to self and were confirmed in the F3 generation. DNA (Ausubel et al., 1987) 
from 41 of these individuals was used in PCR amplification of known PCR-based 
molecular markers (www.arabidopsis.org) to obtain approximate mapping positions. 
This interval was refined using molecular markers we developed (available upon 
request). We used DNA from 939 susceptible F2 individuals to define a 52 kB 
interval on P1 clone MDA7. The ~52kb LRA2 interval lies between a T/A 
polymorphism at position 551 (Jander et al., 2002) and the published CAPS marker 
MDA7 (www.arabidopsis.org) at position 52632 (C/A) relative to the published 
sequence for P1 clone MDA7 (Kaneko et al., 1998). Independent mapping of the 
lra2-2 (195 susceptible individuals) and lra2-3 (312 susceptible individuals) alleles 
showed similar linkage. All mutations where confirmed by sequencing of both DNA 
strands. 
 
Alignments and threading analysis 
Protein alignments of HSP90 N-termini were made using Align X (a 
component of Vector NTI Suite 7.1; Informax, Inc. (Frederick, MD)). This program 
uses CLUSTALW to make alignments. Parameters used were: Gap Opening 
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Penalty=10, Gap Extension Penalty=0.05, Gap Separation Penalty Range=8, % 
Identity for Alignment Delay=40, and Hydrophobic Residue Gap=GPSNQEKR. 
The sequences of AtSGT1a and AtSGT1b were submitted to the threading 
Meta server [META] (http://bioinfo.pl/meta/) to identify structural templates for 
homology modeling. The meta server accessed the following fold-recognition 
servers and reported the consensus: bioinbgu [BIOINBGU], 3D-PSSM [3D-PSSM], 
GenTHREADER [GENTHREADER], FUGUE [FUGUE], and Sam-T99 [SAMT99]. 
The meta server identified the crystal structure of the TPR1-domain of Hop (PDB ID 
1elw) as a structural template for residues 1-115 of AtSGT1a; and the crystal 
structure of the human co-chaperone P23 (PDB ID 1ejf) as a structural template for 
residues 156-237 of AtSGT1a. Models of the P23 and TPR domains were built using 
the Modeler module of the InsightII molecular modeling system from Accelrys Inc., 
(www.accelrys.com). Figures were created with SPOCK. 
 
Protein Blots and co-immunoprecipitations 
For detection of RPM1-myc in hsp90.2-2 and hsp90.2-3, we introgressed 
these mutants into plants expressing RPM1-myc from the native RPM1 promoter 
(Boyes et al., 1998) as described in (Tornero et al., 2002b). Total protein was 
extracted in 50 mM Tris-HCl pH 8.0, 1% SDS, 1mM EDTA, 1 mM 2-
mercaptoethanol, and 1 X plant protease inhibitor cocktail (Sigma). For 
immunodetection, 40 μg protein samples were electrophoresed on 8% SDS-PAGE 
gels. Western blots were performed using standard methods and detected with 
ECL+ (Amersham). 
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For co-immunoprecipitations, tissue was first ground in liquid nitrogen with a 
mortar and pestle. This material was then homogenized by alternate rounds of 
Polytron (Kinematica) and glass douncer (Kontes Glass Company) in 2 ml of sterile 
buffer 20mM Tris-HCL pH 8.0, 0.33M Sucrose,10 mM EDTA , 5mM DTT and 1 X 
plant protease inhibitor cocktail (Sigma) per 1 g of tissue. Debris was removed by 
centrifugation at 5,000XG for 40 minutes at 4°C. 1.5 ml of this supernatant was first 
pre-cleared by adding 50 μl of protein G-agarose (Boehringer Mannheim) and 
incubated at 4°C for 60 minutes on an orbital shaker. The cleared supernatant was 
then removed and combined with one of the following: 5 μl of the anti-RAR1 
(Muskett et al., 2002) antibody, 5 μl anti-SGT1 (Azevedo et al., 2002) antibody, 30 μl 
of a re-suspended anti-HA Affinity Matrix (3F10, Roche), or 30 μl of a re-suspended 
anti-c-Myc Agarose (9E10, Santa Cruz Biotechnology). This was followed by 
incubation at 4°C for 2 hour. 50 μl of protein G-agarose was then added to the 
reactions containing the anti-RAR1 and anti-SGT1 antibodies. All reactions were 
then rolled at 4°C overnight. Beads were pelleted at 1000XG for five minutes. This 
was followed by four washes in 1.5 ml of 50mM HEPES (pH 7.4), 100 mM NaCl, and 
10 mM EDTA pH 8.0. Bound proteins were eluted with 50 μl of sample buffer and 
run on an 8% polyacrylamide gel, and probed with a polyclonal antibody raised 
against the C-terminal portion of Pharbitis nil HSP90 (Krishna et al., 1997). 
HSP90 was not detected in control immunoprecipitations with four different 
antibodies, three of which do immunoprecipitate HSP90 via RPM1-myc, RAR1, or 
SGT1b. Thus, HSP90 is not non-specifically sticking to Agarose-Protein A/G beads 
or other matrix reagents. Furthermore, we used antibodies to actin (soluble) 
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ascorbate peroxidase (soluble), BiP (soluble and ER), toposiomerase II (nuclear), 
RD28 (intergral plasma membrane; Daniels et al., 1994), and Tip (tonoplast intrinsic 
protein). None of these co-IP’ed HSP90. The absence of HSP90 in these IPs (data 
not shown) argues for the specificity of our co-IP data. 
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CHAPTER 3 
 
RIN4 negatively regulates RPS2 and RPM1 downstream or independent of 
NDR1 and is not required for AvrRpt2 or AvrRpm1 virulence functions 
 
Preface 
 The following chapter was previously published as “RIN4 negatively regulates 
RPS2 and RPM1 downstream or independent of NDR1 and is not required for 
AvrRpt2 or AvrRpm1 virulence functions” in Plant Cell (2004, 10, 2822-35).  I made 
intellectual contributions to the whole paper and produced the genetic material for 
Figure 3.3C, 3.4, 3.5, and 3.6B.  Additionally, I performed independent repetitions of 
Figure 3.3C and 3.5, and designed the experiments for Figure 3.4B and 3.6B.  At 
first glance, this chapter may not appear to build on the larger story presented in this 
dissertation.  However, the data presented here generalized rar1’s affect on NB-LRR 
accumulation by showing a second Arabidopsis NB-LRR accumulated less protein in 
a rar1 mutant.  We show here for the first time in any system that increasing NB-
LRR protein levels/signaling can partially overcome the genetic effect of rar1.  This 
finding suggested for the first time that rar1 may not function in a direct linear signal 
transduction pathway and thus built the groundwork of the threshold model 
discussed in Chapters 4 and 5.  Additionally, this paper showed that ndr1, another of 
the few genes known to play a direct role in disease Resistance gene function, did 
not play a role in accumulation of NB-LRRs. 
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Abstract 
Bacterial pathogens deliver type III effector proteins into the plant cell during 
infection. On susceptible (r) hosts, type III effectors can contribute to virulence. 
Some trigger the action of specific disease resistance (R) gene products. The 
activation of R proteins can occur indirectly via modification of a host target. Thus, at 
least some type III effectors are recognized at site(s) where they may act as 
virulence factors. These data indicate that a type III effector’s host target might be 
required for both initiation of R function in resistant plants and pathogen virulence in 
susceptible plants. In Arabidopsis, RIN4 associates with both the RPM1 and RPS2 
disease resistance proteins. RIN4 is post-translationally modified following delivery 
of the Pseudomonas syringae type III effectors AvrRpm1, AvrB, or AvrRpt2 to plant 
cells. Thus, RIN4 may be a target for virulence functions of these type III effectors. 
We demonstrate that RIN4 is not the only host target for AvrRpm1 and AvrRpt2 in 
susceptible plants, as its elimination does not diminish their virulence functions. In 
fact, RIN4 negatively regulates AvrRpt2 virulence function. RIN4 also negatively 
regulates inappropriate activation of both RPM1 and RPS2. Inappropriate activation 
of RPS2 is NDR1-independent, in contrast to the established requirement for NDR1 
during AvrRpt2-dependent RPS2 activation. Thus, RIN4 acts either at, downstream 
or independently of NDR1 to negatively regulate RPS2 in the absence of pathogen. 
We propose that many Pseudomonas syringae type III effectors have more than one 
target in the host cell. We suggest that a limited set of these targets, perhaps only 
one, are associated with R proteins. Thus, while any pathogen virulence factor may 
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have multiple targets, the perturbation of only one is necessary and sufficient R 
activation.  
 
Introduction 
In response to the pressures of infection, plants evolved an immune system 
to specifically detect pathogens and induce defenses against them. The most 
efficient sentinels of the plant immune response are proteins encoded by the 
disease resistance (R) genes (Flor, 1971). The most common and widely distributed 
class of R-proteins has a central nucleotide binding site (NB) domain and carboxy-
terminal leucine rich repeats (LRR). Some of these so-called NB-LRR R-proteins 
have amino-termini with homology to the intracellular portion of the Drosophila Toll 
and mammalian interleukin (IL-1) receptors (TIR-NB-LRR). Other R-proteins have a 
coiled-coil motif at their amino-termini (CC-NB-LRR) (Dangl and Jones, 2001). 
Activation of NB-LRR proteins induces a defense response consisting of a series of 
biochemical and cellular events, and massive transcriptional re-programming within 
and surrounding the infection site (Dangl and Jones, 2001; Hammond-Kosack and 
Parker, 2003; McDowell and Dangl, 2000; Nimchuk et al., 2003). These often, but 
not always, culminate in a localized programmed cell death called the hypersensitive 
response (HR).  
Plant pathogenic bacteria express genes whose products trigger activation of 
specific NB-LRR R proteins. These were historically termed avr genes because their 
presence rendered strains expressing them avirulent on plants expressing the 
corresponding R gene (Staskawicz et al., 1984). These Avr proteins are substrates 
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of the evolutionarily conserved type III secretion system used by a variety of Gram-
negative animal and plant pathogens to deliver type III effector proteins to the 
eukaryotic host cell (Collmer et al., 2002; Greenberg and Vinatzer, 2003; Staskawicz 
et al., 2001). Thus, type III effector proteins in general, including the operationally 
defined Avr proteins, are likely to function primarily as virulence factors contributing 
to pathogen fitness on susceptible hosts. A growing base of experimental evidence 
supports this notion (Chang et al., 2000; Kearney and Staskawicz, 1990; Lorang et 
al., 1994; Ritter and Dangl, 1995; reviewed in Nimchuk et al., 2001).  
The simplest molecular explanation for the genetics of avr-R disease 
resistance systems postulated a direct ligand-receptor interaction, but there is little 
experimental evidence to support this model generally with respect to NB-LRR 
proteins. This paucity of data led to the articulation of an alternative hypothesis in 
which R-proteins monitor the integrity of host targets of pathogen virulence factors 
(Dangl and Jones, 2001; van der Biezen and Jones, 1998; Van der Hoorn et al., 
2002). Experimental support for this “Guard Hypothesis” is mounting (Axtell and 
Staskawicz, 2003; Chen et al., 2000; Kruger et al., 2002; Mackey et al., 2003; 
Mackey et al., 2002; Shao et al., 2003). 
RPM1 encodes a CC-NB-LRR R-protein that confers resistance against P. 
syringae expressing either of two sequence unrelated type III effectors, AvrB and 
AvrRpm1 (Bisgrove et al., 1994; Grant et al., 1995). RIN4 is a plasma membrane 
localized, evolutionarily conserved protein of 211 amino acids. Its sequence provides 
no clues to its function. RIN4 is required for RPM1-mediated disease resistance 
because it is required for RPM1 accumulation before infection. RIN4 is 
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phosphorylated upon infection with P. syringae expressing either AvrB or AvrRpm1, 
though neither of these type III effectors has homology to known kinases (Lee et al., 
2004). AvrB and AvrRpm1-dependent phosphorylation of RIN4 occurs in both RPM1 
and rpm1 plants. These results suggested that RIN4 phosphorylation may result 
from the virulence activity of AvrB and AvrRpm1, and that this event leads to RPM1 
activation when it is present (Mackey et al., 2002). 
RIN4 is also involved in the activation of RPS2 (another CC-NB-LRR protein), 
with which it associates in vivo (Axtell and Staskawicz, 2003; Mackey et al., 2003). 
RPS2 confers resistance against P. syringae expressing the type III effector AvrRpt2 
(Axtell and Staskawicz, 2003; Bent et al., 1994; Mackey et al., 2003; Mindrinos et al., 
1994). AvrRpt2 is a putative cysteine protease (Axtell et al., 2003) that causes post-
transcriptional disappearance of RIN4 (Axtell and Staskawicz, 2003; Mackey et al., 
2003). Over-expression of RIN4 delays its disappearance in the presence of 
AvrRpt2 and, consequently, inhibits RPS2 activation. Thus, RIN4 disappearance is 
required for full RPS2 activation. A rin4 null mutation is lethal, and this lethality is 
rescued in a rin4 rps2 double mutant, indicating that RIN4 negatively regulates 
inappropriate activation of RPS2 (Mackey et al., 2003). We term this “inappropriate 
activation” to distinguish it from normal, AvrRpt2-dependent RPS2 activation 
(Belkhadir, et al.2004). Collectively, these data indicate that RIN4 is a target of 
multiple, unrelated bacterial type III effector proteins, and that RIN4 associates with 
two different NB-LRR proteins. Both findings are consistent with the “Guard 
Hypothesis” for NB-LRR activation (Dangl and Jones, 2001).  
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Plant genes required for disease resistance were defined via genetic screens 
for loss of specific R functions (Glazebrook et al., 1997; Hammond-Kosack and 
Parker, 2003). Relevant to this work are NDR1 and RAR1, genes required for the 
function of various NB-LRR proteins. RAR1 is the founding member of the CHORD 
protein family, containing two novel zinc-coordinating domains (Muskett et al., 2002; 
Shirasu et al., 1999; Tornero et al., 2002). RAR1 may modulate NB-LRR protein 
levels (Tornero et al., 2002) through its association with HSP90 and other 
components of a signal-competent NB-LRR protein complex (Hubert et al., 2003; Liu 
et al., 2003; Lu et al., 2003; reviewed in Holt et al., 2003; Schulze-Lefert, 2004; 
Shirasu and Schulze-Lefert, 2003). RAR1 can associate with SGT1, a possible 
proteasome regulator required for the action of some, but not all, NB-LRR proteins 
(Austin et al., 2002; Azevedo et al., 2002; Tör et al., 2002). NDR1 modulates the 
intensity of signaling through specific NB-LRR proteins (Tornero et al., 2002). NDR1 
may be a glycosylphatidylinositol (GPI) membrane anchored protein (Century et al., 
1995; Century et al., 1997). At least three CC-NB-LRR proteins, RPM1 (Boyes et al., 
1998), RPS2 (Axtell and Staskawicz, 2003) and RPS5 (B. Holt unpublished), and 
their corresponding Avr proteins have been localized to the plasma membrane, or to 
a membrane fraction (Axtell and Staskawicz, 2003; Nimchuk et al., 2000). Thus, 
NDR1 localization at the same sub-cellular address via a GPI anchor would place it 
in an excellent position to participate in the integration and transduction of NB-LRR 
signaling during infection.  
Here, we assess whether RIN4 has any negative regulatory effect on 
inappropriate activation of RPM1, in addition to its requirement for RPM1 
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accumulation and its established negative regulatory effect on RPS2. We address 
the requirements for RAR1 and NDR1 for the inappropriate activation of RPS2 
observed in the absence of RIN4. And finally, we address whether the virulence 
activities of AvrRpm1 and AvrRpt2 in susceptible plants lacking RIN4 are altered. 
Our results establish novel functions for RIN4 in the regulation of RPM1 and RPS2 
activity and prompt a modification of the tenets of the Guard Hypothesis for disease 
resistance protein activation. 
 
Results 
Normal RPM1 function is abrogated in rin4 null plants 
We previously reported that a homozygous T-DNA insertion into the RIN4 
ORF was embryo lethal. We demonstrated that the lethality of this rin4 null allele 
(hereafter rin4; see Methods for allele designations of all mutants and transgenic 
lines used in this study) is largely suppressed in rin4 rps2 plants. This indicated that 
elimination of RIN4 results in inappropriate RPS2 activation (Mackey et al., 2003). 
We tested whether RPM1 is required for inappropriate RPS2 activation and the 
consequent lethal phenotype in selfed progeny from RIN4/rin4 RPS2/RPS2 
rpm1/rpm1 plants. One quarter of these plants died as embryos or early seedlings. 
Thus, the lethality in rin4 plants does not require RPM1 (not shown).  
We tested whether or not rpm1, like rps2, could suppress part or all of the rin4 
lethal phenotype. Plants with reduced levels of RIN4 (rin4K-D; RIN4 knock down 
plants due to an insertion in the RIN4 promoter; Ws-0 background (Mackey et al., 
2002)) are partially compromised for RPM1-mediated inhibition of bacterial growth 
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because they accumulate lowered levels of RPM1. We extended these analyses to 
RPM1 function in rin4 rps2 plants (Figure 3.1). P. syringae pv. tomato (Pto) 
DC3000(vector) grew to high levels by three days after infection on wild type Col-0 
plants. Importantly, this growth was reduced reproducibly by 10-fold in rin4 rps2, 
indicating that these plants expressed enhanced basal disease resistance against 
Pto DC3000 (see below). Growth of Pto DC3000 expressing AvrRpm1, AvrB, or 
AvrRpt2 was inhibited on wild type Col-0 plants, due to RPM1 or RPS2 action, 
respectively. The growth of each strain was enhanced in rpm1 rps2 (Figure 3.1), as 
expected in the absence of the respective R proteins.  
Importantly, the growth of Pto DC3000(avrRpm1) (Figure 3.1) or Pto 
DC3000(avrB) (not shown) was the same in rin4 rps2 plants as in rin4 rpm1 rps2 
plants, indicating a full loss of RPM1 function in the former plants, even though they 
are genotypically RPM1. Finally, the enhanced resistance against Pto DC3000 that 
we noted above in rin4 rps2 plants was not apparent against Pto DC3000 
expressing avrRpm1 or avrRpt2 (Figure 3.1). Thus, these type III effectors (and 
avrB; not shown) allow Pto DC3000 to overcome the enhanced basal disease 
resistance we observed in rin4 rps2 plants, presumably by suppressing an ectopic 
defense response (Figure 3.1). 
 
Enhanced resistance against Pto DC3000 in rin4 is due to ectopic activation of 
residual RPM1 
Numerous mutants exhibiting enhanced heightened resistance to pathogens 
also constitutively express pathogenesis-related (PR) genes, due to activation of 
basal defense responses (Glazebrook et al., 1997; Lorrain et al., 2003). The 
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Figure 3.1: RPM1 function is abrogated in rin4 null plants. Growth of the Pto 
DC3000 strains expressing the indicated type III effector genes, displayed on the 
right, was measured on wild-type and mutant Arabidopsis lines, indicated at bottom. 
Four-week-old plants were infiltrated with 105 cfu/ml and the number of bacteria per 
area of leaf plotted on a log10 scale for day 0 (white columns) and day 3 (black 
columns) (see Methods). Error bars represent the standard deviation among four 
samples. This experiment is representative of four independent replicates. The 
absence of error bars indicates low errors. A one-way ANOVA test was applied to 
each pair of values, and p < 0.01 for rin4 rps2 inoculated with Pto DC3000(vector) 
compared to all the others (*). 
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enhanced resistance we observed in rin4 rps2 plants against Pto DC3000(vector) 
indicated a possible cpr (constitutive expression of PR) phenotype (Bowling et al., 
1994). Therefore, we analyzed PR1 protein expression as a convenient marker 
typical of cpr phenotypes (Figure 3.2A). We observed some residual constitutive 
PR1 protein accumulation in rin4 rps2 plants (Figure 3.2A). No PR1 expression was 
observed in Col-0, rpm1 rps2 or, most importantly, rin4 rps2 rpm1 plants (Figure 
3.2A). For comparison, and as demonstrated previously (Mackey et al., 2002), rin4K-
D plants express constitutively high levels of PR1. Note however, that the rin4K-D 
plants are in Ws-0, precluding direct comparison of PR-1 levels in Col-0 and Ws-0. 
Nevertheless, our results in the isogenic Col-0 lines in Figure 3.2A demonstrate a 
low level of residual RPM1-dependent PR1 expression in rin4 rps2 plants. Ectopic 
RPM1 activation thus explains both the enhanced resistance to Pto DC3000 in rin4 
rps2 and the loss of that enhanced resistance in rin4 rps2 rpm1 plants (Figure 3.1).  
We also tested whether or not ectopic RPM1 activation could be enhanced by 
increasing the RPM1 dose in the context of lowered RIN4 levels represented in the 
rin4K-D plants. We doubled the RPM1 dose by crossing an isogenic RPM1-myc 
transgene (driven by the native RPM1 promoter) into rin4K-D plants. We probed 
protein blots with anti-RIN4, anti-myc, and anti-PR1 antibodies (Figure 3.2B). As 
previously noted, rin4K-D plants accumulated reduced levels of RIN4 compared to 
wild type isogenic RPM1-myc plants (Figure 3.2B). Figure 3.2B also demonstrates, 
however, that rin4K-D (RPM1-myc) plants expressed significantly more PR1 than 
rin4K-D plants. The rin4K-D (RPM1-myc) plants also exhibited accentuated 
phenotypes relative to rin4K-D (data not shown). These included smaller stature,  
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Figure 3.2: Residual RPM1 is sufficient for constitutive defense response in 
rin4 null plants. (A) Total protein extracts were prepared from wild type Col-0, rpm1 
rps2, rin4 rps2, rin4 rps2 rpm1, Ws-0 and rin4 Knock-Down (rin4K-D) plants. These 
extracts were subjected to anti-RIN4 (top, WB:RIN4) or anti-PR1 (middle, WB:PR1) 
Western blot. Ponceau staining of ribulose-1,5-bisphosphate 
carboxylase_oxygenase (Rubisco) (Bottom) was for confirmation of equal loading in 
each lane. This experiment is representative of three independent replicates.  
The models summarize the protein blot data. Grey balls represent the plasma 
membrane. Red shapes represent RPM1 and RPS2 potentially in complex with 
other cellular proteins, light and dark blue. In rin4 null plants (left), RPM1 and RPS2 
are inappropriately activated in the absence of pathogens. In rin4 rps2 plants (right) 
the residual RPM1 present is activated by the lack of RIN4. The pale blue and red 
arrows represent respectively RPM1 and RPS2 activation. The levels of activation 
are proportional to the thickness of the arrows. (B) Total protein extracts were 
prepared from wild type Ws-0, and isogenic RPM1-myc, rin4K-D and rin4K-D RPM1-
myc plants. These extracts were subjected to anti-RIN4 (top, WB: RIN4), anti-PR1 
(middle, WB: PR1) and anti-myc (bottom, WB:myc) Western blots. Ponceau staining 
of ribulose-1,5-bisphosphate carboxylase_oxygenase (Rubisco) (middle 2 panel) 
demonstrates equal loading in each lane for the anti-RIN4 and anti-PR1 antibodies. 
For the myc western blot the nonspecific band detected below RPM1-myc was used 
as an equal loading control. Note that the PR1 immunoblot in Figure 3.2A is slightly 
over-exposed relative to that in Figure 3.2B. This experiment is indicative of three 
independent replicates. The models (symbols as in Figure 3.2A) show that RPM1 
and RPS2 are inappropriateally active when levels of RIN4 are lowered in rin4K-D. 
When more RPM1 is expressed (right, note bigger red RPM1 in model), it expresses 
a higher amplitude of inappropriate activation.  
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lower fertility, loss of apical dominance, and sporadic lesions (Mackey et al., 2002). 
By contrast, doubling the RPM1 dose in the RIN4 (RPM1-myc) control plants did not 
result in detectable PR1 expression (Figure 3.2B), or in any other macroscopic 
phenotype observed in rin4K-D. Thus, the additional copy of RPM1 enhances all 
aspects of the rin4K-D phenotype. 
The level of PR1 expression in both rin4 rps2 and rin4K-D (RPM1-myc) plants 
was influenced by environment. Growth in 16 hr days resulted in more PR1 
expression compared to 8 hr day conditions. This is consistent with our previous 
observation that rin4K-D plants show an exacerbated morphology when grown in 
long day conditions compared to short day conditions (Mackey et al., 2002). We also 
consistently observed a lower mobility of RIN4 in Ws-0 compared to in Col-0 (Figure 
3.2A). This lower mobility is due to constitutive phosphorylation of RIN4 as 
phosphatase treatment restored the mobility of modified RIN4 to that of not modified 
(data not shown). 
Collectively, the results in Figure 3.2 indicate that 1) when levels of RIN4 are 
reduced, residual RPM1 is activated inappropriately, and PR1 expression and 
enhanced resistance are consequently induced. 2) Wild type RIN4 levels are 
necessary and sufficient for both the proper accumulation of RPM1 and for 
prevention of its inappropriate activation; hence RIN4 negatively regulates RPM1. 3) 
The constitutive expression of PR1 in rin4K-D plants is due to the sum of 
inappropriate activation of both RPS2 and RPM1. 
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RAR1 and NDR1 are differentially required for ectopic RPS2 activation in rin4 
rps2 suppresses lethality in rin4 (Mackey et al., 2003). We addressed whether 
mutation in signaling components required for AvrRpt2-dependent activation of 
RPS2 could suppress the ectopic RPS2 activation in rin4. RAR1 and NDR1 are both 
required for RPS2 signaling, and presumably act in the same pathway (see 
Introduction). We therefore followed lethality in selfed progeny from RIN4/rin4 
rar1/rar1 and RIN4/rin4 ndr1/ndr1 plants (Figure 3.3A).  
The rar1 mutation delayed rin4 lethality and we were able to isolate rin4 rar1 
plants. These plants had limited viability, were dwarfed relative to their RIN4 rar1 
siblings by ~2 weeks of age, formed numerous dead cell lesions spontaneously, and 
died before 3 weeks of age (Figure 3.3B). We previously demonstrated that RPM1 
accumulation is severely reduced in rar1 plants (Tornero et al., 2002). To address 
whether RPS2 levels were similarly affected, we crossed rar1 to a transgenic line 
carrying an HA-epitope tagged version of RPS2 (driven by the native promoter in 
rps2; Axtell and Staskawicz, 2003). This line expresses an accelerated HR and 
enhanced inhibition of bacterial growth compared to wild type Col-0 following 
inoculation with Pto DC3000(avrRpt2), presumably due to slight RPS2 protein over-
expression (Axtell and Staskawicz, 2003). We PCR-selected a rar1 rps2 (RPS2-HA) 
triple homozygous line (see Methods). As with RPM1-myc, we detected severely 
reduced levels of RPS2-HA protein in rar1 rps2 (RPS2-HA) plants (Figure 3.3C). 
These results indicate that 1) RAR1 is required for accumulation of at last two CC-
NB-LRR proteins and 2) rar1 does not fully suppress the rin4 lethality because the 
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Figure 3.3: RAR1, but not NDR1, delays the lethality in rin4 null plants. (A) F2 
plants of the genotypes shown at left were allowed to self pollinate. The segregation 
of RIN4 in these progenies was scored on 100 F3 plants by RIN4 Western blot. 
Segregation data was evaluated with chi-square analysis. (B) Pictures of 
representative progenies from selfed RIN4/rin4 rar1/rar1 F2 plants. Note that rar1 
rin4 are smaller and develop spontaneous lesions compared to rar1 RIN4 plants. (C) 
Total protein extracts were prepared from the genotypes listed at the top. These 
extracts were subjected to an anti-HA Western blot (top). The Ponceau stain of the 
ribulose-1,5-bisphosphate carboxylase_oxygenase (bottom) shows that the 
differences observed in rar1 rps2 (RPS2-HA) plants are not due to loading errors.  
 76
residual RPS2 in rin4 rar1 plants remains ectopically activated. These results are 
consistent with a quantitative role for RAR1 in NB-LRR accumulation. 
We did not recover any rin4 ndr1 plants in the analyzed progenies (Figure 
3.3A). Thus, ndr1 cannot suppress inappropriate RPS2 activation in rin4, although it 
is clearly required for AvrRpt2-dependent RPS2 activation (Century et al., 1995). 
Additionally, there is no diminution of RPS2-HA levels in ndr1 rps2 (RPS2-HA) 
plants (Figure 3.3C). 
RPS2-HA is a plasma membrane protein, and this localization is retained in 
the absence of RIN4 following infection with Pto DC3000(avrRpt2) (Axtell and 
Staskawicz, 2003). NDR1 is a predicted GPI anchored protein (B. Staskawicz, pers. 
comm.). We tested whether NDR1 is responsible for RPS2 localization, since RPS2 
mis-localisation could account for the differential NDR1 requirement during AvrRpt2-
dependent RPS2 activation compared to its inappropriate activation in rin4. We 
fractionated crude lysates from rps2 (RPS2-HA), ndr1 rps2 (RPS2-HA) and rar1 rps2 
(RPS2-HA) transgenic plants into total, soluble, and microsomal fractions and 
analyzed protein blots (Figure 3.4A). RPS2-HA remained localized in the microsomal 
fraction in ndr1 and rar1 plants. Thus, gross mis-localization of RPS2 cannot explain 
either the loss of AvrRpt2-dependent RPS2 activation in ndr1, or the differential 
requirement for NDR1 in the two modes of RPS2 activation. Collectively, the results 
in Figures 3.3 and 3.4 indicate that 1) NDR1 is either upstream or independent of the 
inappropriate RPS2 activation in rin4 and 2) NDR1 does not regulate RPS2 function 
by controlling its accumulation, as does RAR1, or its localization.  
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Figure 3.4: Microsomal RPS2 localization and interaction with RIN4 do not 
require NDR1 or RAR1. (A) Total protein extracts (T) from genotypes shown at the 
top were fractionated into soluble (S) and microsomal (M) extracts (see Methods). 
The fractionated samples were analyzed by Western blot with anti-HA, anti-RIN4, 
anti-APX (Ascorbate Peroxidase; control soluble protein) and anti-RD28 (control 
integral membrane protein) anti-sera (Boyes et al., 1998). Microsomal fractions are 
approximately 5 times concentrated relative to total (T) and soluble (S) fractions. (B) 
Protein from genotypes shown at top were immunoprecipitated (IP: RIN4) with anti-
RIN4 sera (I) or with pre-immune sera (PI). Total extracts (T) from rps2 and rps2 
(RPS2-HA) as well as immunoprecipitated samples were analyzed by Western blot 
with an anti-HA antibody (WB: HA). The relative amounts of protein from the immune 
pellet and the total extracts are not equivalent. The pellet is over-represented by 30-
fold. This experiment is representative of two independent replicates. 
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We conducted co-immunoprecipitation experiments to test whether RIN4 also 
interacts with RPS2 in rar1 and ndr1 mutants (Figure 3.4B). Extracts from rps2 
(RPS2-HA), ndr1 rps2 (RPS2-HA) and rar1 rps2 (RPS2-HA) transgenic plants 
immunoprecipitated with anti-RIN4 antisera were analyzed for RPS2-HA in protein 
blots. Neither ndr1 nor rar1 affected the ability of RIN4 to co-immunoprecipitate 
RPS2-HA, despite the overall lower levels of RPS2-HA accumulating in rar1 (Figure 
3.4B). The data presented in Figures 3.3 and 3.4 indicate that neither RAR1 nor 
NDR1 affects the mechanism of inappropriate RPS2 activation in rin4 plants, though 
RAR1 apparently dampens it by modulating RPS2 accumulation.  
 
Wild type levels of NDR1 are sufficient to transduce enhanced RPS2 function 
Our data indicate that NDR1 acts upstream or independently of inappropriate 
RPS2 activation in rin4. There is, however, a possible alternative explanation for the 
inability of ndr1 to suppress rin4 lethality, where NDR1 would act downstream of 
RPS2 activation. Recall that NDR1 acts quantitatively during NB-LRR activation (see 
Introduction). There is obviously sufficient NDR1 in a wild type plant to transduce a 
normal, AvrRpt2-driven RPS2 response. It might be that the quantity of signal flux 
during inappropriate RPS2 activation in rin4 is greater, or more sustained, than 
during infection. Thus, the signal flux during inappropriate RPS2 activation may 
overcome the normal requirement for NDR1 such that the lethal rin4 phenotype is 
generated via bypass in an ndr1 mutant.  
To address this possibility, we took advantage of the accentuated RPS2 
function in our rps2 (RPS2-HA) transgenic line (introduced above; Axtell and 
 80
Staskawicz, 2003). This line should produce more flux through RPS2 during an 
AvrRpt2-driven response than wild type. We established this point by comparing 
RPS2 function in rar1 rps2 (RPS2-HA) and ndr1 rps2 (RPS2-HA) to rar1 and ndr1 
(Figure 3.5). Pto DC3000(avrRpt2) growth was restricted in wild type Col-0, and 
even more restricted in rps2 (RPS2-HA), reflecting enhanced RPS2 action as 
previously noted (Axtell and Staskawicz, 2003). Pto DC3000(avrRpt2) grew to high 
levels on rps2. This growth was 90% reduced in rar1, indicating that the residual 
RPS2 in rar1 plants still functions. Importantly, Pto DC3000(avrRpt2) growth was 
reduced by more than 99.5% in rar1 rps2 (RPS2-HA), indicating that the enhanced 
AvrRpt2-dependent RPS2 activation in this line is sufficient to partially overcome the 
lack of RAR1 in rar1 rps2 (RPS2-HA). By contrast, the growth of Pto 
DC3000(avrRpt2) was identical on ndr1 and ndr1 rps2 (RPS2-HA), demonstrating 
that the enhanced RPS2 signal was still fully NDR1-dependent. These results are 
also consistent with a role for RAR1 in modulating RPS2 stability or accumulation. 
Further, they indicate that wild type levels of NDR1 are necessary and sufficient to 
mediate even the enhanced signaling observed in rar1 rps2 (RPS2-HA). The latter 
result argues against a bypass of NDR1 function during inappropriate RPS2 
activation in rin4.  
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Figure 3.5: Enhanced RPS2 function modulates its requirement for RAR1, but 
does not overcome its requirement for NDR1. Growth of Pto DC3000(avrRpt2) 
was measured on wild-type and mutant Arabidopsis lines, indicated at bottom. 
Bacterial growth was measured as described in Figure 3.1, legend. Error bars 
represent the standard deviation among four samples, and this experiment is 
representative of two independent replicates. The absence of error bars indicates 
low errors. 
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RIN4 levels modulate AvrRpt2 virulence function, but RIN4 is not the only 
target of AvrRpt2  
If RIN4 is the only target for AvrRpt2 when this type III effector acts as a 
virulence factor in rps2, then it could be the case that elimination of RIN4 would 
result in loss of that virulence activity. We used a weak pathogen strain, Pma 
M6C∆E (Rohmer et al., 2003), to examine the contribution of AvrRpt2 to bacterial 
virulence on plants with altered levels of RIN4. Note that we observed only a weak 
RPS2-dependent inhibition of bacterial growth with Pma M6C∆E(avrRpt2) at low 
bacterial doses (Figure 3.6A). However, using a higher titer of bacteria we observed 
consistently RPS2-mediated HR (data not shown). The weak RPS2-mediated 
inhibition of bacterial growth is likely due to the weak intrinsic virulence of Pma 
M6C∆E.  
We reproducibly observed a very slight increase in the virulence of Pma 
M6C∆E(avrRpt2) on rps2 compared to Col-0 (Figure 3.6). AvrRpt2 delivered from 
Pma M6C∆E promotes increased bacterial growth in rin4 rps2 plants compared to 
rps2 plants (Figure 3.6A). This enhanced virulence function of AvrRpt2 is reversed in 
rps2 plants that over-express RIN4 (OxRIN4 rps2 plants; Mackey et al., 2003) 
(Figure 3.6A). These data indicate that 1) RIN4, in a formal sense, negatively 
regulates one or more AvrRpt2 virulence activities; 2) wild-type levels of RIN4 are 
apparently saturating for this negative regulation; and 3) RIN4 is not required for this 
AvrRpt2 virulence activity.  
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Figure 3.6: RIN4, RAR1 and NDR1 modulate AvrRpt2 virulence function(s). (A) 
RIN4 is not required for AvrRpt2 virulence function. Growth of Pma M6C∆E carrying 
either empty vector or avrRpt2 (indicated at bottom) was measured on the 
genotypes indicated at top. Bacterial growth was measured as described in Figure 
3.1, legend. A one-way ANOVA test was applied to each pair of values, and p < 0.01 
for rin4 rps2 inoculated with Pma M6C∆E(avrRpt2) compared to all others (*). Error 
bars represent the standard deviation among four samples, and this experiment is 
representative of six independent replicates. (B) RAR1 and NDR1 negatively 
regulate AvrRpt2 virulence function. Inoculations and labels are as in (A). A one-way 
ANOVA test was applied to each pair of values, and p < 0.01 for rin4 rps2, ndr1 rps2 
and rar1 rps2  inoculated with Pma M6C∆E(avrRpt2) compared to all the others (*) 
(top). Error bars represent the standard deviation among four samples and this 
experiment is representative of two independent replicates 
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The absence of RAR1 and NDR1 enhance AvrRpt2 virulence function(s) 
AvrRpt2 is able to promote the virulence of Pto DC3000 by suppressing plant 
defenses downstream or independently of SA-dependent basal defenses (Chen et 
al., 2004). RAR1 and NDR1 can regulate basal plant defense (see Introduction). We 
therefore addressed the contribution of RAR1 and NDR1 to AvrRpt2 virulence 
activities by inoculating Pma M6C∆E(avrRpt2) onto rar1 rps2 and ndr1 rps2 (Figure 
3.6B). Again, Pma M6C∆E(avrRpt2) grew reproducibly to higher titers on rps2 than 
did Pma M6C∆E(vector), indicative of an AvrRpt2 virulence function. This was 
enhanced in rin4 rps2, as in Figure 3.6A. Importantly, AvrRpt2 promoted more  
bacterial growth in rar1 rps2 and ndr1 rps2 compared to rps2 (Figure 3.6B). These 
results indicate that RAR1 and NDR1 negatively regulate one or more AvrRpt2 
virulence activities, presumably via their functions in the induction of basal defense. 
 
RIN4 is not the only target of AvrRpm1 and AvrB in Arabidopsis 
The ability of AvrRpm1 and AvrB to interact with RIN4 and to induce its 
phosphorylation may contribute to their ability to enhance bacterial virulence in rpm1 
plants (Mackey et al., 2002). Thus, RIN4 might be the target, or be a partner in a 
complex with the target(s), of the AvrRpm1 and AvrB virulence function(s). To study 
the relationship between the virulence activities of these type III effectors and RIN4, 
we tested whether the absence or over-expression of RIN4 alters the phenotypes 
associated with AvrRpm1 and AvrB in rpm1 rps2, rin4 rpm1 rps2 or OxRIN4 rpm1 
plants (Mackey et al.,2003). Pma M6C∆E(vector) grew to intermediate levels (Figure 
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Figure 3.7: RIN4 is not the only virulence target for AvrRpm1 and AvrB in 
Arabidopsis. (A) Growth of Pma M6C∆E carrying empty vector or avrRpm1 
indicated at bottom was measured on the genotypes indicated at top. Four-week-old 
plants were infiltrated with 104 cfu/ml and the number of bacteria per area of leaf 
plotted on a log10 scale for day 0 (white columns) and day 3 (black columns) (see 
Methods). Error bars represent the standard deviation among four samples and this 
experiment is representative of three independent replicates. The absence of error 
bars indicates insignificant differences. (B) Agrobacterium carrying empty vector or 
dexamethasone (DEX) inducible avrB-HA as indicated at bottom were inoculated 
onto leaves of various genotypes indicated at top, at 1010 cfu/ml. Leaves were 
sprayed 24 hours post-inoculation (hpi) with DEX (20μM), and photographed 96 
hours after that. Total protein extracts were prepared 96 hours after DEX and 
subjected to an anti-HA Western blot. 
 86
3.7A). This growth was unaffected by the expression level of RIN4, and was RPM1 
and RPS2 independent (data not shown). Pma M6C∆E(avrRpm1) growth in wild 
type Col-0 was significantly reduced, due to RPM1 action, compared to growth in 
rpm1 rps2, rin4 rps2 rpm1 or OxRIN4 rpm1 plants. The virulence activity of AvrRpm1 
(Ritter and Dangl, 1995; Rohmer et al., 2003) causes Pma M6C∆E(avrRpm1) to 
grow reproducibly 10-fold more than Pma M6C∆E(vector) in rpm1. This was 
observed on each rpm1 genotype tested, including rin4 rpm1 rps2 (Figure 3.7A). We 
conclude that the lack, or over-expression, of RIN4 does not affect this virulence 
activity of AvrRpm1.  
We carried out a similar set of experiments with Pma M6C∆E(avrB) (not 
shown). Unlike AvrRpm1, AvrB is not able to promote pathogen growth on rpm1, 
though it can add to P. syringae virulence on susceptible soybean genotypes 
(Ashfield et al., 1995). Altered levels of RIN4 did not alter the growth of this strain 
compared to Pma M6C∆E (vector) on any tested plant line (data not shown). 
AvrB can cause a chlorotic response when expressed in rpm1, potentially 
indicative of its virulence activity (Nimchuk et al., 2000). We addressed whether 
modifications of RIN4 levels alter this phenotype. Figure 3.7B demonstrates that 
AvrB-dependent chlorosis in rpm1 is RIN4 independent. Further, AvrB accumulates 
in a RIN4-independent manner (the modest difference in the levels of AvrB in this 
experiment is sporadic and does not correlate with expression of RIN4, not shown). 
The results presented in Figure 3.7 indicate that while RIN4 is certainly an 
avirulence target for both AvrRpm1 and AvrB, it is not their only virulence target. 
 87
Alternatively, a direct requirement of RIN4 for the virulence activities of AvrRpm1 
and AvrB cannot be measured in our assays. 
 
DISCUSSION 
 
This work was aimed at clarifying the role of the Arabidopsis RIN4 protein in 
the control of RPM1 and RPS2 activation. We further tested whether RIN4 is the 
unique target of AvrRpm1, AvrB and AvrRpt2 when these type III effectors function 
as virulence factors. We show that RIN4 has a negative regulatory function that 
blocks the inappropriate activation of RPM1, in addition to a similar regulatory 
function previously established for RIN4 in RPS2 activation (Axtell and Staskawicz, 
2003; Mackey et al., 2003). We propose that wild type levels of RIN4 are required to 
maintain RPM1 and RPS2 in a non-signaling configuration. We demonstrate that 
inappropriate RPS2 activation, leading to lethality in rin4 plants, is quantitatively 
dependent on RAR1, but independent of NDR1. The latter observation differentiates 
this mode of RPS2 activation from its normal, AvrRpt2-driven activation and strongly 
indicates that RIN4 functions at, downstream, or independently of NDR1 to control 
RPS2 activity. We also demonstrate that RIN4 is not the only target of AvrRpm1, 
AvrB and AvrRpt2 with respect to the virulence activities of these three type III 
effectors. Surprisingly, RIN4 negatively regulates at least one virulence activity of 
AvrRpt2. We propose that P. syringae type III effector proteins may frequently have 
multiple targets in susceptible plants. Their manipulation of a subset of these targets 
(one, in fact), is demonstrably sufficient for activation of at least RPM1 and RPS2. 
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Our data extend the notion that NB-LRR proteins monitor the activities of type III 
effector proteins expressed by pathogenic bacteria, and have implications for the 
evolution of the plant immune system. 
 
RIN4 negatively regulates inappropriate RPM1 activation 
The rin4 lethality was largely suppressed in a rin4 rps2 double mutant, 
proving that inappropriate RPS2 activation is negatively regulated by RIN4 (Mackey 
et al., 2003). Yet residual signaling in rin4 rps2 is sufficient to drive enhanced basal 
defense against Pto DC3000 (Figure 3.1) and PR1 expression (Figure 3.2A). The 
residual RPM1 present in rin4 rps2 is responsible for these phenotypes, as they are 
eliminated in rin4 rps2 rpm1 triple mutants. Note that this residual RPM1 is not 
competent to transduce AvrRpm1- or AvrB-dependent signals (Figure 3.1; and not 
shown). Thus, RIN4 also negatively regulates inappropriate RPM1 activity. Wild type 
RIN4 levels are apparently saturating for maintaining RPM1 in an inactive state, as 
neither a doubling of the RPM1 dose (Figure 3.2B) nor RIN4 over-expression 
(Mackey et al., 2002) affects RPM1 function. RPM1 was inappropriately active in 
wild-type plants when over-expressed (Leister and Katagiri, 2000), possibly due to 
an elevated RPM1/RIN4 ratio. 
Four related models can explain these data. 1) RPM1 is activated in rin4 
plants because RIN4 is a negative regulator of RPM1 activation and that regulation 
is lacking. The lowered RPM1 levels we observed in rin4K-D (Figure 3.2B) would 
then be a consequence of RPM1 disappearance following its activation (Boyes et al., 
1998). 2) Specific RPM1 activation might require the physical interaction of AvrRpm1 
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or AvrB with RIN4 (Mackey et al., 2002) or a RIN4-containing complex, and that 
interaction could be disrupted when residual RPM1 mis-accumulates in the absence 
of RIN4. 3) Residual, activated RPM1 might lose its responsiveness to AvrRpm1 and 
AvrB. This would be analogous to CARD15/NOD-2 variants that ectopically activate 
the NF-κB pathway, but lose responsiveness to LPS and subsequent, appropriate 
NF-κB activation (Tanabe et al., 2004). 4) RPM1 simply might not accumulate 
enough in the absence of RIN4 to allow a robust AvrRpm1- or AvrB-specific 
response in rin4 plants. This possibility, though, is inconsistent with the established 
notion that NB-LRR protein activation requires a lower threshold of signal than does 
activation of basal defense (Tao et al., 2003). 
Lowering of RPM1 levels, however, is not necessarily accompanied by 
activation of basal defense. Arabidopsis rar1 mutants accumulate very low levels of 
RPM1, but display normal susceptibility to Pto DC3000 (Tornero et al., 2002), rather 
than the enhanced resistance that we observed in rin4 rps2. Arabidopsis athsp90.2 
mutants also express severe RPM1 reduction that is correlated with a diminution of 
RPM1 function (Hubert et al., 2003). Thus, RPM1 is destabilized in atrar1 or 
athsp90.2 without concomitant activation of basal defense. This is consistent with a 
proposed function of RAR1/SGT1/HSP90 for assembly of signal-competent RPM1 
"upstream" of any activation (Hubert et al., 2003; Schulze-Lefert, 2004). 
Activation of the Rx NB-LRR protein is dependent on finely tuned intra-
molecular interactions (Moffett et al., 2002; Rathjen and Moffett, 2003). Intra-
molecular interactions are often conditioned and modulated by intermolecular 
interactions (Autiero et al., 2003; Djordjevic et al., 1998). The inappropriate RPM1 
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activation in rin4 rps2 might also be due to the consequences of intra-molecular 
changes induced by the absence of normal interactions between RPM1, RIN4 and 
other putative components. This model is consistent with a possible requirement for 
RIN4 phosphorylation during AvrRpm1- or AvrB-induced activation of RPM1, as 
phosphorylation events are known to induce changes in protein-protein interactions 
(Djordjevic et al., 1998).  
 
Inappropriate RPS2 activation is independent of NDR1 and modulated by 
RAR1  
NDR1 is required for AvrRpt2-driven activation of RPS2. It was previously 
shown that NDR1 is not required for the AvrRpt2-induced disappearance of RIN4 
(Axtell and Staskawicz, 2003). Here, we show that NDR1 is not required for RPS2 
accumulation, gross localization, or association with RIN4. Thus, three important 
requirements for the RIN4-dependent activation of RPS2 by AvrRpt2 are NDR1-
independent. These results corroborate our genetic demonstration that ndr1 is not 
able to suppress inappropriate RPS2 activation in rin4. Thus, the events leading to 
either AvrRpt2-driven RPS2 activation or its inappropriate activation in rin4 are 
separable. Very little is known about how NDR1 functions in NB-LRR activation. 
Based on our data, we propose that NDR1 does not affect 1) NB-LRR stability, or 2) 
NB-LRR localization, and 3) that NDR1 is not required for signaling downstream of 
NB-LRR protein activation. Instead we envision that NDR1 functions upstream of 
NB-LRR activation by various pathogens. 
RAR1 is required for RPS2 and RPM1 signaling in Arabidopsis (see 
Introduction). The accumulated data indicates that RAR1 limits defense signal flux, 
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perhaps by modulating NB-LRR stability or accumulation (Tornero et al., 2002). Our 
results indicate that RAR1 also modulates RPS2-HA accumulation (Figure 3.3). 
Heightened RPS2 signaling capacity, presumably achieved by slight over-
expression, can partially overcome the lack of RAR1 in rar1 rps2 (RPS2-HA) plants 
(Figure 3.6). We propose that RAR1 acts generally on NB-LRR proteins by 
controlling their accumulation and/or stability, and not by modulating a common 
downstream signal.  
 
AvrRpt2, AvrRpm1 and AvrB manipulate basal defense 
The enhanced resistance against Pto DC3000 in rin4 rps2 plants is abrogated 
when the bacteria express AvrRpm1 or AvrRpt2 (Figure 3.1), or AvrB (not shown). 
Thus, these proteins can presumably suppress the basal defense activated in rin4 
rps2. Our findings are also consistent with recent data indicating that AvrRpt2 acts 
as a virulence factor downstream, or independent, of SA accumulation (Chen et al., 
2004) and with recent data suggesting that a variety of P. syringae type III effectors 
manipulate plant basal defense responses (Abramovitch and Martin.,2004).  
Pto DC3000(avrRpm1) and Pto DC3000(avrRpt2) suppress the enhanced 
basal resistance against Pto DC3000 observed in rin4 rps2 (Figure 3.6). These data 
clearly indicate that RIN4 is either not a virulence target or not the only target for 
AvrRpm1 and AvrRpt2 in rin4 rps2. In fact, AvrRpt2-dependent virulence is 
enhanced in rin4 rps2 (Figure 3.6; see below). The enhancement of AvrRpt2-
dependent virulence on rin4 rps2 was also observed when it was delivered from 
Pma M6C∆E (Figure 3.6). Because we did not observe enhanced resistance against 
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Pma M6C∆E on rin4 rps2, AvrRpt2 may enhance the growth of this strain in a 
manner distinct from its function in Pto DC3000.  
 
rar1 and ndr1 mutations enhance AvrRpt2 virulence function(s) 
ndr1 plants are impaired in basal defense responses (our unpublished data). 
AvrRpt2 was recently shown to promote virulence in rps2 by suppressing defense 
gene expression downstream or independent of SA (Chen et al., 2004). We extend 
these results by demonstrating that ndr1 rps2 and rar1 rps2 support significantly 
more AvrRpt2-dependent Pma M6C∆E growth than rps2 (Figure 3.6). Hence, the 
loss of basal defense signaling normally induced via NDR1 and RAR1 enhances the 
observed effect of AvrRpt2. We therefore propose that there are multiple basal 
defense pathways that are downstream or independent of SA. Some of these are 
targeted by AvrRpt2, while others are NDR1 and/or RAR1 dependent.  
 
RIN4 is not the only target of AvrRpm1, AvrRpt2, or AvrB 
If each type III effector has a specific, single host target, then it follows that 
elimination of that target would diminish pathogen virulence. We hypothesized that 
elimination of RIN4 in the rin4 rps2 rpm1 triple mutant would allow us to determine 
whether the known virulence function of AvrRpm1 requires RIN4. Our data clearly 
indicate that AvrRpm1 virulence function and AvrB-dependent chlorosis are 
maintained (Figure 3.7), and that AvrRpt2 function is unexpectedly enhanced (Figure 
3.6) in rin4 rps2. Thus, while RIN4 is assuredly a target of AvrRpm1, AvrB and 
AvrRpt2 (Axtell and Staskawicz, 2003; Mackey et al., 2003; Mackey et al., 2002), it 
 93
is not the only target for any of them. We propose that type III effectors from P. 
syringae, like those from Shigella flexneri, have multiple host cellular targets (Hilbi et 
al., 1998; Lafont et al., 2002).  
We established that, surprisingly, RIN4 negatively regulates virulence 
mediated by AvrRpt2 (Figure 3.6). AvrRpt2 encodes a probable cysteine protease, 
and it was proposed that this activity destabilizes RIN4 or a RIN4 containing 
complex (Axtell et al., 2003). Our observations of 1) increased bacterial growth 
mediated by AvrRpt2 on rin4 rps2 plants, and 2) reversal of that effect by RIN4 over-
expression fit a model where a limited number of translocated AvrRpt2 molecules 
could operate on several cellular substrates. We envision that the specific activity of 
the AvrRpt2 protease for other substrates is increased in rin4 plants. As a result, the 
other targets are neutralized more quickly or more efficiently and the fitness of the 
bacteria on rin4 plants is increased. Alternatively, RIN4, like NDR1, regulates a 
basal defense pathway that is possibly targeted by AvrRpt2.  
 
Is RIN4 the only bacterial type III effector target “guarded” by RPM1 and 
RPS2? 
RIN4 is evolutionarily conserved in at least rice, maize, tobacco, tomato and 
potato (unpublished). The functional association of two NB-LRR proteins (RPM1 and 
RPS2) with RIN4 in Arabidopsis, combined with RIN4’s conservation, raises the 
possibility that RIN4 regulates defense responses in those plant species as well. Our 
work indicates, though, that RIN4 is not the only virulence target of AvrRpm1, AvrB 
and AvrRpt2. It is thus legitimate to question whether RPS2 and RPM1 monitor the 
 94
homeostasis of RIN4 alone or, alternatively, of RIN4 and a subset of other AvrRpm1, 
AvrB, and AvrRpt2 targets. 
 Ashfield et al., 2004 very recently demonstrated that the NB-LRR protein that 
recognizes AvrB (but not AvrRpm1) in soybean, Rpg1-b, is not the closest ortholog 
of RPM1. They further showed that AvrRpt2 could interfere with AvrB dependent 
activation of Rpg1-b, consistent with results in Arabidopsis (Ritter and Dangl, 1996), 
but that this interference may not be due to the AvrRpt2-dependent elimination of 
RIN4, as observed in Arabidopsis (Mackey et al., 2003). Further, they saw no clear 
AvrB-dependent mobility changes in anti-RIN4 cross-reacting bands in soybean 
protein extracts. Thus, although more work remains to be done, it may be that Rpg1-
b is not associated with RIN4, but rather with another host target of both AvrB and 
AvrRpt2.  
The evolution of a single NB-LRR protein guarding any of the several 
potential targets of a given virulence factor is demonstrably sufficient to initiate 
successful disease resistance against pathogen strains expressing that virulence 
factor. Particularly effective virulence factors would presumably spread through the 
pathogen population, at frequencies balanced by the rate of evolution of NB-LRR 
proteins that detect their action. This might drive evolution of multiple NB-LRR 
genes, whose products recognize the action of a single virulence factor at different 
targets. 
There may be, however, fundamental evolutionary pressures limiting the 
number of targets that a particular NB-LRR protein can simultaneously guard. The 
first is structural. If the various virulence factor targets are divergent, a single NB-
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LRR protein might not be able to productively interact with all of them. The second 
may be reflected by the fact that maintenance of RPM1 expression in Arabidopsis 
results in a substantial fitness cost for the plant (Bergelson et al., 2001; Grant et al., 
1998; Stahl et al., 1999). This might be generally true, since constitutive NB-LRR 
activation results in cell death (Collins et al., 1999; Hu et al., 1996; Shirano et al., 
2002; Zhang et al., 2003). Thus, a potential explanation for the apparently limited 
number of AvrRpm1, AvrB and AvrRpt2 targets that are effectively guarded by 
RPM1 and RPS2 could be an inherent fitness cost associated with increasing NB-
LRR expression levels. An increase in the number of host targets guarded by a 
particular NB-LRR protein might result in an increase in overall levels of that protein 
and an attendant fitness costs. 
 
Materials and Methods 
 
Pseudomonas syringae 
Pto DC3000 carrying either pVSP61 or derivatives of this plasmid containing 
avr genes have been described (Mackey et al., 2003; Mackey et al., 2002). and Pma 
M6C∆E is a derivative of a weakly virulent isolate of P. syringae pv. maculicola 
(Rohmer et al., 2003). Bacterial growth in plant leaves was measured by two 
methods. Figure 3.1 was done by inoculating four weeks old plants with 105 cfu/ml. 
In Figures 3.5 and 3.6, four weeks old plants were inoculated with 104 cfu/ml. For 
each sample, four leaf discs were pooled, four times per data point (16 leaf discs 
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total). Leaf discs were bored from the infiltrated area, ground in 10 mM mgCl2, and 
serially diluted to measure bacterial numbers.  
 
 
 
Protein 
Total protein extracts were prepared, and cell fractionation and co-
immunoprecipitation assays performed, as described in (Mackey et al., 2003; 
Mackey et al., 2002). Anti-RIN4 serum was used at a dilution of 1:5000. The Anti-
PR-1 serum (gift of Dr. Robert A. Dietrich, Syngenta) was used at a dilution of 
1:10000. The anti-RD28 and anti-APX (respectively gifts of Dr Maarteen Chrispeels 
and Dr Daniel Kliebenstein) antibodies were used at a dilution of 1:5000. Detection 
of HA and myc epitope tags was with supernatants from cultures of hybridoma 3F10, 
monoclonal anti-HA antibody (Roche), at a dilution of 1:1000 and the hybridoma 
9E10, monoclonal anti-myc antibody, at a dilution of 1/10 (Boyes et al.,1998). 
 
Plants and mutant construction 
The following plant genotypes were used in this work: rps2-101C in an allele 
of RPS2 in Col-0 with a stop codon following amino acid 235 (Bent et al., 1994); 
rpm1-3 is an allele of RPM1 with a stop codon following amino acid 87 (Grant et al., 
1995). The rin4 null is a T-DNA insertion in the RIN4 ORF in Col-0 (Mackey et al., 
2003). The rin4K-D is a T-DNA insertion in the promoter of RIN4 in Ws-0 (Mackey et 
al., 2002). The triple mutant rin4 rpm1 rps2 was constructed like the rin4 rps2 double 
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mutant described in (Mackey et al., 2003) using the Col-0 rin4 null allele. The RPM1 
PCR product was digested with EcoRV which cut the wild type, but not rpm1-3, into 
a doublet. The rin4K-D RPM1-myc line was made by crossing a Ws-0 based RPM1-
myc transgenic line to the Ws-0 rin4 K-D plants. The rin4 K-D plants were used as a 
pollen source. RPM1-myc was followed by hygromycin resistance and rin4K-D was 
followed phenotypically. The RPM1-myc and rin4 K-D RPM1-myc plants in the Ws-0 
background have both an endogenous and the transgenic copy of RPM1. Mutant 
alleles of the ndr1-1 null (Century et al., 1997) and the premature stop in rar1-21 
(Tornero et al., 2002) were PCR selected using primers and conditions are available 
on request. 
 
Agrobacterium Transient Expression Assays 
2 ml overnight Agrobacterium cultures were grown at 30°C in YEB (5 g bacto 
beef extract, 1 g bacto yeast extract, 5 g bacto peptone,5 g sucrose, 2 mM MgSO4, 
pH 7.2, per liter) containing 100 mg/ml each of rifampicin, kanamycin, and 
gentamycin for strain GV3101.The following day, 150 ml of saturated culture was 
inoculated into3 ml of YEB plus antibiotics, and grown for 13 hr. Two milliliters were 
collected and re-suspended in 3ml Agrobacterium induction medium (10.5 g 
K2HPO4, 4.5 g KH2PO4, 1 g (NH4)2SO4, 0.5 g (NaCitrate), 1 mMMgSO4, 1 g 
glucose, 1 g fructose, 4 ml glycerol, 10 mM MES, pH5.6, per liter, 50 mg/ml 
acetosyringone), grown at 28C for 5–7 hr., collected and resuspended in infiltration 
medium (1/2 MS-MES) to an OD600 of 0.4. The underside of 3-week-old leaves was 
inoculated using a needle less syringe. Plants were grown in 120 µE of light and 
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sprayed with 20 μM DEX (Sigma, St. Louis, MO), To inducibly express AvrB in 
planta, the gene with a carboxy-terminal HA-tag was cloned into pTA7002 (Aoyama 
and Chua, 1997). 
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CHAPTER 4 
A second generation forward screen for Arabidopsis mutants unable to  
recognize avrRpm1 
 
Preface 
 This chapter represents all unpublished work.  Over the years several people 
have contributed towards it progress.  Undergraduate Jonny Chen helped with the 
initial screening.  Allison Osborne helped with finishing the confirmatory Estradiol 
retest and the initial bacterial tests.  Anna Newton also helped with the bacterial 
tests.  David Rybnicek and Tim Eitas have worked on the characterization of lra6. 
 
Abstract 
 Plants recognize pathogens by an evolutionarily conserved innate immune 
system.  Central to the immune response are disease Resistance (R) genes 
required by the plant to recognize specific avirulence (avr) proteins encoded by the 
pathogen.  In this paper, we present the results of a second generation genetic 
screen to identify additional loci required for the function of the Arabidopsis R gene 
RPM1, which confers resistance to Pto DC3000 (avrRpm1).  The screen builds on a 
previous screen for mutants unable to respond to inducible expression of AvrRpm1.  
This screen improves on this previous screen by utilizing an additional, transgenic 
copy of RPM1 to prevent the repeated identification of multiple rpm1 alleles.  
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Additional changes in screening methodology are described which aided in 
identifying several novel loci, one of which, lra6, compromises the function of several 
R genes.  As opposed to previously identified mutants that block accumulation of R 
proteins, lra6 mutants appear to block accumulation of R gene transcript.   
 
Introduction 
 Plants must fight pathogens or die.  While the plant arsenal for use against 
pathogens ranges from a build-up of cell wall fortifications to the release of toxins, 
nearly all resistance responses require pathogen recognition to function maximally.  
The basis of that recognition can be found in plant disease Resistance (R) genes 
(Flor, 1971).  R proteins are highly specific and recognize at most one or two 
pathogen gene products.  Given that R protein recognition of pathogen gene 
products enables the plant to mount an effective defense response, these pathogen 
genes have been dubbed avirulence (avr) genes. 
 Immediately, one questions why pathogens maintain genes that trigger a 
plant resistance response.  Obviously, they must confer to the pathogen some 
evolutionary advantage.  After the first avr genes were cloned, it became apparent 
that, in the absence of pathogen recognition by the plant, these avr genes allow for 
better pathogen growth in plants (Ritter and Dangl, 1995). Thus, in the absence of 
their corresponding R gene, avr genes act as virulence factors.   
 While avr gene products are structurally and sequence diverse, R proteins 
have a much more conserved structure.  The majority of R proteins contain a 
nucleotide binding site (NB) domain and a C-terminal leucine-rich repeat (LRR) 
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domain.  The NB domain has been shown to bind and hydrolyze ATP, while LRRs 
are often protein-protein interaction domains (Kobe and Kajava, 2001; Tameling et 
al., 2002).  The N-terminal domain differentiates the two major classes of R proteins.  
One class contains a domain with homology to Toll and the Interleukin-1 receptor 
and is referred to as TIR domain (Dangl and Jones, 2001).  The other class has an 
N-terminal coiled-coil domain.  R genes in this class are referred to as CC-NB-LRR.   
These two classes of R genes differ in their functional requirement for additional loci. 
 Three loci, EDS1, PAD4, and SAG101, are specifically required for TIR-NB-
LRR signaling, and are not required for the function of CC-NB-LRR type R proteins 
(Feys et al., 2005).  While no locus has been shown to be specifically required for 
CC-NB-LRR function, several loci have been shown to be required for the function of 
both classes of NB-LRR protein.  These include the genes NDR1, RAR1, SGT1, and 
HSP90 (Azevedo et al., 2002; Hubert et al., 2003; Liu et al., 2004; Schornack et al., 
2004; Tornero et al., 2002b; van der Biezen et al., 2002).  Interestingly, the majority 
of these loci play a role in NB-LRR protein stability (Holt III et al., 2005; Hubert et al., 
2003; Tornero et al., 2002b). 
 The Arabidopsis R gene RPM1 encodes a CC-NB-LRR protein that 
recognizes the Pseudomonas gene products AvrB and AvrRpm1 (Grant et al., 
1995).  No direct interaction has been reported between RPM1 and either of these 
two avirulence proteins.  However, another plant protein, RIN4, can interact with 
both RPM1 and AvrB (Mackey et al., 2002).  RIN4 becomes phosphorylated in the 
presence of either AvrB or AvrRpm1.  Currently, it is understood that this post-
translational modification of RIN4 serves as the trigger of RPM1 action. 
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 Consistent with the genetic requirements of other CC-NB-LRR type R genes, 
RPM1 does not require EDS1, PAD4, or SAG101 (Feys et al., 2005), nor has any 
requirement for either of the two paralogs of Arabidopsis SGT1 been observed (Holt 
III et al., 2005).  On the other hand, there are clear requirements for NDR1, RAR1, 
and HSP90 for RPM1 function (Hubert et al., 2003; Tornero et al., 2002b).  
Additionally, null mutations in rar1 and specific mutations within the ATPase domain 
of one of the four paralogs of Arabidopsis cytosolic HSP90, hsp90.2, lead to loss of 
accumulation of RPM1 protein (Hubert et al., 2003; Tornero et al., 2002b).  SGT1, 
RAR1, and HSP90 can physically interact, and HSP90 can physically interact with 
RPM1 (Hubert et al., 2003).  Thus, loss of RPM1 accumulation in rar1 and hsp90.2 
likely occurs through a similar, though currently unknown, mechanism. 
 We were interested in finding additional loci required for RPM1 function. In 
order to uncover these genetically-required loci, we performed a large-scale mutant 
screen, based on a previously described transgenic system (see below; Tornero et 
al., 2002a).  Our new screen was modified to solve several problems present in the 
original screen.  These problems included a high number of mutations in RPM1 
(over ninety), identification of few other loci (only four), loss of several potentially 
interesting mutants due to plant stress, and loss of time due to a need to introgress 
in necessary genetic material. This new screen attempted to rectify these problems 
with the addition of a second, transgenic copy of RPM1 and major changes in 
methodology.   
 We identified several, apparently novel loci based on the accumulation of 
RPM1 protein and sequencing of candidate genes.  These mutants fell into three 
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classes: low accumulators of RPM1 reminiscent of rar1 and hsp90.2, mutants that 
showed no accumulation of RPM1, and, finally, mutants with normal accumulation of 
RPM1.  This last class is perhaps the most exciting, since they are likely to define 
genes required for RPM1 signal transduction.  We also describe new alleles of rar1 
and hsp90.2.  Finally, we provide initial genetic and pathology characterization data 
for lra6, a recessive mutant falling into the “no RPM1 accumulation” class.  We 
present evidence that lra6 affects RPM1 transcript levels and is required for maximal 
function of several other CC-NB-LRR type R genes.  
 
Results 
 
A novel genetic screen to identify genes required for RPM1 function 
 In order to identify new genes required for RPM1-mediated recognition of 
avrRpm1, we undertook a second generation forward genetic screen.  This screen 
relied on a previously described β-Estradiol-inducible avrRpm1 transgenic system 
(Tornero et al., 2002a).  In the initial screen utilizing this system, several problems 
were encountered, as explained above, which we attempted to ameliorate in this 
new screen. 
In the previous screen, over ninety loss-of-function alleles of rpm1 were 
identified.  While this over-abundance of rpm1 alleles enabled an elegant structure-
function analysis of RPM1, the excess undoubtedly prevented the identification of 
rare mutations in additional loci required for RPM1 function (Tornero et al., 2002a).  
To prevent the identification of more loss-of-function mutations in rpm1 in our new 
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screen, we used plants containing an additional, transgenic copy of RPM1 (Boyes et 
al., 1998).  Since these plants effectively carry four copies of RPM1 at two loci, we 
hoped to greatly reduce the possibility of identifying loss-of-function mutations in 
rpm1.   
 Mutations in previously identified loci affecting RPM1 function have often 
affected the accumulation of RPM1 protein (Hubert et al., 2003; Tornero et al., 
2002b).  For instance, mutations in both rar1 and hsp90.2 resulted in significantly 
lower accumulation of RPM1 protein (Figure 4.3A).  Unfortunately, a native RPM1 
antibody which would easily allow us to monitor RPM1 accumulation in any newly 
identified mutant is unavailable.  Thus, the additional, transgenic copy of RPM1 used 
in this new genetic screen was expressed from one kb of the native RPM1 promoter 
and translationally fused to a C-terminal c-myc-epitope (Boyes et al., 1998).  RPM1 
protein levels in the newly identified mutants can thus be monitored with anti-myc 
antibodies.  Hence, the genotype of the plants used in this new screen was 
Arabidopsis ecotype Col-0 containing an Estradiol-inducible copy of avrRpm1 and 
carrying both the wild-type endogenous copy of RPM1 as well as an additional 
transgenic copy of RPM1-myc. 
 A corollary of the large number of rpm1 alleles obtained in the previous 
screen was the comparatively low number of alleles of other genes (Tornero et al., 
2002a).  The previous screen yielded 8 alleles of rar1 and 4 alleles of hsp90.2 
(Hubert et al., 2003; Tornero et al., 2002a).  One possible explanation for the 
observed low frequency of alleles in other loci required for RPM1 function was that 
the high mutation rate of rpm1 made finding an allele of rpm1 far more likely than 
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finding a rarer allele of another locus.  Other possibilities include redundancy and/or 
lethality of additional components required for RPM1 function. Additionally, the 
Estradiol-driven avrRpm1 transgene is itself a target for mutagenesis, and hits 
therein would lead to a false positive “loss of RPM1 function” phenotype. Our 
previous screen uncovered a great number of these (Tornero et al., 2002a).  
We choose to attack these limitations through both the addition of the second 
copy of RPM1 detailed above and through changes in the methodology of the 
second generation screen.  Normally, in Arabidopsis screens, seeds are treated with 
mutagen and plants grown from them that contain mutated gametes.  Small 
numbers of resulting M1 generation plants are allowed to self-fertilize, generating 
pools of M2 seed that may contain either homo- or heterozygous mutant alleles.  
The dose of Ethyl methanesulfonate (EMS) we used is thought to give rise to 
roughly 30 hits per haploid genome (Meyerowitz and Somerville, 1994).  Each such 
M2 seed collection is termed an independent seed “lot”.  Hence, one could isolate 
from any given lot sibling mutations, or independent mutations.  Because sibling 
mutations are more likely in a given lot than independent mutations, Arabidopsis 
screens typically collect only 2-3 putative mutants per seed lot (Page and 
Grossniklaus, 2002).  We arbitrarily choose to select eight putative mutants from 
each lot.   
Sibling mutants likely display similar phenotypes.  Thus, in order to increase 
the likelihood of isolating multiple mutants per mutagenized seed lot, we selected a 
range of phenotypes by arbitrarily collecting eight putative mutants per M2 seed lot 
screened.  By choosing individuals of varying phenotypic severity, we sought to 
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decrease our likelihood of simply collecting eight individuals containing the same 
mutation.  As an added benefit, choosing mutants of varying phenotypic severity 
allowed us to recover loci not recovered in the previous screen, which relied on 
strong loss-of-function phenotypes.  We expected to consequently recover mutations 
in genes which contribute quantitatively to RPM1 function.   
We also anticipated that recovery of more rare alleles would be increased if 
we increased the number of total plants and lots screened.  The previous screen 
was performed on roughly 5 X 105 plants in 172 independent M2 seed lots (Tornero 
et al., 2002a).  In this new screen we looked at approximately 1 X 106 plants from 
200 independent M2 seed lots. 
Putative M2 mutant plants were recovered in the previous screen as loss of 
response mutants following Estradiol application (and transcriptional activation of 
avrRpm1) (Figure 4.1, Step 1). These were subjected to a secondary screen three 
weeks later (in the same generation) that entailed infection of leaves with Pto 
DC3000 (avrRpm1) (Figure 4.1, Step 3) (Tornero et al., 2002a).  This secondary 
screen was performed to remove mutations in the Estradiol-inducible system since 
such plants would still respond to bacterially-delivered AvrRpm1.  This method, 
though effective in removing false loss of response mutants, also caused a great 
deal of physiological stress, resulting in a high mortality rate.  Therefore, in the 
current screen we decided to perform two secondary screens in the M3 generation 
(following self-fertilization of the eight single M2 putative mutants collected per seed 
lot).  In this manner, we hoped to increase generally our recovery of mutants, but 
more importantly to increase the recovery of mutants with intermediate phenotypes. 
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This change is important because mutants with intermediate phenotypes are 
precisely those that would have experienced the most physiological stress from the 
original screen’s selection regime. 
 
Performance of screen and identification of putative mutants 
Our primary screen recovered 1187 putative mutants from 192 independent 
M2 seed lots (Table 4.1, “Primery Screen”).  To confirm their lack of response to 
Estradiol-driven expression of avrRpm1, we first re-applied Estradiol to the M3 
families obtained by selfing of the M2 putative mutants from the primary screen 
(Figure 4.1, Step 2).  This confirmatory step was necessary since choosing mutants 
with subtle phenotypes increased our likelihood of recovering non-mutant 
individuals.  In fact, this step removed 164 M3 mutant families (Table 4.1, 
“Confirmation of Phenotype”).  While roughly 16% of the putative mutants were thus 
removed in this retest, 189 independent M2 seed lots were still represented.  
However, due to low fertility in some M3 families, we had to obtain more seeds, and 
consequently perform our secondary screens on these families in the M4 generation 
(Table 4.1, “Bulked”).  Given the added time required to obtain testing material for 
these lines, we did not perform the Estradiol re-test on these lines and carried them 
directly forward to the second, secondary screen. 
The purpose of our second, secondary screen was the removal of mutations 
in the avrRpm1 inducible system.  Previously, Tornero et al., 2002a removed 
Estradiol-inducible avrRpm1 system mutations by hand inoculation of high titres of  
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Figure 4.1: Flowchart depicting the screening process used to identify new 
loci required for RPM1 function.  The action undertaken in each major step of the 
screening process, the generation of plants used for each step, and the purpose of 
each step are indicated to the right.  Those plants which do not respond to Estradiol, 
or exhibit disease resistance to Pto DC3000 (avrRpm1) are indicated as dark green.  
Plants responding to Estradiol, or are disease susceptible in bacterial dip assays are 
indicated by their pale green color.  Analysis of PCR marker amplification is 
indicated by white bands on a dark grey field, while western blot analysis of RPM1-
myc levels is indicated as dark bands on a pale grey field. 
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avrRpm1 expressing Pto DC3000, followed by observation of the hypersensitive 
response (HR), a form of programmed cell death thought to limit the spread of some 
pathogens.  Since we decided to perform all of our secondary screens in the M3 
generation, hand inoculation of more than 6000 plants in 90 flats was not an 
appealing option.  Instead, we analyzed disease symptoms in plants dipped into a 
suspension of Pto DC3000 expressing avrRpm1 (Figure 4.1, Step 3).  We expected 
that true mutants that lost RPM1 function would be disease susceptible, while 
“system hits” in the Estradiol-inducible avrRpm1 expression transgenes would retain 
RPM1 function and remain resistant to Pto DC3000 (avrRpm1).  Of the 1023 
putative mutant progenies tested in this manner, 892 families, or 87%, were found to 
be resistant, indicative of system hits.  These families were not studied further. 
33 independent mutants were found to have intermediate phenotypes after 
bacterial inoculation, in that their level of disease symptoms lay between full 
susceptibility and resistance when compared to appropriate genetic controls (Figure 
4.2, Table 4.1, Step 3).  A further group of 28 independent mutants were fully 
disease susceptible. Finally, 30 independent mutants showed clear segregation in 
their response to bacteria.    Only 14 independent seed lots contained individuals 
which fell into more than one loss of resistance phenotypic category (Figure 4.2), 
suggesting a total of 76 independent mutants.  Given the large number of mutants 
obtained, we decided to focus our energies on the 28 mutants displaying a fully 
disease susceptible phenotype (Figure 4.2, Table 4.1, Step 3).  
 
Removal of contaminants and initial characterization of mutants 
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1187 (192) Responder 164
Non-Responder 753 Resistant 665
Intermediate 33 (22) 88 (55)
Segregating 33 (24)
Susceptible 22 (22)
Intermediate 24 Resistant 16
Intermediate 5 (5) 9 (6)
Segregating 0 (0)
Susceptible 4 (3)
Segregating Response 62 Resistant 51
Intermediate 2 (2) 11 (10)
Segregating 6 (5)
Susceptible 3 (3)
Bulked- Not Retested with Estradiol 184 Resistant 160
Intermediate 10 (9) 24 (18)
Segregating 2 (2)
Susceptible 12 (11)
Total Resistant 892
Total Intermediate 50 (33)
Total Segregating 41 (30)
Total Susceptible 41 (28**)
Step 1     
Primary Screen
Step 2                                                 Confirmation 
of Phenotype- Estradiol Retest
Step 3                                                   Pto 
DC3000 (AvrRpm1 ) Dip Assay Totals
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Table 4.1: Identification of 28 independent putative disease susceptible 
mutants, grouped by screening step and phenotypic class.  Indicated steps 
correspond to those shown in Figure 4.1.  M3 families, defined as progenies from 
self-fertilized individual M2 plants, which showed full response to avrRpm1 induction 
are indicated as Responder under the column corresponding to Step 2.  M3 families 
in which all individuals showed no response to Estradiol induction of avrRpm1 are 
classed as Non-responder. M3 families which only weakly responded or families 
displaying a mixture of responding and non-responding plants are classed as 
Intermediate or Segregating Response, respectively.  In Step 3, M3 families in which 
all individuals were resistant to Pto DC3000 (avrRpm1) in a dip assay are placed in 
the Resistant class and are discarded as mutations in the inducible system.  
Individuals in Intermediate families showed slight loss of disease resistance to Pto 
DC3000 (avrRpm1).  Segregating families contained both individuals resistant to Pto 
DC3000 (avrRpm1) and individuals which were susceptible.   In Susceptible families, 
all infected individuals showed complete loss of resistance when compared to a 
negative genotypic control.  The number of M3 families, and hence M2 mutants, 
falling into each phenotypic class is indicated, and the number of M2 seed lots 
represented by these phenotypic classes is shown in parentheses.   
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 Any genetic screen of the magnitude presented here is prone to 
contamination from outside genetic material.  Fortunately, given the several 
transgenes present in the parental line used for this screen, we were easily able to 
distinguish contaminating genotypes from true mutants.  To determine if the M3 
family (progeny from a self fertilized M2 mutant) represented a contamination event, 
we used dominant PCR-based molecular markers which amplify transgenes present 
in the screen’s parental line (Figure 4.1, Step 4).  The first was a primer pair which 
amplifies the conditional expression cassette that contains avrRpm1, while the 
second was a primer pair which specifically amplifies the 3’ end of the RPM1-myc 
transgene.  At the time of our screen, only three avrRpm1-susceptible plant lines 
containing both of these transgenes were present in the lab, one allele of rar1 and 
two alleles of hsp90.2, which could be checked for by using specific molecular 
markers.  One mutant lacked RPM1-myc and avrRpm1 transgenes, and was hence 
a contaminant.  Another represented contamination from a known allele of hsp90.2, 
based on a molecular marker specific for this allele.  Seven mutants were removed 
from further study due to heavy pleiotropism.  This pleiotropism included severe 
dwarfism and high basal anthocyanin content which can be misconstrued as 
evidence of disease in bacterial dip assays.  This left nineteen independent mutants 
derived from the 28 at the bottom of Step 3, Table 4.1.  
 Since mutants affecting RPM1 function can also affect RPM1 protein 
accumulation (Figure 4.3A), we took advantage of the fact that the parental line used 
in this screen contained the RPM1-myc transgene.  We began characterizing our 
mutants by observing their RPM1-myc levels (Figure 4.1, Step 5).  Western blot  
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Figure 4.2: Venn diagram presenting the number of lots represented by each 
putative mutant class based on susceptibility to Pto DC3000 (avrRpm1).  
Mutants were classed as either segregating susceptible (Segregating), intermediate 
susceptible (Intermediate), or fully susceptible (Susceptible) to Pto DC3000 
(avrRpm1) in a bacterial dip assay.  Total number of M2 seed lots represented by 
each class is shown next to the circle representing the respective class.  Mutants 
falling into the same mutant class, recovered from the same independent M2 seed 
lot, are presumed to carry the same mutation and were excluded from the 
calculations used in the creation of this diagram.  The number of total independent 
mutants was calculated as the number of independent lots which contained a mutant 
falling into any of the three classes. 
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analysis using α-myc antibody showed that the putative mutants differed in their 
accumulation of RPM1.  rar1 and hsp90.2 mutations recovered from previous 
screens fall into the class which accumulate lower levels of RPM1-myc (compare 
Figure 4.3A and B). Among the new mutants, three classes could be distinguished 
based on this assay: a class which accumulated wild type levels of RPM1-myc (8 
independent mutants), a class which accumulated lower levels of RPM1-myc (9 
independent mutants), and a class without discernible RPM1-myc accumulation (3 
independent mutants, Figure 4.3B). This totals 20 mutants, not 19. The reason for 
this is as follows. We noted that one seed lot contained mutants from two different 
RPM1-myc accumulation classes: one exhibiting normal RPM1-myc levels, the other 
displaying low levels of RPM1-myc. Neither of these mutants is segregating and we 
therefore consider them independent mutants from the same seed lot. Hence, there 
are 20 interesting independent new mutants derived from this screen (Table 4.1, at 
bottom of Step 3). 
 
Identification of new alleles of hsp90.2 and rar1 
 We next decided to sequence possible candidate genes.  We began by 
sequencing RAR1 and HSP90.2 in all 20 putative mutants.  Given the depth of this 
screen, we considered the possibility of uncovering alleles of both genes that might 
separate their function in RPM1 accumulation from any requirement for RPM1 
signaling.  Consequently, we decided the safest course would be to not only 
sequence these two genes in the mutants which showed less than normal RPM1- 
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Figure 4.3: Mutants affecting RPM1 function show differential RPM1-myc 
accumulation.  (A) hsp90.2 and rar1 mutations severely affect RPM1-myc 
accumulation.  Western blot probed with α-myc monoclonal antibody of total protein 
extracts from the indicated genotypes.  (B) Three classes of mutants are observable 
based on RPM1-myc accumulation.  Representative α-myc-probed western blot 
showing the three observed RPM1-myc accumulation classes.    The class marked 
as Normal had levels of RPM1-myc accumulation indistinguishable from wild type.  
The Lower class shows similar accumulation as seen in rar1 and hsp90.2 mutants 
seen in (A).  Finally in the class marked None, no RPM1-myc protein could be 
detected.  
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myc, but also in those mutants which showed normal RPM1-myc accumulation.  Of 
the 20 mutant families remaining, four contained typical EMS mutations in rar1 
(Figure 4.4A), and one contained a mutation in hsp90.2 (Figure 4.4B).  These five 
mutant families all showed lower accumulation of RPM1-myc.   
 The previous screen failed to identify mutations in the other three paralogs of 
cytosolic HSP90 (Hubert et al., 2003).  The reason remains unclear.  We decided 
that such a mutation remained a possibility, and therefore sequenced the genes 
encoding the other three isoforms of HSP90 in all mutants showing lower than 
normal levels of RPM1-myc.  We failed to identify any mutations in these other 
HSP90 paralogs in this new screen. 
 RIN4 is required for RPM1 function and protein accumulation and currently 
thought to serve as an intermediary between AvrRpm1 and RPM1.  In essence 
RPM1 detects post-translational changes in RIN4 caused by RIN4’s affiliation with 
AvrRpm1 (Mackey et al., 2002).  RPS2, another CC-NB-LRR disease resistance 
protein which recognizes the bacterial cysteine protease AvrRpt2, recognizes the 
disappearance of RIN4 due to cleavage by AvrRpt2 (Axtell et al., 2003).  Loss of rin4 
leads to constitutive RPS2 activation and resultant lethality (Mackey et al., 2003).  
Recent experiments in our lab have shown that RPM1 also requires for its function a 
protein with homology to RIN4, NOI5 (A.J. Wu, unpublished data).  However, unlike 
rin4, loss of noi5 is not lethal, presumably because NOI5 levels are not monitored by 
RPS2.  For these reasons, NOI5 was a candidate gene.  Sequencing of NOI5 in the 
fifteen remaining mutants failed to uncover a mutation. 
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Figure 4.4: Newly identified rar1 and hsp90.2 mutations.  (A) Schematic diagram 
of RAR1 protein showing all known rar1 mutations.  The CHORDI domain is shown 
in red, the CCH domain is shown in yellow, and the CHORDII domain is shown in 
blue.  Mutations found in this study are highlighted in red type.  Two cysteine 
mutations and one premature stop were uncovered.  The fourth new mutation is in 
Intron 4.  (B) The crystal structure of the ATPase domain of yeast HSP90 bound to 
ADP.  Residues shown as green ball and stick models were found to be altered in 
previously identified hsp90.2 mutants (Hubert et al., 2003).  Alanine 42, shown in 
yellow, was changed to threonine in the newly identified hsp90.2 mutant.  ADP is 
shown in the middle of the structure as the space filling molecule. 
 126
 Dominant negative mutations in R genes have been uncovered in reverse 
genetic screens (Dinesh-Kumar et al., 2000; Tao et al., 2000).  This kind of mutation 
in RPM1 was also a possibility in our screen.  In order to address this possibility, we  
next sequenced both the endogenous copy of RPM1 and the transgenic copy of 
RPM1-myc.  No mutations were recovered in the RPM1-myc transgene, however 
two mutations were uncovered in the endogenous copy of RPM1.  Both mutants 
display normal levels of RPM1-myc.  Both mutations are nonsense mutations which 
lead to an immediate stop (W109STOP and W681STOP) in either the coiled-coil 
domain or the leucine rich repeat domain.  However, very recent segregation 
analysis suggests that these mutants may not be responsible for the mutant 
phenotype (see Discussion, T. Eitas, unpublished data). 
 
Preliminary characterization of a mutant that accumulates no detectable 
RPM1-myc 
Test-crosses to determine the number of complementation groups 
represented by the identified mutants are ongoing.  However, initial results indicate 
that mutants that accumulate different levels of RPM1-myc fall into different 
complementation groups. Specifically, and interestingly, mutants that accumulate 
low levels of RPM1-myc and mutants that accumulate no detectable RPM1-myc fall 
into different complementation groups.  However, based on F1 allelism tests, two 
independent mutants that do not accumulate any RPM1-myc, lra6-1 and lra6-2, fall 
into the same complementation group.  Since this mutant phenotype has not been 
previously observed we decided to investigate these mutants further.   
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 We began our analysis by determining the specificity of these alleles’ loss of 
disease resistance.  Plants were inoculated with bacteria expressing either avrRpm1 
recognized by RPM1, avrRpt2 (RPS2), or avrPphB (RPS5).  After three days, the 
resultant bacterial growth was quantified.  Both alleles displayed a complete loss of 
RPM1 protein and loss of resistance to Pto DC3000 (avrRpm1) when compared to 
an rpm1 null mutant (Figure 4.5A).  However, the alleles behaved differently in 
response to the other two bacterial genotypes.  lra6-1 was partially impaired in its 
response to both avrRpt2 and avrPphB (Figure 4.5B and C).  This suggests that 
lra6-1 plays a broad role in disease resistance to bacteria.  However, lra6-2 
displayed little, if any, loss of resistance to these two pathogens.  Together these 
data suggest that RPM1 has a greater requirement for LRA6 than other R genes.  
Also, lra6-2 may represent an allele with less severe effects on the function of the 
encoded protein.  The increased requirement of RPM1 for LRA6 may be so high that 
the weak activity maintained in lra6-2 is insufficient to have an observable effect on 
RPM1 function. 
 Given the severe effect on RPM1-myc accumulation, the locus affected in 
these mutants might either represent a novel mode of RPM1 regulation or be 
involved in the same stability regulating mechanism as RAR1 and HSP90.2 (see 
Chapter 2) but with a closer physical association with RPM1.  It has been previously 
shown that rar1 does not affect transcript levels of a barley rar1-dependent NB-LRR 
gene, Mla6 (Bieri et al., 2004).  The same is true of RPM1 transcription in rar1 (T. 
Eitas, unpublished data).  Thus, we predicted that RPM1 transcript levels may allow 
insight into the phenotypes of lra6-1 and lra6-2.  Semi-quantitative RT-PCRs were 
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Figure 4.5: A newly identified mutant, lra6, affects the function and transcript 
levels of several R genes. Bacterial growth assays measuring resistance to Pto 
DC3000 expressing avrRpm1 (A), avrRpt2 (B), or avrPphB (C). The two allelic 
mutants lra6-1 and lra6-2 are impaired in RPM1-mediated resistance (A).  RPS2 (B) 
and RPS5 (C) are affected to a lesser extent.  (D) Semi-quantitative RT-PCR 
reaction of the CC-NB-LRR type Resistance genes RPM1, RPS2, and RPS5 and the 
TIR-NB-LRR type R gene, TAO1.  Changes in transcript levels correlate with 
changes in bacterial resistance.  (E) Schematic representation of the third 
chromosome of Arabidopsis.  The area showing strong genetic linkage 
disequilibrium between the mutant phenotype and molecular markers is indicated by 
a green bar, and is demarcated by the telomere and an INDEL molecular marker 
contained within the P1 clone MQD17.  The location of RPM1 is also indicated.  The 
location of the centromere is indicated by a red circle.   
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performed using primers specific to RPM1.  Both mutants appear to lack RPM1 
transcripts (Figure 4.5D, top panel).  We next determined whether effects on 
transcript levels of other R genes could explain the observed changes in resistance.  
lra6-1 appears to strongly affect RPS2 transcript level, and has a more moderate 
affect on RPS5 transcript levels (Figure 4.5D, two middle panels).  lra6-2 has little or 
no observable effect on these two genes’ transcript levels, consistent with its 
phenotype.  RPM1, RPS2, and RPS5 encode R proteins belonging to the CC-NB-
LRR type.  Another class of R proteins, TIR-NB-LRRs, represent an ancient 
divergence, as evidenced by their absence in monocots (Myers et al., 1999; Zhou et 
al., 2004).  This ancient divergence may have led to differences in gene regulation.  
Consequently, we next looked at transcript levels of an R gene belonging to the TIR-
NB-LRR class, TAO1.  We could not discern any affect on TAO1 transcript levels in 
either mutant (Figure 4.5D, bottom panel).  Phenotypic analysis of TAO1 effects 
must await creation of appropriate genetic material. 
 In order to isolate the lesion responsible for these phenotypes in lra6-1, we 
created a mapping population by crossing this mutant to the ecotype Landsberg-
erecta which also carries a functional RPM1 gene (Grant et al., 1995). F2 individuals 
were then screened for loss of RPM1-mediated resistance.  Based on phenotypic 
analysis of the segregating F2 population, lra6-1 appears to be recessive.  Two 
pools of DNA representing 12 susceptible individuals each were created.  Bulk 
segregant analysis was performed on these two pools using molecular markers 
arrayed across all five chromosomes of the Arabidopsis genome (Michelmore et al., 
1991).  Linkage was only observed between the mutant phenotype and molecular 
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markers corresponding to the Col-0 ecotype on the north arm of Chromosome III.  
The strongest linkage was found between the mutant phenotype and a marker on 
the BAC clone F8A24 (4 recombination events in 29 plants or 58 meioses).  
Additional minor linkage to the Landsberg ecotype was observed on the bottom of 
Chromosome III, and may represent a genetic modifier. 
 
Discussion 
 
We describe here a novel genetic screen to discover new loci required for 
RPM1-mediated disease resistance.  This screen takes advantage of tailored 
genetic materials and unconventional methodology to achieve this goal.  There are 
many screens which have suffered from the problem of an overabundance of 
mutations in a single locus (Gil et al., 2001; Lease et al., 2001).  In our case we had 
to contend with three very large mutagenesis targets, RPM1 and the two T-DNAs 
comprising our inducible avrRpm1 gene expression system.  We overcame these 
issues using a combination of engineered genetic redundancy for RPM1 and by 
increasing per lot sampling.  Based on the total number of mutants and the 
phenotypes obtained, this strategy was successful.  We additionally describe initial 
characterization of one mutant class with a previously unobserved phenotype.  The 
implications of this mutant class are unexpected, and could profoundly impact the 
field of plant disease resistance. 
While previous analyses have shown little in the way of regulation of R gene 
transcript levels, our data suggest that CC-NB-LRR type R genes may be under a 
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common pre-translational regulatory mechanism.  The lack of an observable effect 
on a TIR-NB-LRR R gene could be indicative of another force driving diversification 
of different R gene types in dicotyledonous plants.  Since structural variations of 
plant R proteins are part of animal innate immune systems (Ting and Davis, 2005), it 
is also possible that these results could have implications outside of the plant 
research community. 
 
An effective approach to identifying new loci in previously screened pathways 
One of the main differences between this genetic screen and many others 
performed in Arabidopsis is the high level to which the parental material was 
genetically modified.  The plants used in this screen contain three separate T-DNAs.  
While these refinements solved several problems, the main genetic advantage 
inherent in this screen is a reiteration of a previous screen (Tornero et al., 2002a).   
Given the near lethal phenotype of avrRpm1 expression in Arabidopsis, its 
use can be described as being more akin to a genetic selection process than a 
genetic screen.  We found one must select for mutants with extremely weak 
phenotypes to recover false positives.  We selected eight plants per independent 
seed lot in this screen, representing a range of phenotypes from a near full loss of 
function in RPM1 mediated cell death response (e.g. fully green) to a near full 
response (e.g. only slightly more green than background).  If the eighth plant 
selected in each lot was a false positive, we would expect a false positive rate of 
12.5%.  The observed rate was 13.8%, only slightly higher than expected.  This 
suggests that we were capturing the full range of phenotypes within each lot.   
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The selection of multiple individuals from each seed lot proved an effective 
filter for the expected high rate of mutations in the Estradiol-inducible system gene 
expression system.  In nearly every lot containing a true susceptible mutant, false 
susceptible system hits were also recovered. Had we only chosen one or two 
individuals per lot, our mutant yield would have assuredly been diminished.  This 
bias towards system mutations is even more evident when one considers that 87% 
of all avrRpm1 non-responsive mutants obtained from the primary screen were 
found to be completely disease resistant to Pto DC3000 (avrRpm1) (Table 4.1).   
Unfortunately, the necessity of using disease symptoms rather the HR that 
follows hand inoculation of bacteria to screen many progeny families probably led to 
the loss of an important phenotypic class.  Our secondary screening strategy 
prevented us from identifying mutants which had normal disease resistance, but 
lacked the ability to perform the hypersensitive response.  One mutant of this class 
was identified in the previous screen utilizing inducible avrRpm1, from the over 100 
mutants identified.  While the hypersensitive response is not required for resistance 
to P. syringae, it is necessary for full resistance to Hyaloperonospora parasitica (Holt 
III et al., 2005).  This lack of effect on P. syringae resistance increases the likelihood 
that such mutants were lost.  In hindsight, the loss of these mutants is perhaps 
distressing given our current knowledge that a gene that negatively regulates R 
protein accumulation, SGT1B, has such a phenotypic profile (Holt III et al., 2005).   
 
Mutations in known genes 
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On the other hand, we did uncover several loci that act to positively regulate 
NB-LRR protein levels, including rar1 and hsp90.2.  Our recovery of new mutations 
in these two genes, however, does not shed new light on their function in disease 
resistance.  Our recovered hsp90.2 allele, G95E, is a new mutation in the ATPase 
domain, as were all previously identified mutations (Figure 4.4B and Hubert et al., 
2003).  Recovered rar1 alleles either represent non-functional proteins encoding 
protein truncations or alter conserved cysteines required for zinc coordination 
(Figure 4.4A).  The nature of our newly recovered rar1 alleles holds some interest.  
The C66S mutation is caused by an A to T transversion mutation.  This type of 
mutation is quite rare for EMS mutants in Arabidopsis, occurring at a rate of much 
less than 1% (Greene et al., 2003).  This mutation is probably more likely the result 
of a spontaneous mutation event, which occur in Arabidopsis at a rate of between 
10-7and 10-8 base pairs per generation (Kovalchuk et al., 2000).  Another interesting 
mutation found in rar1 occurred within the fourth intron in neither a splice donor nor 
an acceptor site.  One would presume that such a mutation would have little or no 
effect on splicing.  However, a small deletion in the middle of an intron in an 
Arabidopsis syntaxin gene led to a larger transcript, showing that such mutations 
can impact splicing (Ohtomo et al., 2005).  To see if the case is the same here 
requires further experimentation.  All of the mutations we recovered in rar1 and 
hsp90.2 led to decreased RPM1-myc levels as was observed in previously identified 
mutations in these genes (Hubert et al., 2003; Tornero et al., 2002b). 
At first glance, it appears surprising that we only recovered four alleles of rar1 
and one allele of hsp90.2.  Extrapolating from the previous screen using the 
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inducible avrRpm1 system, we expected to recover approximately ten alleles of rar1 
and five alleles of hsp90.2.  However, this result may be easily explained by the 
additional copy of RPM1.  It has been shown that both rar1 dependent and rar1 
independent NB-LRR proteins show reduced accumulation in a rar1 mutant 
background (Bieri et al., 2004).  It has also been shown that increases in NB-LRR 
protein amount can partially overcome rar1 dependency (Belkhadir et al., 2004).  
This has led to the development of a “threshold” model for NB-LRR protein function. 
In this model, NB-LRR protein levels may be modulated by RAR1, but these levels 
must drop below a certain threshold before phenotypic effects can be seen in rar1 
mutant plants (Holt III et al., 2005).  By adding an additional copy of RPM1, we may 
have created a situation in which only very strong mutations in either rar1 or hsp90.2 
have an observable phenotype.  This decreases our likelihood of identifying 
mutations in these two genes. 
Two mutations were identified in the endogenous copy of RPM1.  It is unclear 
whether they cause the loss of RPM1 function we selected (though see below). If so, 
they must be dominant in order for them to have been recovered.  Previous 
dominant negative mutations in two R genes, N and RPS2, have been uncovered 
through reverse genetic strategies (Dinesh-Kumar et al., 2000; Tao et al., 2000).  
However, these mutations have all been point mutations in the P-loop of the NB 
domain, in the case of N gene, or the coiled-coil domain, in the case of RPS2.  One 
truncation causing dominant negative effects was uncovered in RPS2.  Unlike the 
new mutants of RPM1 presented here, that truncation was an N-terminal truncation.  
Furthermore, it was found that C-terminal truncation products of RPS2 showed 
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simple loss-of-function phenotypes (Tao et al., 2000).  This may also be the case 
here.  Very recent segregation analysis suggests that these mutations are not 
responsible for the mutants’ phenotype (T. Eitas, unpublished results).   
In a genetic screen as large as the one presented here, one can isolate 
mutations in two genes, both of which have roles in plant disease resistance.  In the 
previous screen utilizing the Estradiol-inducible avrRpm1 expression system, a 
mutant was isolated that compromised both RPM1- and RPS2-mediated resistance.  
After many testcrosses and sequencing, it was discovered that this phenotype was 
not caused by mutation of a single gene, but rather two point mutations, one in 
RPM1 and the other in RPS2 (P. Tornero, unpublished data).  Unfortunately, it will 
be necessary to remove these two RPM1 mutations by backcrossing before a 
mapping of the pertinent new loci can commence.   
 
A new mutant affecting NB-LRR gene transcript levels 
 Proper control of NB-LRR protein levels has been shown to be crucial for 
proper disease resistance signaling (Belkhadir et al., 2004; Bieri et al., 2004; Holt III 
et al., 2005; Hubert et al., 2003; Tornero et al., 2002b).  However, in all of these 
cases the control was at the post-transcriptional level.  Our identification of a new 
phenotypic class of mutant, represented by lra6, shows that R protein accumulation 
can also be regulated at the transcriptional level. 
Instances of transcriptional control of NB-LRR genes have been rare, and 
rarely appear to have functional consequences (Levy et al., 2004; Yoshimura et al., 
1998).  One case of functional transcriptional control can be found in the Xa27 R 
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gene in rice (Gu et al., 2005).  There are two characterized alleles of Xa27, which 
does not encode an NB-LRR protein but rather a protein of unknown function.  One 
allele confers resistance, while rice plants containing the other are susceptible to 
bacteria expressing avrXa27.  The resistant allele has the same predicted protein 
sequence as the susceptible allele.  However, while both have undetectable 
constitutive expression, presence of avrXa27 carrying bacteria is sufficient to induce 
expression of the resistant allele but not of the susceptible.  Constitutive expression 
of Xa27 leads to resistance both to avrXa27 containing bacteria, but also to bacteria 
which are normally able to colonize rice.  It is possible that avrXa27 itself is directly 
responsible for the induction of Xa27 expression, as this effector contains nuclear 
localization signals and a transcription activation domain (Gu et al., 2005).  However, 
tests to determine if avrXa27 can bind to the promoter sequence of Xa27 have, to 
our knowledge, not been performed. 
 A more pertinent example of a second site locus controlling NB-LRR gene 
transcription was recently found in our lab.  edm2 was isolated in a screen for loss of 
disease resistance to a Hyaloperonospora parasitica isolate, Hiks1, that is 
recognized by RPP7 (Eulgem et al., 2007).  Interestingly, RPP7 transcript levels are 
reduced in the edm2 mutant background.  EDM2 was isolated and found to encode 
a protein with plant homeodomain (PHD)-finger-like domains, which are zinc finger-
like motifs that could act in regulation of transcription (Aasland et al., 1995; 
Kalkhoven et al., 2002).  However, there are some important distinctions between 
the effects of the edm2 mutation and our lra6 mutant.  The first is that edm2 
suppresses only RPP7.  Microarray data comparing wild type, edm2, and rpp7 
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shows that any effect by edm2 on the transcript levels of other NB-LRR genes can 
be explained by edm2’s effect on RPP7.  This is in contrast to the effect of lra6-1 on 
the transcript level of several other tested NB-LRR genes.  The second distinction is 
that rpp7 transcript levels are only slightly down-regulated in edm2.  The wholesale 
loss of RPM1 transcript in lra6 is quite striking in comparison.  However, these 
disparities could be explained by differences in functional overlap between family 
members.  It is interesting to note that while the interval containing lra6-1 is currently 
rather large (~5 Mbp), it does contain a gene with homology to edm2 (At3g14980, 
3e-04) that is also annotated as a PHD finger transcription factor. 
 The identification of new loci required for RPM1 function is central to 
continued progress in this field.  We have shown that through unique genetic 
tailoring and screen methodology, one can successfully achieve this goal.  Different 
phenotypic requirements for various NB-LRR genes for different loci demonstrate 
that pursuing a similar screen for other NB-LRR gene pathways may be equally 
successful.  Additionally, the principles underlying this screen can be carried forward 
to the study of other processes in plants. 
  
Materials and Methods 
 
Plant lines 
The parental plant line used for this screen, Col-0 containing β-Estradiol 
inducible avrRpm1 and transgenic RPM1-myc, has been previously described 
(Tornero et al., 2002b).  rar1-21 and hsp90.2-3 containing RPM1-myc  shown in 
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Figure 4.3 have been described in (Hubert et al., 2003; Tornero et al., 2002b).  
Additional mutant alleles used in Figure 4.5 were rpm1-1 containing inducible 
avrRpm1 (Tornero et al., 2002a), rps2-101c (Mindrinos et al., 1994), and rps5-2 
(Warren et al., 1998).   
 
Estradiol induction and screening 
 M2 plants grown under long day conditions (greenhouse) were sprayed twice 
at one and two weeks of age with 10μM β-Estradiol (Sigma E 8875) in distilled water 
from a 10 mM β-Estradiol stock dissolved in 100% ethanol.  Since Estradiol does not 
move systemically through plants, the absence of a surfactant allowed for recovery 
of weak HR response mutants (Tornero et al., 2002a).  Eight individual M2 plants 
showing a range of phenotypic severity (less HR than parental) were selected from 
each of 200 lots and M3 seeds were collected from each M2 individual.  Secondary 
screening was similarly performed, except that plants were grown under short day (8 
hr.) conditions.  
 
Bacterial strains, inoculation, and growth quantification 
 Maintenance of Pto DC3000 containing the kanamycin selectable plasmid 
pVSP61 with an avrRpm1, avrRpt2, or avrPphB insert was as described (Ritter and 
Dangl, 1996).  Secondary screening of M3 families was performed by dipping two-
week-old plants grown in short day conditions in a suspension of Pto DC3000 
(avrRpm1) at an inoculum of OD600=0.1 (5 X 10
7 colony-forming units/mL) in 10 mM 
MgCl2 and 0.02% Silwet L-77 (CKWitco Corporation).  Plants were assayed for 
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disease symptoms between four and seven days post inoculation compared to wild 
type and rpm1-3 controls.  Plants used for mapping were assayed for disease 
symptoms by spraying four- to five-week-old, short-day-grown plants with the same 
solution of bacteria described above for dip assays.  These plants were then 
covered for four hours with a clear plastic lid and assayed for symptoms between 
four and seven days.  Bacterial quantifications were performed as described 
(Tornero and Dangl, 2001).   
 
Sequencing of candidate genes 
Genomic fragments corresponding to candidate genes were amplified with 
specific oligonucleotides (sequence available upon request) using LA Taq (TaKaRa).  
Sequencing was performed at the University of North Carolina at Chapel Hill 
Genome Analysis Facility using primers spaced approximately 300 base pairs apart 
allowing for a minimum of two-fold coverage.  Known mutations in rar1 were 
compiled from various sources including this study (Muskett et al., 2002; Shang et 
al., 2006; Tornero et al., 2002b), and mapped onto a schematic of the RAR1 protein 
using Vector NTI 10.3.0 (Invitrogen Corporation) and Photoshop 7.0 (Adobe 
Systems Incorporated).  Residues mutated in hsp90.2 were displayed on the crystal 
structure of the ATPase domain of yeast HSP90 (PDB ID 1A4H) using Viewerlite 5.0 
(accelrys) and Photoshop 7.0. 
 
Protein blots 
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A buffer containing 50 mM Tris-HCl pH 8.0, 1% SDS, 1mM EDTA, 1 mM 2-
mercaptoethanol, and 1 X plant protease inhibitor cocktail (Sigma) was used to 
extract total protein. 40 μg protein samples were separated on 8% SDS-PAGE gels. 
Western blots were performed with anti-myc monoclonal antibody (9E10) utilizing 
standard methods and detected with ECL+ (Amersham). 
 
Semi-quantitative reverse transcription analysis 
NB-LRR gene transcript levels were analyzed by grinding two-week-old 
seedlings in liquid nitrogen and extracting their RNA with Trizol according to the 
manufacturer’s instructions (GibcoBRL).  Reverse transcription was then performed 
on RNA samples (RETROscript, Ambion). RT-PCRs were performed according to 
the manufacturer's instructions. Plant 18S Competimer Primers (Ambion) were used 
at ratios appropriate for each specific RT product to co-amplify the 18S internal 
loading control. 
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CHAPTER 5 
 
Analysis of the genetic and physical interactions underlying the 
RAR1/SGT1/HSP90 complex 
 
Abstract 
 Plants recognize specific pathogens through the action of specific disease 
Resistance (R) proteins, which positively regulate cell death.  Maintaining 
appropriate steady state levels of these R proteins is of tremendous importance to 
this recognition.  Three genes, HSP90, RAR1, and SGT1, involved in maintenance 
of NB-LRR type R protein levels have been previously identified.  Cursory genetic 
and physical interaction studies have been performed, but little data is available that 
links these three NB-LRR accumulation regulators to a single biological function.  
We present here a detailed analysis of the genetic and physical interactions 
underlying the HSP90/RAR1/SGT1 machinery responsible for maintaining steady 
state levels of NB-LRR protein accumulation.   
We present data demonstrating a functional relationship between HSP90 
isoforms in Arabidopsis.  We demonstrate genetic interactions between hsp90.2 and 
sgt1b.  We explore the functional role of HSP90 in general, and provide evidence 
that contradicts the widely-held view that loss of ATP binding and subsequent 
hydrolysis abolishes HSP90 function.  In addition, the physical interactions between 
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HSP90, RAR1, and SGT1 are explored using point mutations in HSP90.2 and RAR1 
and truncations of RAR1 in an attempt to biochemically explain phenotypic results.   
 
Introduction 
 The watchmen standing ready to trigger a plant defense response are known 
as disease Resistance (R) genes.  These R genes are responsible for the detection 
of specific pathogen gene products which betray the pathogen’s presence.  Over-
expression and inappropriate activation of R genes has been repeatedly shown to 
lead to an ectopic defense response, evidenced by spontaneous cell death and 
generally lower fecundity (Bendahmane et al., 2002; Mackey et al., 2003; Shirano et 
al., 2002; Tao et al., 2000; Zhang et al., 2003).  Consequently, plants must maintain 
appropriate R protein levels to remain healthy.  Forward genetic screens have 
yielded several genes shown to play a role in maintaining the accumulation of 
proteins of the NB-LRR class of R proteins.  One of these genes encodes the RAR1 
protein.  Originally identified in barley, RAR1 has been shown to be required for 
disease resistance in diverse plant species (Liu et al., 2002a; Muskett et al., 2002; 
Shirasu et al., 1999; Tornero et al., 2002b).  It is composed of two tandem zinc-
binding CHORD domains separated by a plant conserved CCCH domain allowing 
for the binding of five zinc ions (Heise et al., 2007).  rar1 mutants show loss of 
accumulation of all NB-LRR proteins tested thus far (Belkhadir et al., 2004; Holt III et 
al., 2005; Tornero et al., 2002b).  This is also the case for NB-LRR proteins which do 
not genetically require RAR1 for their function (Bieri et al., 2004).  This suggests that 
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rar1 reduces the levels of most, if not all, NB-LRR proteins, but only affects their 
function if NB-LRR levels drop below a threshold level. 
 Another protein shown to be involved in NB-LRR protein stability is SGT1.  
SGT1 was originally identified in yeast as a suppressor of the G2 allele of skp1, 
implicating SGT1 as part of the SCF-ubiquitin ligase complex which targets proteins 
to the proteasome (Kitigawa et al., 1999).  SGT1 is composed of three domains, an 
N-terminal TPR domain, an SGT1 specific SGS domain, and a C-terminal CS 
domain.  Each domain is separated by a region highly variable between all species 
of plants and animals.  The CS domain led to SGT1’s functional characterization in 
Arabidopsis by reverse genetics because this domain is homologous to a domain in 
mammalian RAR1 homologs that is absent in plant RAR1 (Azevedo et al., 2002).  
The lack of a CS domain in plant RAR1 proteins suggested that plant RAR1 may 
require a CS-containing accessory protein in order to function properly.  
Simultaneously, SGT1 was also identified in forward genetic screens as a positive 
regulator of resistance to Hyaloperonospora parasitica (Austin et al., 2002; Tör et al., 
2002).   
SGT1 is encoded by two isoforms in Arabidopsis, SGT1a and SGT1b, but 
only SGT1b has been shown to play a role in disease resistance (Azevedo et al., 
2002).  Mutations in sgt1b cause loss of the hypersensitive response (HR), a 
pathogen triggered form of programmed cell death, which is mediated by several 
NB-LRR proteins. On its own, loss of SGT1b appears to not affect NB-LRR protein 
levels (Holt III et al., 2005).  However, sgt1b mutation was found to suppress rar1 
leading to recovery of nearly wild-type levels of some NB-LRR proteins, suggesting 
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that the wild-type function of SGT1b is to stabilize at least some R protein levels 
(Holt III et al., 2005).  This genetic interaction between RAR1 and SGT1b is 
corroborated by in planta evidence showing that SGT1 and RAR1 can physically 
interact (Azevedo et al., 2002; Liu et al., 2002b).   
 The third gene found to affect NB-LRR protein levels in plants is HSP90.  In 
yeast and animals, cytosolic HSP90 is a well-characterized protein which plays a 
role in the maturation of steroid receptors (Pratt and Toft, 1997).  Its role in plant 
disease resistance was demonstrated in three ways:   
1.  HSP90 was shown to interact with RAR1 in a yeast two hybrid screen (Liu et al., 
2004; Takahashi et al., 2003).   
2.  Silencing of hsp90  in tobacco caused loss of Pto-mediated disease resistance 
(Lu et al., 2003).  Both Liu et al (2004) and Lu et al (2003) further demonstrated that 
silencing of HSP90 caused loss of N- and Rx-mediated resistance, respectively. 
However, results supporting an effect of HSP90 on RPS2-mediated resistance 
(Takahashi et al., 2003), could not be reproduced by outside labs (this manuscript, 
B. Staskawicz, personal communication and Holt III et al., 2005). 
3.  HSP90 was identified in a genetic screen for mutants that lose RPM1-mediated 
disease resistance.  This screen provided three different mutations, all within the 
ATPase domain of hsp90.2, one of four Arabidopsis isoforms of HSP90 (see 
Chapter 2 and Hubert et al., 2003).  These mutations seemed to have specific 
effects on RPM1-mediated resistance, and did not affect any other pathway tested.   
 Hence, four independent labs reported physical interaction between HSP90 
and RAR1, SGT1, and the respective NB-LRR protein, in either yeast two hybrid or 
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co-immunoprecipitation experiments.  Thus, HSP90 provided a physical link 
between RAR1 and SGT1 action and NB-LRR protein stability.  In addition, NB-LRR 
protein levels were found to decrease in both HSP90-silenced tobacco plants and in 
the specific hsp90.2 ATPase mutants in Arabidopsis (Hubert et al., 2003; Lu et al., 
2003).   
Previous work in yeast indicated that ATPase activity was essential for 
HSP90 function.  In yeast, an ATPase-mutant allele of HSP90 was unable to 
complement an hsp90 null mutant (Borkovich et al., 1989; Obermann et al., 1998; 
Panaretou et al., 1998).  Further work showed that yeast carrying the ATPase-
mutant allele resembled those with the null mutant even in the presence of wild-type 
HSP90, indicating the presence of ATPase-mutant HSP90 protein negatively 
regulates the function of wild-type HSP90 protein.  Therefore, it was reasoned that 
chemicals that blocked ATP binding and hydrolysis were inhibitors of HSP90 (Roe et 
al., 1999).  However, we present evidence below that ATPase domain mutations in 
hsp90 act differently than null alleles.  Our data resurrect a previously dismissed 
theory that HSP90 is an ATP-independent molecular chaperone (Wiech et al., 1992). 
Additionally, we show genetic interaction between HSP90.2 and SGT1b.  This 
demonstrates for the first time a biological relevance for the SGT1/HSP90 physical 
interaction with respect to disease resistance phenotypes.  We identify a previously 
unobserved role for HSP90.2 and SGT1b in RPS2 function, partially resolving the 
paradox presented by the previously observed specificity of hsp90.2 mutation on 
RPM1 function.  We also explore diversification of HSP90 isoform function, and a 
requirement for a minimum level of HSP90 for Arabidopsis survival.  Finally, we 
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present an analysis of RAR1/HSP90/SGT1 interactions using yeast two hybrid 
methods which potentially explains the phenotypes of previously recovered mutants 
of rar1 and hsp90.2. 
 
Results 
HSP90 expression and analysis of loss-of-function mutations in Arabidopsis
HSP90 paralogs 
 We previously demonstrated that specific point mutations within the ATPase 
domain of Arabidopsis hsp90.2 lead to specific decline of RPM1 function (see 
Chapter 2 and Hubert et al., 2003).  No such mutations were found in the other three 
paralogs of cytosolic HSP90.  Differences in the expression level of the different 
isoforms might explain this result.  Due to the extremely high degree of homology 
between the four HSP90 genes (79-96% nucleotide identity), we were unable to 
generate unique primer pairs to differentiate 3 different isoforms of HSP90 
(HSP90.1, HSP90.2, and HSP90.3), therefore semi-quantitative RT-PCRs were 
unsuccessful.    
Rather than directly measure transcript abundance, we used the publicly-
available Arabidopsis Massively Parallel Signature Sequencing (MPSS) database 
(Meyers et al., 2004).  Since this dataset is created through the direct sequencing of 
unique signature sequences rather than through hybridization techniques, the MPSS 
database is one of the few datasets able to address the differential abundance of 
these highly-homologous transcripts.  We found that while all isoforms are  
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No. of Specific 
Sequence Tags 
Identified   
  Isoform AGI # untreated 0.3 mM SA   
  HSP90.1 At5g52640 11 55   
  HSP90.2 At5g56030 135 1670   
  HSP90.3 At5g56010 13 0   
  HSP90.4 At5g56000 20 7   
            
            
 
Table 5.1: HSP90.2 shows higher levels of expression than any other HSP90 
isoform.  Total number of unique sequence tags identified for each HSP90 isoform 
in untreated 3-week-old leaves or 52 hours after treatment with 0.3 mM salicylic 
acid.  Data obtained from the Arabidopsis MPSS database.  20 bp signature 
sequence data is shown.   
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expressed in leaves, HSP90.2 showed the highest expression levels (Table 5.1).  
Interestingly, after treatment with salicylic acid, a plant hormone involved in disease 
resistance, both HSP90.1 and HSP90.2 showed a five- to ten-fold increase in levels, 
while HSP90.3 and HSP90.4 actually showed a decrease in expression. 
We previously observed that a T-DNA insertion within hsp90.2 had no 
obvious phenotype.  We assumed that this lack of phenotype was due to 
compensation by other isoforms of HSP90.  We next looked to see if this was the 
case for all isoforms of cytosolic HSP90.  In order to address this question, we 
obtained T-DNA insertions within all isoforms of cytosolic HSP90 and looked for an 
effect on plant disease resistance. 
 We initially investigated the effect of these mutations on the function of 
RPM1.  The T-DNA insertion allele of hsp90.2, henceforth hsp90.2KO, showed 
complete resistance to Pto DC3000 (avrRpm1), similar to wild-type plants.  
Insertions in the other three isoforms of HSP90 also showed full resistance to this 
pathogen.  This suggests redundancy- that other isoforms can compensate for the 
loss of any particular HSP90 isoform (Figure 5.1A).  This result is consistent with the 
yeast data that suggested that expression of ATPase-impaired hsp90 can attenuate 
the function of wild-type HSP90. 
 We next determined whether this pattern held true for the function of another 
R gene.  The RPS2 protein recognizes the avirulence protein AvrRpt2.  It has been 
previously reported that a T-DNA insertion in hsp90.1 partially compromises the 
RPS2 pathway (Takahashi et al., 2003).  We independently obtained homozygous 
mutant plants carrying the same T-DNA insertion previously reported to have the 
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Figure 5.1: Null alleles of hsp90 isoforms do not affect disease resistance.  
Bacterial growth assays assaying (A) RPM1- and (B) RPS2-mediated resistance for 
T-DNA insertion lines corresponding to each of the four isoforms of HSP90.  Note 
that the slight increase in growth seen in the hsp90.4 insertion is not reproducible.  
None of the insertions show an increase in bacterial growth compared to wild-type. 
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strongest effect on RPS2 function.  In contrast to the results reported by Takahashi 
et al., we did not detect any difference in growth of bacteria expressing avrRpt2.  
Additionally, we were unable to observe an effect on the RPS2 pathway by knock-
outs in any of the other three isoforms of HSP90, identical to the results observed for 
the RPM1 pathway (Figure 5.1B). 
 
Genetic interactions between hsp90.1 and hsp90.2 
 HSP90.1 is the most highly divergent HSP90 isoform and shows the second 
highest level of expression of all HSP90 paralogs (Table 5.1 and Krishna and Gloor, 
2001).  Although HSP90.1 is located on Chromosome V like the other three isoforms 
of HSP90, it does not belong to the same syntenic group. The combination of these 
three attributes led us to explore HSP90.1’s relationship to the other three isoforms.   
As stated previously, we did not observe a phenotype directly attributable to 
loss of hsp90.1, possibly because the other isoforms are able to compensate for 
hsp90.1’s absence.  We crossed hsp90.2KO, hsp90.3KO, and hsp90.4KO to 
hsp90.1KO.  In the F2 generation, we were able to identify individuals of genotypes: 
hsp90.1KO/hsp90.1KO hsp90.2KO/HSP90.2, hsp90.1KO/hsp90.1KO 
hsp90.3KO/HSP90.3, and hsp90.1KO/hsp90.1KO hsp90.4KO/HSP90.4.  In the 
context of a homozygous hsp90.1KO mutant, hsp90.3KO heterozygous and 
hsp90.4KO heterozygous genotypes resulted in wild-type appearance.  However, 
hsp90.1KO homozygous hsp90.2KO heterozygous plants exhibited dwarfed stature 
and low fecundity, producing less than 50 µL of seeds per plant compared to the 
 157
greater than 500 µL of seeds per plant produced by its siblings grown in the same 
flat.   
Furthermore, we were able to identify homozygous hsp90.1KO hsp90.3KO 
and hsp90.1KO hsp90.4KO double mutant plants which were wild-type in 
appearance.  However, we were unable to isolate hsp90.1KO hsp90.2KO double 
mutant plants. This synthetic lethality suggests that for at least one normal 
physiological function, either there is no longer enough total HSP90 left in these 
plants to maintain HSP90 function, or that HSP90.2 and HSP90.1 play redundant 
roles for which the remaining two isoforms are unable to compensate. 
Drugs that inhibit HSP90 ATP hydrolysis are referred to as HSP90 inhibitors 
(Jez et al., 2003; Roe et al., 1999; Stebbins et al., 1997).  Contrary to this 
nomenclature, our results indicate that loss of ATPase activity leads to a gain-of-
function phenotype inconsistent with a simple loss-of-function mutation (Hubert et 
al., 2003).  However, we could not exclude the possibility that the gain-of-function 
nature of our mutation was due to the mutation acting in a dominant negative fashion 
over the other HSP90 isoforms.  The lethality of hsp90.1KO hsp90.2KO gave us a 
clear phenotype for hsp90.2 loss of function (albeit in combination with hsp90.1), 
and afforded us the possibility of directly testing the functional nature of our 
hsp90.2ATPase mutant.   
We immediately saw a phenotypic difference between the knock-out and 
ATPase alleles in the F2 generation of a cross between hsp90.1KO and 
hsp90.2ATPase.  Using allele-specific markers, we found that whereas 
hsp90.1KO/hsp90.1KO hsp90.2KO/HSP90.2 plants exhibited the dwarf phenotype 
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mentioned above, plants of genotype hsp90.1KO/hsp90.1KO 
hsp90.2ATPase/HSP90.2 were completely wild-type in appearance.  If the ATPase 
mutation was a dominant negative, we would expect the dwarf phenotype of the 
knock-out or a stronger phenotype if this allele interfered with the function of 
HSP90.3 and HSP90.4 as has been previously asserted (Panaretou et al., 1998).   
We continued to the next generation, and were easily able to identify the 
hsp90.1KO/hsp90.1KO hsp90.2ATPase/hsp90.2ATPase double mutant, again in 
contrast to the lethality of hsp90.1KO hsp90.2KO.  This implies that loss of ATPase 
domain activity is not equivalent to full loss of HSP90 activity, and as a corollary, that 
ATPase inhibitors are not necessarily inhibiting all HSP90 activities.   
ATPase mutants of hsp90.2 cause intermediate loss of RPM1 function when 
compared to an rpm1 mutant and are wild-type for RPS2 function.  Given our 
demonstration of a strict requirement for HSP90.1 and HSP90.2 in viability, the 
possibility existed that this partial loss of RPM1 function and absence of effect on the 
RPS2 pathway was due to interference or compensation by HSP90.1 with the 
activity of hsp90.2ATPase.  Consequently, we assayed our hsp90.1KO hsp90.2ATPase 
double mutant for effects on disease resistance.  This double mutant displayed the 
same phenotypes as the hsp90.2ATPase single mutant: an intermediate phenotype 
for the RPM1 pathway (Figure 5.2A) and no effect on RPS2 function (Figure 5.2B). 
These data strongly suggest that the intermediate affect on RPM1-mediated 
resistance and the lack of effect on RPS2-mediated resistance is not due to 
interference or compensation by HSP90.1. 
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Figure 5.2: hsp90.2ATPase mutations do not show additivity with hsp90.1KO 
mutants and do not act in a dominant fashion over other HSP90 isoforms. 
Bacterial growth assays assaying (A) RPM1- and (B) RPS2-mediated disease 
resistance.  While hsp90.1KO hsp90.2KO double mutants are nonviable, hsp90.1KO 
hsp90.2ATPase double mutants display the hsp90.2ATPase mutant phenotype.   
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Genetic interaction of hsp90.2ATPase with sgt1b  
 rar1 and hsp90.2ATPase mutants share a similar phenotype: loss of RPM1 
accumulation (Figure 4.3; Hubert et al., 2003; Tornero et al., 2002b).  These two 
proteins interact in yeast two hybrid and co-IP experiments, suggesting that the loss 
of RPM1 in these mutant backgrounds is likely due to a common mechanism.  
SGT1b, another protein shown to have a role in plant disease resistance, also 
interacts with both RAR1 and HSP90 in yeast two-hybrid and co-IP experiments 
(Hubert et al., 2003; Liu et al., 2004; Takahashi et al., 2003).  In addition, SGT1b 
interacts with several proteins shown to play a role in proteasome-dependent protein 
degradation (Azevedo et al., 2002), suggesting that it might direct substrates to the 
proteasome.  Consistent with this observation, sgt1b can suppress rar1 deficiency 
for several NB-LRR functions, including resistance mediated by  RPP4, RPP8, and 
RPS5 (Holt III et al., 2005).  Additionally, these authors demonstrated that RPS5 re-
accumulated in the rar1 sgt1b double mutant, showing that RAR1 and SGT1b act 
antagonistically. 
 We were therefore interested in the genetic interactions between rar1, sgt1b, 
and hsp90.2ATPase mutants.  We generated the rar1 hsp90.2ATPase double mutant.  
This double mutant exhibited the rar1 phenotype: full loss of RPM1 function (data 
not shown).  No additivity was discernible, consistent with these two genes operating 
in the same pathway.  Quantification of bacterial growth confirmed the visual assay 
(Y. He, unpublished data).    
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Figure 5.3: hsp90.2ATPase and sgt1b display a synthetic genetic interaction 
and both play a role in RPS2-mediated resistance.  Bacterial growth assays 
assaying (A) RPM1- and (B) RPS2-mediated resistance for the hsp90.2ATPase sgt1b 
double mutant.  While there is no consistent difference for RPM1-mediated 
resistance, the hsp90.2ATPase sgt1b double mutant displays decreased RPS2-
mediated resistance. 
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When hsp90.2ATPasesgt1b plants were assayed for visible symptoms 
indicative of disease susceptibility following inoculation with Pto DC3000 (avrRpm1), 
this double mutant appeared to be more susceptible than the hsp90.2ATPase single 
mutant and certainly more susceptible than the fully resistant sgt1b single mutant.  
Quantification of bacterial growth was less consistent.  While we were able to see 
slightly more growth (5X greater than hsp90.2ATPase) in one experiment, two 
subsequent experiments showed no difference (Figure 5.3A).  On the other hand, a 
clear and reproducible difference was seen when this double mutant was assayed 
for RPS2 function by infection with DC3000 (avrRpt2).  While neither single mutant 
affects RPS2 function, we were consistently able to see 100X more growth of 
bacteria in the double mutant (Figure 5.3B).  Such a synthetic interaction is not 
unexpected for two genes whose products physically interact (Han et al., 2004).  
However, this result was surprising, since we expected a sgt1b mutant to have either 
no effect on the hsp90.2ATPase phenotype or for sgt1b to suppress hsp90.2ATPase 
as it does for rar1 (Holt III et al., 2005).  When we probed RPS5 function using 
DC3000 (avrPphB), we found between 5X-10X more growth (data not shown), a 
similar though less dramatic result as found with DC3000 (avrRpt2).  These results 
validate the previously observed physical interaction between HSP90 and SGT1b, 
and also show that this physical interaction has previously undemonstrated 
functional consequences for NB-LRR function.  Furthermore, these results show that 
both HSP90.2 and SGT1b play a previously unobserved role in RPS2 and RPS5 
mediated resistance. 
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Physical interaction between hsp90.2ATPase domain mutants and RAR1 or  
SGT1 
 We were interested in addressing how the different ATPase domain mutants 
affected the physical interaction between HSP90.2 and RAR1 and SGT1 for two 
reasons. First, we wanted to further investigate the synthetic genetic interaction 
observed between sgt1b and hsp90.2ATPase mutations described in the previous 
section.  This observation raises the possibility that the ATPase point mutations 
function by altering the interaction between HSP90.2 and SGT1b.  Secondly, one of 
the hsp90.2ATPase point mutations, S100F, was previously found to have a partially 
penetrant phenotype as opposed to the fully penetrant phenotype of the other 
hsp90.2ATPase alleles (Hubert et al., 2003).  I proposed that this phenotypic 
difference may be attributable to differences in how the partially penetrant allele 
interacts with RAR1 and/or SGT1. 
Full length cDNAs corresponding to RAR1, SGT1a, SGT1b and HSP90.2 
were cloned into LexA yeast two hybrid system vectors, and all four isolated ATPase 
mutations were introduced into HSP90.2 by site-directed mutagenesis (see Chapter 
4 and Hubert et al., 2003).  As previously reported for the in vivo interactions 
between these proteins (Hubert et al., 2003), HSP90.2 interacted with RAR1 and 
SGT1b but not SGT1a (Figure 5.4A, B and C, first column).  HSP90 shows a 
preference to interact with SGT1b even though the two SGT1 isoforms are 87% 
similar at the amino acid level (Azevedo et al., 2002).  Because these controls 
worked as expected, the yeast interaction system can serve as a suitable proxy for  
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Figure 5.4: hsp90.2ATPase domain mutants lose the ability to interact with 
RAR1 and SGT1b.  The interaction of HSP90.2 and hsp90.2 ATPase domain 
mutants with (A) RAR1, (B) SGT1b, or (C) SGT1a as quantified by β-galactosidase 
activity in yeast-two-hybrid assays.   Miller units were calculated as 1000 X 
OD420/(OD600 X time in minutes).  Fully penetrant point mutants completely lose 
interaction with RAR1 and SGT1b, while the partially penetrant S100F mutant 
maintains strong interaction with RAR1. (D) Western blot analysis of yeast protein 
extracts probed with anti-HA antibody to show HSP90 levels.  This panel shows that 
the differences observed in A and B are not due to differences in expression level.   
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in planta interactions.  We found that the three fully-penetrant alleles of 
hsp90.2ATPase were unable to interact with either RAR1 or SGT1b.  This includes 
the D80N mutant which has been shown to be unable to bind ATP in vitro 
(Panaretou et al., 1998).  Western blot analysis of accumulation of HSP90 showed 
that these results were not due to changes in accumulation level.  Since  the three 
fully penetrant hsp90.2ATPase mutant proteins are completely unable to interact with 
SGT1b, the hsp90.2ATPase mutant phenotype is unlikely be due to titration of 
SGT1b from a RAR1/SGT1b complex. Similarly, the synthetic phenotype observed 
in the sgt1b hsp90.2ATPase double mutants with respect to RPS2 function is likely 
not due to a loss of residual SGT1b binding to hsp90.2ATPase mutant proteins.   
Interestingly, while the partially-penetrant allele S100F also lost the ability to 
interact with SGT1b, it maintained a strong interaction with RAR1 (Figure 5.4A, last 
column).  This suggests that loss of interaction with RAR1 is a likely cause of the 
fully penetrant hsp90.2ATPase phenotype.   
 
Detailed analysis of RAR1 and HSP90.2 physical interactions 
 The apparent importance of RAR1 for HSP90 function led us to investigate 
the interaction between these two proteins in more detail.  As has been previously 
shown (Azevedo et al., 2002), we observed RAR1 interaction with HSP90, and also 
with both SGT1a and SGT1b.  Unlike HSP90, RAR1 does not show a preference for 
either isoform of SGT1.  RAR1 is composed of three domains:  two CHORD 
domains separated by the CCCH domain.  By creating truncations of RAR1, we 
were able to isolate the interaction between RAR1 and SGT1a or SGT1b to the 
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Figure 5.5: Structure/function analysis of RAR1.  (A) Results of yeast-two-hybrid 
assays between HSP90, SGT1a, or SGT1b and various RAR1 truncations and point 
mutations.  Strong interaction is shown as dark blue rectangles marked with a “+”, 
weak interaction is shown as light blue rectangles marked with “+/-“, and loss of 
interaction is signified as a light yellow rectangle marked with a “-“.  Interaction with 
HSP90 maps to the CHORDI domain, while interaction with SGT1 maps to the 
CHORDII domain.  C49, within CHORDI, is necessary for the HSP90 interaction, 
and H217, within CHORDII, is fully required for the interaction with SGT1b, but only 
partially required for the interaction with SGT1a.  (B) Alignment of the CHORDI and 
CHORDII domains of RAR1 displaying position of point mutants shown in panel A.  
Positions of nonsense and missense mutations described in text are also shown.   
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CHORDII domain, consistent with previous analysis (Azevedo et al., 2002).  
Additionally, we found that the CHORDI domain was necessary and sufficient for the 
HSP90/RAR1 interaction as was inferred previously in planta (Hubert et al., 2003).
 We previously reported that a nonsense mutant of RAR1 leading to a 
premature stop at amino acid position 52, rar1-21, was able to co-immunoprecipitate 
HSP90 even though no RAR1 protein was detectable by western blot (Figure 2.9; 
Figure 5.5B; Hubert et al., 2003).  However, it was also discovered at the same time  
that another nonsense mutant only five amino acids shorter, rar1-28, was unable to 
co-immunoprecipitate HSP90 (Y. Belkhadir, unpublished data).  Two possible 
explanations existed for this result.  Either this shorter fragment was less stable than 
the rar1-21 fragment, or those five amino acids were required for the interaction.  We 
noticed that the previously isolated point mutant rar1-26 (C49Y), was able to 
accumulate a significant amount of RAR1 protein, but still had a complete loss-of-
function phenotype (Tornero et al., 2002b).  This suggested that this residue could 
account for the differential interaction between rar1-21 and rar1-28 and HSP90. 
We introduced the C49Y mutation into our yeast-two-hybrid clones and found 
that this Cysteine residue alone was necessary for the interaction with HSP90, but 
not for interaction with SGT1a and SGT1b (Figure 5.5A).  A mutation with a 
presumably less-severe effect on protein structure, C49A, was also introduced with 
the same result.  Additionally, by introducing this mutation into our truncated RAR1 
variants, we were able to engineer a peptide which completely lost interaction with 
both HSP90 and SGT1 (Figure 5.5A).   
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A mutation in the second cysteine of this pair (the analogous CHORDII 
residue of C50), C197, in the CHORDII domain has also been isolated, rar1-15 
(Figure 5.5B).  We recreated this C197Y mutation to test if a mutation in this 
cysteine pair in CHORDII would block interaction with SGT1.  Surprisingly, this 
mutation did not affect the RAR1 interaction with SGT1a, SGT1b or with HSP90. We 
then created a CHORDII mutation analogous to the CHORDI C49Y mutation, 
C196Y, and the double cysteine mutation C196Y C197Y to determine if either of 
these cysteines in CHORDII is necessary for the interaction with SGT1 like the first 
cysteine in this pair in CHORDI is necessary for the interaction with HSP90.  Neither 
of these affected the RAR1 interaction profile (Figure 5.5A).  To rule out the 
possibility of CHORDI compensating for the loss of CHORDII interaction with SGT1, 
we created a triple mutant, C49Y C196Y C197Y.  While this mutant lost interaction 
with HSP90 as expected, the interactions with SGT1 and SGT1b were unaffected.  
Taken together, this data suggests that RAR1 interacts with HSP90 in a different 
way than with SGT1, since a residue (C49) in CHORDI necessary for interaction 
with HSP90 is not necessary in CHORDII (C196) for the interaction with SGT1. 
 Recently, a new mutation of RAR1 has been reported, H217Y (Shang et al., 
2006).  The authors show that, while RPM1 function is abolished, this allele is still 
able to produce a significant amount of RAR1 protein.  Furthermore, they 
demonstrate in yeast two hybrid assays that while interaction with HSP90 was 
maintained, the H217Y mutant allele lost the ability to interact with SGT1b.  We re-
created these constructs and independently confirmed these results.  However, in 
contrast to the loss of interaction with SGT1b, RAR1 interaction with SGT1a is not 
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completely abolished.  This suggests that like HSP90, RAR1 interacts differently with 
SGT1a and SGT1b.  This mutation was also introduced into our RAR1 truncation 
variants with expected results, namely loss of SGT1b interaction and a weak SGT1a 
interaction.  Finally, we introduced both the C49Y and H217Y mutations in a single 
RAR1 construct.  As expected, this construct was unable to interact with either 
HSP90 or SGT1b. 
 
Discussion 
 We present here a detailed analysis of the genetic and physical interactions 
underlying the HSP90/RAR1/SGT1 machinery responsible for maintaining steady 
state levels of NB-LRR protein accumulation.  Our data suggest that different HSP90 
“client” proteins may have distinct requirements for HSP90 isoform homo- and 
heterodimers in Arabidopsis. Our data reveal genetic interactions between two 
isoforms of HSP90 and between hsp90.2 and sgt1b.  We prove that, contrary to 
accepted dogma, loss of ATP binding and subsequent hydrolysis does not equate to 
full loss of HSP90 function.  Furthermore, we demonstrate a novel synthetic role for 
HSP90.2 and SGT1b in RPS2-mediated disease resistance in Arabidopsis.  In 
addition, we explored the physical interactions between HSP90, RAR1, and SGT1 
using point mutations in HSP90.2 and RAR1 and truncations of RAR1.  These 
results may explain the phenotypes of hsp90.2ATPase mutants and of rar1 missense 
mutations. 
 
The role of individual HSP90 isoforms in disease resistance and plant growth 
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 Based on expression data, one likely reason that only mutations in hsp90.2 
are recovered in forward genetic screens for loss of RPM1 function becomes 
apparent.  HSP90.2 is expressed at higher levels (nearly 40-fold greater) than all 
other isoforms combined.  It may be counterintuitive, then, that the seemingly 
insignificant additional decrease in total HSP90 levels caused by combining T-DNA 
insertions in hsp90.1 and hsp90.2 leads to lethality.  However, it proves that this 
system is finely balanced, and while redundancy allows for major perturbation of 
HSP90 levels without obvious effect as seen in Figure 5.1, some HSP90 threshold 
level needs to be maintained.  This is perhaps most saliently seen in HSP90 
silencing experiments in tobacco (Liu et al., 2004; Lu et al., 2003).  Adult plants 
silenced for HSP90 show heavy pleiotropism including stunting and leaf deformation.  
Effects were so severe that at times they proved lethal to the plants.   
  
Loss of HSP90 ATPase activity does not equal loss of HSP90 function 
 While gene duplications in plants are often a hindrance to studies of gene 
function, the duplication of HSP90 in Arabidopsis has enabled us to obtain data that 
are impossible to acquire in systems with only one or two copies of HSP90.  The 
hypothesis that loss of ATP hydrolysis is synonymous with loss of HSP90 function 
arose when point mutations in the ATPase domain of HSP90 were first assayed for 
their ability to rescue yeast lacking any wild-type HSP90.  Yeast lacking HSP90, as 
well as yeast expressing only the ATPase domain mutant, synonymous with the 
ATPase domain mutant used here, displayed the same lethality (Obermann et al., 
1998; Panaretou et al., 1998).  Dead men tell no tales, and it is not possible to assay 
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dead hsp90ATPase mutant yeast to discern if they die in the same way as HSP90 
nulls.  If the hsp90.1KO hsp90.2ATPase double mutant used here had been lethal, we 
would have reached the same conclusion.  Even in yeast, however, there were clues 
that ATPase mutations are not null mutations, specifically when it was found that 
overexpression of these ATPase mutants showed a semi-dominant negative effect 
on yeast growth in the presence of wild-type HSP90 (Panaretou et al., 1998).  At the 
time, this was attributed to sequestering of client proteins or co-chaperones, i.e. that 
an ATPase mutant is null for function and also blocks wild-type HSP90 by 
binding/titrating other proteins required for function.  However, this would imply that 
these mutants are “more null than a null.” 
Our results suggest another hypothesis.  When HSP90 chaperone activity 
was first described in vitro, it was shown to work in an ATP-independent manner 
(Jakob et al., 1995; Wiech et al., 1992; Yonehara et al., 1996).  While previous 
reports have tried to reconcile the in vitro results with the in vivo results by 
suggesting ATP-dependent and ATP-independent steps in chaperone activity, that 
hypothesis is inconsistent with our results (Panaretou et al., 1998).  If such were the 
case, our ATPase mutants would nevertheless be impaired in chaperone activity, 
and would have a phenotype at least as severe as the null. 
Rather, our results suggest that HSP90 actually has two separate activities: 
one ATP-independent activity and one ATP-dependent or, to be more precise, ATP 
regulated activity (see below).  Since in vitro “chaperoning” has been shown to occur 
in an ATP-independent fashion, it is possible that this represents the apparent ATP 
independent activity.  This ATP-independent activity is absent in HSP90-silenced 
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plants and in hsp90.1KO hsp90.2KO double mutants, and is thus necessary for plant 
survival as has been previously shown for yeast (Borkovich et al., 1989).  R proteins 
are unstable in both HSP90-silenced lines and in our ATPase domain mutant 
suggesting that both activities are required for R protein accumulation. 
 
HSP90 maintains client protein steady state levels by an active mechanism 
We will now consider the ATP-dependent activity of HSP90.  Loss of ATP 
binding leads to a gain-of-function phenotype based on the comparison between the 
hsp90.2ATPase and the hsp90.2KO single mutants (Hubert et al., 2003).  This 
excludes the possibility of ATPase mutations being hypomorphic.  Thus, the loss of 
ATP binding and subsequent hydrolysis is either neomorphic or hypermorphic.  It is 
highly unlikely, given the conservation of the ATPase domain, that changes in ATP 
hydrolysis rates can be truly neomorphic.  In fact several known co-chaperones are 
known to modulate ATPase rates either positively or negatively (Panaretou et al., 
2002; Richter et al., 2004).  This suggests that, in contrast to the accepted belief that 
loss of ATPase activity is equivalent to loss of HSP90 activity, loss of ATPase 
activity actually leads to higher HSP90 activity, i.e. that the ATPase domain is a 
negative regulatory domain.  Given that the phenotypic output of a gain-of-function 
ATPase mutant is loss of client protein accumulation, the wild type ATP-regulated 
activity must negatively regulate client protein levels.   
It has previously been shown that loss of ATPase activity causes HSP90 to 
have higher affinity for its client proteins, which could provide a mechanism for how 
the ATP-independent and ATP-regulated activities are linked in one protein (Young 
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and Hartl, 2000).  If a protein is grossly misfolded or at too high a concentration, one 
would expect that the time spent in interaction with HSP90 would increase, either 
due to increased chaperoning or due to simple concentration-dependent on/off rates.  
If increased interaction time also leads to higher ATP-regulated activity, then HSP90 
would cause removal of the client protein from the cellular pool in both cases.  In 
fact, we are unable to exclude the possibility that HSP90 is acting as an additional 
subunit of the SCF or proteasome complex (Eleuteri et al., 2002), as HSP90 can 
interact with SKP1 via SGT1 (Catlett and Kaplan, 2006; Lingelbach and Kaplan, 
2004) and  is required for the assembly of the 26S proteasome (Imai et al., 2003). 
 
HSP90 co-factors also separate HSP90 nurturing and destroying activities 
If the ATPase domain acts to balance HSP90 between its ATP-independent 
function and ATP-regulated functions, then one would expect HSP90 co-factors to 
also be able to differentiate between these two activities.  Since the in vitro 
chaperoning function can occur in the absence of other co-factors, one would expect 
that many of these ATPase modulating co-factors would be non-essential to living 
cells.  In fact, while it was found very early that HSP90 is an essential protein, 
phenotypes for loss of HSP90 co-factors have been much harder to identify 
(Borkovich et al., 1989).  The yeast homolog of the HSP90 co-factor P23, SBA1, has 
been shown to decrease HSP90 ATPase activity. However, deletion of SBA1 has no 
immediate effect on client protein function and the only phenotype found for SBA1 
deletion mutants is an increased sensitivity to inhibitors of HSP90 ATPase activity 
(Bohen, 1998). 
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Figure 5.6: Schematic genetic models of possible RAR1, SGT1, and HSP90 
interactions and their relative effects on R protein stability. All three models 
show the HSP90 ATPase domain acting as a negative regulator of HSP90 activity 
consistent with the data presented in this manuscript.  This also implies that HSP90 
normally functions to decrease R protein levels.  (A) shows the possibility of a direct 
linear pathway controlling HSP90 function.  (B) shows a pathway in which RAR1 and 
SGT1 antagonize each other via HSP90.  (C) shows a hybrid model of (A) and (B) in 
which RAR1 and SGT1 antagonize each other not only via HSP90 but also directly. 
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RAR1 has been shown to be required for maximal accumulation of R 
proteins.  It has also been shown that the decrease in R protein accumulation in a 
rar1 mutant is dependent on SGT1b (Holt III et al., 2005), and that functional R 
proteins are produced in the absence of both RAR1 and SGT1b.  Consequently, 
these proteins may not be necessary for HSP90’s role in chaperoning, and must be 
regulating some other aspect of HSP90 function.  Therefore, these proteins might 
act to control HSP90 ATPase rates.  Effects of RAR1 on HSP90 ATPase rates have 
not been reported so far.  While one report shows no SGT1 effect on HSP90 
ATPase rates, it did not take demonstrated concentration ratios necessary for effects 
on HSP90 ATPase rates into account (Catlett and Kaplan, 2006; Lee et al., 2004; 
Richter et al., 2004). 
 
Possible models explaining the functional interactions between
RAR1/SGT1/HSP90 
 In this manuscript we show a clear genetic interaction between HSP90 and 
SGT1b.  This proves that our previously described physical interaction between 
these two proteins is biologically relevant (Hubert et al., 2003).  sgt1b is able to 
suppress a rar1 mutant which supports the functional validity of their physical 
interaction (Azevedo et al., 2002; Holt III et al., 2005; Liu et al., 2002b).  Our result 
that a partially-penetrant allele of hsp90.2 maintains physical interaction with RAR1 
supports the requirement of this physical interaction for HSP90 function.  Recently, 
mutations outside the ATPase domain of hsp90.2 were found to suppress a rar1 
mutant phenotype (Y. He, unpublished data).  While the consequences of these 
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missense mutations on hsp90.2 function are currently unclear, it supports evidence 
presented here in two ways.  First, HSP90.2 represents the predominant isoform 
involved in plant disease resistance with six total mutations in hsp90.2 versus none 
in another isoform.  Second, the previously observed physical interaction between 
RAR1 and HSP90.2 also has biological relevance (Hubert et al., 2003).  
Consequently these three proteins all interact with each other both physically and 
genetically. 
 Based on our genetic data we generated models explaining the relationships 
between HSP90, RAR1 and SGT1 (Figure 5.6).  hsp90.2 and sgt1b likely act 
downstream of RAR1 as they both can act to suppress rar1.  While sgt1b is unable 
to suppress an hsp90.2ATPase mutant, the structural homology of the CS domain of 
SGT1 to the HSP90 co-chaperone P23 suggests that SGT1b also modulates HSP90 
ATPase activity. 
 As stated previously, it appears that the ATPase domain of HSP90 acts as a 
negative regulatory domain of HSP90 function.  The loss of client protein 
accumulation found after treatment with HSP90 ATPase inhibitor has been shown to 
be reversible by proteasome inhibitors (Segnitz and Gehring, 1997; Whitesell and 
Cook, 1996).  To our knowledge, this has not been demonstrated for ATPase 
domain mutants, but we expect that it will be the case since both mutation and 
inhibitor block ATP hydrolysis.  Thus it is reasonable to predict that the ATP-
regulated activity feeds client proteins into the proteasome.  This output and its 
inhibition by HSP90 ATPase activity is the basis of all of our models (Figure 5.6). 
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 The relationship of HSP90 ATPase activity with RAR1 and SGT1 is less clear.  
Since the CS domain of SGT1 folds similarly to P23, a protein with known effects on 
HSP90 ATPase rates, it is plausible that SGT1 directly modulates HSP90 ATPase 
activity.  Thus all of our models show a direct effect of SGT1 on HSP90 ATPase 
rates.  We can also predict that SGT1 negatively regulates ATPase rates for two 
reasons.  The first is that P23 decreases ATP hydroysis rates, and the other is that 
sgt1b mutants cause R protein levels to increase in a rar1 mutant background which 
can be explained by higher rates of HSP90 ATP hydrolysis in a sgt1b mutant (Holt III 
et al., 2005). 
 The placement of RAR1 in this pathway is problematic.  We know that 
functionally it acts upstream of HSP90, since hsp90.2 mutants can act as 
suppressors of rar1.  However, the ability of sgt1b to suppress rar1 places SGT1b 
downstream of RAR1 function.  A direct linear model where SGT1 acts as an 
intermediary between RAR1 and HSP90 explains the genetic data, but discounts the 
physical association between RAR1 and HSP90 (Figure 5.6A).  To explain the lower 
R protein levels observed in a rar1 mutant, RAR1 may either directly increase 
ATPase rates (Figure 5.6B) or indirectly increase ATPase rates by negatively 
regulating SGT1 (Figure 5.6A).  These two models are not mutually exclusive, as 
RAR1 and SGT1 may be able to antagonize each other directly through their 
interaction, while at the same time antagonizing each other indirectly through their 
interaction with the ATPase domain of HSP90 (Figure 5.6C).  This last model also 
explains the correlation between our partially-penetrant mutant phenotype and its 
loss of interaction with SGT1b but not RAR1.  
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 These models are unable to explain two observations.  The first is the 
synthetic genetic interaction between hsp90.2ATPase and sgt1b.  They also cannot 
explain the fact the sgt1b alone cannot suppress rar1 for all R gene pathways 
tested, or that the two mutants show additivity for some pathways.  However, the 
action of other isoforms of HSP90 and of the other isoform of SGT1 may explain 
these inconsistencies. 
While the fact that these proteins work together was found using biochemical 
techniques, the phenotypic relevance of these interactions has been shown utilizing 
epistasis analysis.  To test these models directly requires a return to biochemical 
techniques, specifically measurement of the effects of RAR1 and SGT1 on HSP90 
ATPase hydrolysis rates.  To that end we have set up in our lab a previously 
described method for determining HSP90 ATPase hydrolysis rates (Panaretou et al., 
1998).  We have purified wild-type HSP90.2 and found that its ATPase hydrolysis 
rates fall within previously described parameters (B. McNulty and DH, unpublished 
results).  The identification of residues which block RAR1’s ability to interact with 
HSP90 or SGT1 described here will enable us to directly test each of these models 
in vitro for RAR1’s role.  Mutations of SGT1b which block HSP90 and RAR1 
interaction separately are also available (Jack Peart, personal communication).  
These mutations have been introduced into protein expression vectors containing 
the cDNAs corresponding to each of these proteins, and protein expression and 
purification is underway.   
This manuscript offers a revealing look inside the genetic machinery 
regulating R protein accumulation.  There are much broader implications for these 
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results within plant science and medical science.  sgt1b was found to be an 
enhancer of a tir1 F-box mutant, and SGT1b overexpression can partially suppress 
tir1 (Gray et al., 2003).  HSP90 and the mammalian homolog of RAR1 have also 
recently been shown to play a role in regulation of NOD proteins, animal proteins 
involved in animal innate immunity similar to R proteins (Hahn, 2005).  Findings 
presented here may find applications in the treatment of human disease, as they are 
analogous to the innate immunities of animals.  Additionally, our findings of the 
difference between HSP90 ATPase inhibition and general HSP90 inhibition implies 
that suggested gene therapy approaches may have different and unexpected effects 
compared to pharmacological approaches currently being tested (Latchman, 2001; 
Sharp and Workman, 2006). 
 
Materials and Methods 
 
Plant lines 
All plant lines used in this manuscript are in the genetic background Col-0. 
The a11 line (Tornero et al., 2002b) contains Estradiol inducible avrRpm1.   
hsp90.2ATPase refers to hsp90.2-3 unless otherwise noted (Hubert et al., 2003).  
Additional mutant alleles used were rpm1-3 (Grant et al., 1995), rps2-101c 
(Mindrinos et al., 1994), and the edm1 allele of sgt1b (Tör et al., 2002).  hsp90KO 
lines (HSP90.1 At5g52640 SALK_075596, HSP90.2 At5g56030 SALK_058553, 
HSP90.3 At5g56010 SALK_013240 and SALK_040191, HSP90.4 At5g56000 
SALK_036835) were obtained as segregating populations from the Arabidopsis 
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Biological Resource Center (ABRC) and were originally created by the J. Ecker lab 
at the Salk Institute for Biological Studies.  Homozygous insertions were determined 
by presence of a PCR product for a primer pair corresponding to the left border of 
the T-DNA insert and a gene specific primer and absence of a PCR product for a 
primer pair found to give specific isoform amplification.  Homozygosity was 
confirmed in the next generation for all lines.  Primers are available upon request.  
Selection of homozygous sgt1bedm1 plants was made by western blot analysis 
utilizing a native antibody to SGT1 (D. Hubert, unpublished data), and confirmed in 
the next generation.  hsp90.2-3 homozygous plants were selected by a specific 
dCAPS marker.  (Primers and conditions available upon request.) 
 
Bacterial strains, inoculation, and growth quantification 
 Maintenance of Pto DC3000 containing the kanamycin selectable plasmid 
pVSP61 with an avrRpm1 or avrRpt2 insert was as described (Ritter and Dangl, 
1996).  Four- to five-week-old plants were spray-inoculated with 5 X 107 colony-
forming units/mL of Pto DC3000 (avrRpm1) in 10 mM MgCl2 and 0.02% silwet L-77 
(CKWitco Corporation).  These plants were then covered for four hours with a clear 
plastic lid and assayed for symptoms between four and seven days after treatment.  
Bacterial quantifications were performed as described (Tornero and Dangl, 2001).   
 
Estradiol induction and screening 
 Two-week-old short-day-grown plants were sprayed with 10μM β-Estradiol 
(Sigma E 8875)/ 0.02% Silwet L-77 in distilled water, diluted from a 10 mM β-
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Estradiol stock dissolved in 100% ethanol (Tornero et al., 2002a).  Trypan Blue 
staining was performed 5 days later (Koch and Slusarenko, 1990).  A light 
microscope with attached camera was used to obtain pictures of stained leaves 
(Nikon Eclipse). 
 
Semi-quantitative reverse transcription analysis 
To analyze HSP90 transcript levels, two-week-old seedlings were ground in 
liquid nitrogen and RNA was extracted with Trizol according to the manufacturer’s 
instructions (GibcoBRL).  RNA reverse transcription and RT-PCRs were performed 
according to the manufacturer's instructions (RETROscript, Ambion).   
 
Yeast two-hybrid 
cDNAs for RAR1 from an RT-PCR reaction are described above.  cDNAs 
corresponding to HSP90.2, SGT1a and SGT1b were obtained from ABRC.  These 
cDNAs were placed in pENTR D-TOPO cloning vectors (Invitrogen).  From the entry 
clone, cDNAs were recombined into pEG202gw and pJG4-5gw (kind gift of Hironori 
Kaminaka; described in Holt III et al., 2005).  Mutations were engineered using site-
directed mutagenesis with overlapping primer pairs containing a mismatch 
corresponding to the mutation (Ausubel et al., 1987).  These PCR products were 
then transferred into pENTR D-TOPO.  Directed interactions were performed using 
yeast strain EGY48 (Bieri et al., 2004).   β-galactosidase activity was performed as 
previously described (Kaminaka et al., 2006).  
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Protein blots 
3 mL overnight culture of HSP90 wild-type and mutant forms cloned into 
pJG4-5gw and transformed into EGY48 containing pEG202 were grown in Ura-His-
Trp- selective media.  Cultures were centrifuged and washed in 1 mL of cold distilled 
water containing 1 mM PMSF and 1 mM EDTA.  Samples were resuspended in 250 
µL 1X SDS-PAGE loading buffer, boiled for 5 minutes and vortexed for 1 minute with 
0.3 mL glass beads to lyse cells.  Samples were then centrifuged again to precipitate 
cellular debris. 30 μL of each sample was run on 8% SDS-PAGE gels. Western blots 
were performed with anti-HA (Roche) monoclonal antibody utilizing standard 
methods and detected with ECL (Amersham). 
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Chapter 6 
Conclusions and Future Directions 
Background and Significance 
 The pace of discovery in the field of plant disease resistance has continued to 
accelerate over the last decade.  During the same period our view of the molecular 
mechanisms underlying the activity of disease Resistance (R) proteins has radically 
changed.  We no longer believe that a simple receptor-ligand model holds true for 
recognition of all pathogen avr genes by R genes (Baker et al., 1997).  It is now 
apparent that many avr genes are recognized indirectly by their virulence effect on 
plant cellular targets (Dangl and Jones, 2001).  
 Upon their identification, it was widely believed that most if not all identified 
mutants affecting R gene function did so by directly affecting the resistance signal 
transduction cascade (Century et al., 1995; Tornero et al., 2002; Warren et al., 
1999).   Since then it has become evident that several of these loci act indirectly in 
the pathway by modulating the levels of NB-LRR type R proteins (Holt III et al., 
2005).  
 The work presented in this dissertation focuses on studying whether these 
mutants affecting R gene function alter R-protein levels.  Specifically, I established 
that one gene, LRA2, affects accumulation of the Arabidopsis R protein RPM1 and 
encodes cytosolic HSP90 (Chapter 2).  In contrast, I ascertained that the previously 
described mutant, ndr1, does not affect the levels of an R-protein known to fully 
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require NDR1 for function (Chapter 3). This suggests that NDR1 may in fact act in 
the R gene signal transduction pathway.  I helped extend the previously observed 
effect of rar1 on NB-LRR accumulation by showing that this finding was not specific 
for RPM1 accumulation (Chapter 3).  I additionally helped demonstrate that the rar1 
mutant phenotype can be suppressed by increasing levels and/or signaling of NB-
LRR proteins (Chapter 3).  I also identified new mutants affecting NB-LRR 
accumulation, including one that reveals the importance of transcriptional control 
(Chapter 4). 
 As well as identifying an effect on NB-LRR levels by different mutants, I also 
studied the mechanism involved in this process.  Data presented in Chapter 2 
demonstrates that RAR1/SGT1/HSP90 physically interact.  Genetic interactions 
between HSP90 and SGT1 presented subsequently in Chapter 5 validate the 
physical interaction’s biological relevance.  Additionally, I show that several 
phenotypic mutants of rar1 and hsp90.2 have defects in their ability to interact with 
other members of the RAR1/SGT1/HSP90 trinity (Chapter 5).  I also importantly 
demonstrate that the belief that HSP90 ATPase mutants are null or dominant 
negative alleles is ill-founded (Chapter 5).  This has important implications for our 
continued study of the role of HSP90 in plant disease resistance.  We are currently 
studying an ATPase allele of hsp90.2, whereas many groups are studying HSP90’s 
function using transient gene silencing. It is important to realize that the conclusions 
drawn from these experiments are not necessarily comparable.  I have shown that 
SGT1b plays a broader role in disease resistance than previously thought, and I also 
extended the known role of HSP90.2 (Chapter 5). 
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Future Directions 
 Much work remains to be done, especially for the work presented in Chapters 
4 and 5.  The new mutants described in Chapter 4 will allow us to identify new genes 
involved in R-gene mediated disease resistance, as they have already revealed new 
processes at work.  To this end, complementation analysis is ongoing.  Mapping has 
already commenced on another mutant with normal levels of RPM1 protein. 
Additionally, the 30 segregating mutant lines shown in Table 4.1 will be 
homozygotized, and included in our ongoing mutant analyses.  The transition of this 
project to other hands is well underway. 
 The models I describe in Chapter 5 are clearly and easily testable.  I have set 
up a system for testing these models and will soon know how the different HSP90 
mutations affect ATPase activity.  In order to determine the effects of RAR1 and 
SGT1 on ATP hydrolysis rates, I have already established conditions to express and 
solubilize RAR1 and SGT1.  This work is in conjunction with research being 
performed by Y. He in our lab on alleles of hsp90.2 that suppress a rar1 mutant 
phenotype.  Together we are currently extending the analysis presented in Chapter 
5 to these new alleles.   
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